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Genomic integrity in mouse embryonic and induced pluripotent stem cells can be 
compromised by factors such as extended time in culture and cellular reprogramming. 
Surprising, only a few studies have thus far examined the accumulation of 
chromosomal imbalances in mouse pluripotent populations upon prolonged 
propagation in vitro. It is presumed that specific recurring genetic changes can confer 
selective growth advantage and resistance to apoptosis and/or differentiation to the 
affected cells, although the genes that drive these processes remain elusive. The 
presence of these changes in published studies can confound the analysis of the data 
and hinder the reproducibility of the results.    
 
At the transcriptional level, aneuploidy manifests as large chromosomal regions of 
aberrant gene expression. This thesis presents a method to identify these regions in 
large-scale datasets and interrogate for recurrent patterns. The present analysis shows 
that over half of the 315 mouse pluripotent samples examined carry whole or partial-
chromosome spanning clusters of aberrant transcription. Furthermore, there are 
common gene expression changes across samples with any type of predicted 
aneuploidy and samples with chromosome-specific aberrations. These transcriptional 
signatures have been used to train classification models which can predict aneuploid 
samples with over 90% accuracy. This is an important step towards the development of 
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This thesis is concerned with the identification of aneuploidies and sub-chromosomal 
aberrations in mouse pluripotent stem cell populations by means of bioinformatics 
analysis of large collections of gene expression data. A number of recent studies have 
reported recurrent patterns of aneuploidy in human and mouse pluripotent cells that 
undergo culture for prolonged periods of time (Draper et al., 2004; Maitra et al., 2005; 
Baker et al., 2007; Amps et al., 2011; Laurent et al., 2011; Liu et al., 1997; Sugawara et 
al., 2006). These studies mainly perform conventional cytogenetic or array-based 
analysis to characterise the karyotype of the cells. However, the vast majority of 
published datasets in the field of stem cell biology consists of gene expression profiling 
data that are typically not accompanied with appropriate cytogenetic validation. When 
aneuploidies or other chromosomal alterations pass undetected in a sample, they may 
confound the experimental conclusions and hinder the reproducibility of the results. It 
has been shown that genomic changes can be detected at the transcriptional level as 
they can alter the expression levels of a high percentage of the genes present in the 
affected region (Pollack et al., 2002; Hyman et al., 2002; Schoch et al., 2006). It is 
therefore possible to use the transcriptional data for a first and quick test of the 
genomic integrity of the samples and several bioinformatics tools have been developed 
for this purpose ((Nilsson et al., 2008; De Preter et al., 2008; Callegaro et al., 2006) 
among others). Nonetheless, the application of these tools is still not common practise 
as indicated by the low number of stem cell related publications that report their use. 
This could be due to certain factors that might be limiting for the non-expert user such 
as the complexity of the computational model which they apply, lack of user-
friendliness or requirement of prior familiarisation with statistical or computational 
packages. This thesis aims to overcome these limitations by providing a powerful and 
intuitive software application that can be used for the analysis of gene expression data 
and the identification of underlying patterns of chromosomal aberrations.  
 
In addition, the present thesis is concerned with the discovery and quantification of 
genomic changes in large collections of murine pluripotent stem cell data. This is 
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particularly interesting since the obvious model for the recurrence of specific 
aneuploidies is their ability to confer a selective advantage to the carrier cells. 
Unveiling the commonly affected genomic intervals may reveal the candidate genes in 
the region, shed light to the mechanisms of growth advantage ascribed by aneuploidy 
and most importantly it may lead to a better understanding of normal and disease 
processes in stem cell biology. This thesis presents a large-scale integrated search 
methodology for the prediction of recurring patterns of aneuploidy in large collections 
of transcriptional data and reports the results of this type of analysis in mouse 
embryonic and induced pluripotent stem cells. 
 
Finally, given the large quantity of analysed gene expression profiles, the present thesis 
explores the presence of distinct transcriptional signatures associated with different 
types of aneuploidy affecting specific chromosomes. In addition, the presence of a 
transcriptional signature linked to any type of aneuploidy discovered in the data, 
possibly as a downstream effect of the presence of any type of chromosomal aberration 
that can give a selective advantage to the cell, is also identified for the first time. This 
thesis uses these signatures to train classification models that can be used for the 
accurate prediction of genomic changes in uncharacterised samples.      
  
To sum up, the scientific developments described in this thesis include the following: 
 
 Development of a software application for the prediction of genomic 
aberrations at the transcriptional level for a single-experiment type of analysis. 
 Development of a framework for the analysis of large collections of genome-
wide expression data from mouse pluripotent stem cell populations for the 
prediction of chromosomal abnormalities  
 Prediction of frequently recurring aneuploidies affecting specific chromosomes  
 Discovery of distinct transcriptional signatures related with chromosome-
specific aneuploidies 
 Discovery of a global signature linked to the presence of any type of underlying 
aneuploidy 
 Training and validation of classification models that can use a small number of 




1.2. Thesis Structure  
 
The structure of the thesis is as follows:  
 
The Background presents an overview of the field of embryonic stem cell and induced 
pluripotent stem cell biology. A summary of the findings to date regarding the loss of 
genomic integrity in human and mouse pluripotent stem cell lines is also presented. In 
addition, a brief description of the transcriptomics tools and methods as well as the 
fundamental concepts of the machine learning techniques that are relevant to this 
thesis is provided.  
 
Chapter 3 focuses on the software application DI.S.C.O. (DIscovery of Subtle Clustered 
Organisation). DI.S.C.O. can be used in order to identify clusters of concordant changes 
of gene expression levels that can be also diagnostic of underlying aneuploidies. The 
requirements, the development and the functionality of the tool as well as detailed 
description of the integrated computational methods are presented. In addition, 
extended validation of the computational methods in DI.S.C.O. with synthetic and 
biological data is performed.  
 
Chapter 4 presents a methodology for the analysis of large collections of gene 
expression data for the prediction of patterns of aneuploidy. The application of the 
framework in a collection of mouse pluripotent stem cell samples and the results from 
the analysis are described.  
 
Chapter 5 is concerned with the discovery of transcriptional signatures that are 
associated to frequently recurring chromosomal abnormalities in mouse pluripotent 
stem cells or to the presence of any type of aneuploidy in general. In addition, it 
discusses the training and the validation of classification models that can predict these 
aberrations in previously uncharacterised datasets using only a small number of 
diagnostic genes.   
 
Chapter 6 contains the final discussion and the future directions of this work.  
 
Finally, in the interest of brevity, supplemental material can be found in the attached 
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CD (referenced in the main text when appropriate). The list of supplemental files 





This chapter presents the origin and the basic biological concepts of embryonic and 
induced pluripotent stem cells. It then explores the genomic integrity of human and 
mouse pluripotent stem cells and provides a summary of the findings of different 
studies about the type and the frequency of genomic changes observed in these cell 
populations. Finally, it gives an overview of the transcriptomics tools and the machine 
learning techniques that are relevant to the present study.   
 
2.1. Pluripotent Stem Cells 
 
2.1.1. Pre-implantation Mouse Embryo Biology 
 
Mouse embryonic development starts with the union of the sperm and the oocyte to 
form the fertilised egg (zygote). The embryo travels along the oviduct and in 4.5 days 
after fertilisation it is implanted in the uterus. The period between fertilisation and 
implantation consists of two distinct stages of early-embryo development, the cleavage 
and the blastulation.  As cleavage proceeds from the two-cell stage embryo to 16-cell 
stage, accompanied with the activation of embryonic genes and the rapid degradation 
of the majority of maternally expressed mRNAs, two distinct lineages arise: the 
trophectoderm (TE) and the inner cell mass (ICM). The segregation of the two lineages 
starts with compaction and polarisation of the cells to form the morula at the 16-cell 
stage. The morula consists of two cell populations, the inner cells that will eventually 
give rise to the ICM, and the outer cells that will subsequently give rise to the 
trophoblast cells (trophectoderm). This process is completed through cavitation where 
the outer trophoblast cells start secreting fluid into the morula in order to create the 
blastocoel. The resulting structure, shown in Figure 2.1, is called the blastocyst and it 
consists of the ICM and the trophectoderm (Gilbert, 2000). By the 64-cell stage, the two 
lineages are completely segregated (Dyce et al., 1987). Prior to implantation, the ICM 
cells form the epiblast which, after implantation, will progressively differentiate into 
the three germ-cell layers, endoderm, ectoderm and definitive mesoderm and eventually 




2.1.2. Embryonic Stem Cells 
 
Embryonic stem cells (ESCs) are derived from the ICM cells of the pre-implantation 
embryo. They have the ability to self-renew through symmetric division in vitro (Smith, 
2001), presumably indefinitely under the appropriate culture conditions (Suda et al., 
1987), and to give rise to cells from any of the three primary germ layers in vitro and in 
vivo (Beddington and Robertson, 1989). The isolation of ESCs from two independent 
groups in 1981 is one of the most important achievements of mammalian 
developmental biology. ESCs were first isolated from mouse blastocysts and 
propagated in culture using feeder layers by Evans and Kaufman (1981) and Martin 
(1981). As it was later discovered, this had been possible because mouse fibroblast 
feeder cells express the leukaemia inhibitor factor (LIF) which blocks differentiation 
(Gearing et al., 1987; Smith et al., 1988). Mouse ESCs were subsequently derived with 
the use of LIF without feeders (Smith and Hooper, 1987).  
 
 
Figure 2.1 Schematic representation of the blastocyst of the mouse embryo. 
 [Image from (De Miguel et al., 2010)] 
 
 
The idea that the ICM might contain cells that could be kept in an undifferentiated state 
was based on the study of embryonic carcinoma cells (ECs). ECs are pluripotent cells 
derived from teratocarcinomas, a malignant neoplasm that contains undifferentiated 
cells as well as cells from all the three primal germ layers in various stages of 
differentiation. ECs can be maintained in vitro under defined conditions and 
demonstrate similar patterns of differentiation with normal ICM cells during 
development (Martin and Evans, 1974; Martin and Evans, 1975; Martin, 1975). When 
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ECs are injected in a host blastocyst they fail to contribute to the germ line and they 
often show aneuploidy (Chambers and Smith, 2004).  
 
Contrary to ECs, ESCs can contribute to the germ line after blastocyst injection and re-
implantation to a surrogate mother (Bradley et al., 1984). It was this important 
characteristic that paved the way for the genetic manipulation of ESCs (Robertson et al., 
1986; Gossler et al., 1986), the generation of transgenic mice and their subsequent use 
for the study of specific gene mutations and as disease models. These findings 
highlighted the great number of potential applications of ES cells for the understanding 
of normal biological processes, drug discovery and regenerative medicine.   
 
The isolation of human ESCs by Thomson et al. (1998) marked an important milestone 
that made the culture and directed differentiation of hESCs possible and enabled their 
applications in medical research as means of transplantation and drug testing. 
However, it has been suggested that human ESCs represent a later developmental stage 
than mouse ESCs and they depend on different extrinsic pathways that are more 
similar to the recently isolated mouse post-implantation epiblast-derived stem cells 
(EpiSCs) (Tesar et al., 2007; Brons et al., 2007). In addition, the process of X-
chromosome inactivation (XCI) is an active field of research in both human and mouse 
ESCs and iPSCs. Current findings indicate that both human ESCs and mouse EpiSCs have 
undergone X-chromosome inactivation (XCI), contrary to mouse ESCs where both X 
chromosomes are active (Ng and Surani, 2011). It has been recently shown that ectopic 
expression of specific transcriptional factors in combination with defined culture 
conditions can revert human ESCs in a “naive” state of pluripotency more similar to 
mouse ESCs (Hanna et al., 2010). 
 
2.1.3. Extrinsic pathways of Self-Renewal 
 
As it has been mentioned in section 2.1.2, the initial derivation of mouse ESCs on feeder 
layers was possible because they were able to maintain self-renewal through the 
inhibition of differentiation that is conferred by the feeder-supplied LIF (Smith et al., 
1988). LIF, a member of the IL-6 type of cytokines, and several related members of the 
IL-6 type cytokines can inhibit differentiation via the gp130 receptor (Yoshida et al., 
1994). The activation of  gp130 by homodimerisation or heterodimerisation with the 
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LIF receptor is required for the activation of the JAK/STAT signalling pathway and the 
SHP2/Erk mitogen-activated protein kinase cascade. These two pathways are involved 
in the fine tuning of the equilibrium between self-renewal and differentiation (Niwa et 
al., 1998; Burdon, 1999; Matsuda, 1999) (Figure 2.2).  
 
 
Figure 2.2 Extrinsic signalling pathways of ESC self-renewal and differentiation. 
ESC self-renewal and differentiation is tuned by the Lifr/gp130 mediated activation of the 
JAK/STAT and SHP2/Erk signalling pathways [Image from (Smith, 2001)]. 
 
In addition, Ying et al. (2003) found that the combination of LIF with BMP4 resulted to 
enhanced self-renewal and obliterated the need for serum during ESC derivation and 
culture. BMP4 blocks mainly neuronal differentiation by activating Smads which 
subsequently induce the transcription of Id (Inhibitors of Differentiation) genes.  
 
Recently, it has been shown that ESCs can be also maintained in culture with the use of 
two small-molecules that inhibit the Fgf4-mediated Erk activation as well as an 
inhibitor of Gsk3β (Ying et al., 2008). This is termed the “3i” culture medium with the 





Figure 2.3 The “3i” medium inhibited pathways in mouse ESC cultures  
[Image adapted from (Ying et al., 2008)]      
 
2.1.4. The Core Transcriptional Network of Pluripotency and Self-
Renewal 
 
Besides the extrinsic signalling pathways discussed in the previous section, a delicate 
intrinsic orchestration of a number of transcription factors is required for the 
maintenance of pluripotency and self-renewal. The ternary of Oct4, Nanog and Sox2, 
specifically, is found in the core of the transcriptional network that determines self-
renewal and differentiation. During mouse development, both Oct4 and Nanog are 
required for the establishment of the pluripotent identity, but not Sox2, presumably 
because of the high levels of lingering maternal Sox2 (Chambers and Tomlinson, 2009).   
 
Oct4 (a member of the POU class of transcription factors, also known as Pou5f1, Oct3, 
Oct3/4) is one of the most extensively studied intrinsic regulators of pluripotency and 
cell fate decisions in ESCs. Upon Oct4 deletion in vivo the cells of the blastocyst 
differentiate to trophectoderm (Nichols et al., 1998). Oct4 expression is also required 
for ESC maintenance in vitro in a LIF-independent way (Niwa et al., 2000). Niwa and 
colleagues used two ES cell lines to study the effects of Oct4 gene dosage in self-renewal 
and pluripotency: (i) the ZHTc6 cell line where one Oct4 allele is disrupted and Oct4 
expression from a tetracycline-suppressible Oct4 transgene can be induced upon 
removal of tetracycline and (ii) the ZHBTc4 cell line where both Oct4 alleles are 
inactivated and the tetracycline-suppressible Oct4 transgene is the only source for Oct4 
expression. Niwa et al. (2000) has shown that there are specific Oct4 gene dosage 
effects that control lineage specification. Less than 50% expression of Oct4 results in 
differentiation to trophectoderm, while a two-fold increase induces differentiation to 
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endoderm or mesoderm. Nevertheless, expression of Oct4 is not adequate to prevent 
differentiation upon LIF withdrawal (Niwa et al., 2000).  
 
Nanog is a homeodomain protein that is specifically expressed in ESCs (Chambers et al., 
2003; Mitsui et al., 2003). Over-expression of Nanog is sufficient to sustain pluripotency 
in the absence of STAT3 activation (Chambers et al., 2003; Mitsui et al., 2003). This 
indicates that Nanog is not downstream of the LIF signalling cascade. However, in the 
presence of LIF, Nanog over-expressing ESCs demonstrate enhanced self-renewal 
which could suggest that Nanog and STAT3 act independently but activate overlapping 
downstream transcriptional events (Chambers et al., 2003). Moreover, (Chambers et 
al., 2007) have shown that Nanog expression is heterogeneous in ES cell cultures, with 
cells expressing low levels of Nanog being more prone to differentiate. Interestingly, 
Nanog-null cells can still self-renew and contribute to all somatic tissues of chimaeras 
but not the germ line (Chambers et al., 2007).  
 
Sox2 is expressed in ESCs (Avilion et al., 2003) and neural stem cells (NSCs) (Zappone 
et al., 2000). Deletion of Sox2 in ESCs has similar characteristics with Oct4 deletion and 
results to differentiation towards the trophectoderm lineage (Masui et al., 2007). Sox2 
and Oct4 bind DNA cooperatively, as it has been shown for the activation of the Fgf4 
enhancer in mouse ES and EC cells (Ambrosetti et al., 1997; Ambrosetti et al., 2000).  
 
Great efforts have been made towards the identification of downstream targets of these 
transcription factors (see (Chambers and Tomlinson, 2009) for a review). 
Understanding the exact molecular mechanism that the Nanog/Oct4/Sox2 trio employs 
in order to maintain pluripotency is an ongoing goal for the stem cell community.    
 
2.1.5. Induced Pluripotent Stem Cells 
 
The differentiated cells of the adult organism can be forced towards an embryonic-like 
state by a process that reverts the unidirectional lineage specification: reprogramming. 
Different methods have demonstrated thus far that adult multipotent or terminally 
differentiated cells still retain the nuclear plasticity that allows them to reset to an ES-




 Nuclear transfer (see (Hochedlinger and Jaenisch, 2006) for a review) 
 Cell fusion ((Tada et al., 2001; Cowan et al., 2005)) 
 Direct reprogramming with ectopic expression of specific transcriptional factors 
(Takahashi and Yamanaka, 2006; Wernig et al., 2007; Maherali et al., 2007) 
 
In a bench-mark experiment, (Takahashi and Yamanaka, 2006) showed that ectopic 
expression of the transcription factors Oct4, Klf4, Sox2 and c-Myc by retroviral 
transduction can generate cells that resemble the blastocyst-derived ES cells in 
morphology and transcriptional profile. These cells were named induced pluripotent 
stem cells (iPSCs) by Yamanaka.  These first iPSCs were selected by the activation of a 
drug resistance allele incorporated in the Fbxo15 locus which is specifically expressed 
in ESCs. Fbxo15-based selection could only identify, however, partially reprogrammed 
iPSCs that did not demonstrate full demethylation of key developmental regulators 
such as Oct4, could not give raise to post-natal chimeras and contribute to the germ line 
(Takahashi and Yamanaka, 2006). Follow-up experiments refined the procedure by 
basing the selection on the expression of Nanog and Oct4 (Okita et al., 2007; Wernig et 
al., 2007; Maherali et al., 2007), even by using integration-free mechanisms (Okita et al., 
2008; Stadtfeld et al., 2008b).  
 
Following these initial studies, numerous researchers have demonstrated that defined 
transcription factors can be introduced to different types of mouse lineage-restricted 
cells or terminally differentiated cells for iPSCs generation (i.e. liver and stomach cells 
(Aoi et al., 2008), bone marrow cells (Kunisato et al., 2010), terminally differentiated 
pancreatic β-cells (Stadtfeld et al., 2008a) and lymphocytes (Hanna et al., 2008)). In 
addition, iPSCs have been also generated from other species, such as human (Takahashi 
et al., 2007; Yu et al., 2007; Park et al., 2008), rat (Li et al., 2009) and rhesus monkey 
(Liu et al., 2008).  
 
iPSCs could provide a cell source per individual with invaluable therapeutic 
applications as well as a model for understanding the mechanisms of normal 
development.  Nonetheless, there are still many parameters that need to be 
investigated before such an application is possible. Safe and efficient generation of fully 
reprogrammed iPSCs can depend on many molecular and biological processes, 
including epigenetic modifications, micro-RNA regulation, cell cycle and DNA damage 
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control and apoptosis, that still need to be fully understood (Na et al., 2010). 
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2.2. Genomic Integrity of Pluripotent Cells 
 
2.2.1. Genomic instability 
 
Genomic instability refers to the processes that can increase the mutation rates in the 
genome and it is believed to contribute to carcinogenesis. Genomic instability mainly 
manifests by two mechanisms: chromosomal instability (CIN) and microsatellite 
instability (MIN or MSI). Microsatellites consist of multiple repetitive short sequences 
of DNA. These sequences also exist in normal cells but appear lengthier in certain 
tumours and are the result of faulty DNA repair pathways (Lengauer et al., 1997). 
Although, MIN may not necessarily affect the phenotype of the cell, it is by definition a 
type of genomic instability that has been observed in certain human tumours (Morgan 
et al., 1996). 
 
Chromosomal instability affects whole or large parts of the chromosomes and includes 
events such as duplications, deletions, partial gain or losses and translocations. 
Aneuploidy can be defined as the deviation of the modal chromosomal number of an 
organism by means of gain or loss of whole or partial chromosomes. Segmental 
aneuploidies refer to the acquisition of extra chromosomal regions from amplification, 
deletions or rearrangements (Geigl et al., 2008). As shown in Figure 2.4, chromosomal 
abnormalities can be either numerical (when they affect the overall number of 
chromosomes in the cell) or structural (when they result in an alteration of the normal 
chromosome structure) (Atwood, 2011). Aneuploidy is closely related to CIN but it is 
not necessarily the case that aneuploid cells demonstrate higher rates of CIN (Geigl et 
al., 2008).  
 
2.2.2. Tools for the Detection of Chromosomal Aberrations 
 
There are various methods that can be applied for the identification of chromosomal 
abnormalities and the evaluation of the genomic integrity of a single cell or a cell 
population. These tools can be grossly divided in three categories: conventional 
cytogenetic analysis, molecular cytogenetics and array-based techniques (Catalina et 





Figure 2.4 G-banding karyogram. 
A G-banding karyogram of a HeLa cell (cervical tumour) consisting of various examples of 
numerical and structural chromosomal aberrations 
[Image adapted from (Gagos and Irminger-Finger, 2005)] 
 
 
Classical cytogenetic analysis examines the chromosome complement of a cell during 
metaphase where the condensed chromatin is visible in the form of chromosomes. The 
metaphase chromosomes can be stained producing distinct banding patterns. 
Chromosome bands arise from specific chromosomal regions that may vary in size and 
number of encompassing genes. Popular banding techniques include G-banding 
(trypsine Giemsa staining), R-banding (reverse bands of Giemsa staining with heat 
treatment) or DAPI-banding (fluorescent based 4'-6-Diamidino-2-Phenylindole (DAPI) 
staining) (Bayani and Squire, 2004). The above techniques produce ~300-400 stained 
bands and allow the identification of aneuploidies as well as gross chromosomal 
aberrations (gain, losses or rearrangements) (Rebuzzini et al., 2011). The achieved 
resolution is quite low ~5-10 Mb, nonetheless, the time and cost requirements of these 





Fluorescent in situ hybridization (FISH) was the first cytogenetic technique based on 
principles of molecular biology, introduced in the early 80’s (Van Prooijen-Knegt et al., 
1982). In FISH fluorescent labelled DNA probes designed to hybridise to specific 
genomic regions of interest can be visualised under a fluorescent microscope. The 
resolution depends on the size of the probe, around 1-2 Mb. FISH is mostly used for the 
examination of the integrity of already known conspicuous regions i.e. recurrent 
aberrations in cancer. It is however a quite labour intensive technique (Gijsbers and 
Ruivenkamp, 2011). Two more molecular cytogenetic methods, similar to FISH, have 
been recently developed: spectral karyotype or SKY and multicolour fluorescent in situ 
hybridization (mFISH) (Schröck et al., 1996; Speicher et al., 1996). Both these methods 
output the whole karyotype and they have a much higher resolution than conventional 
cytogenetic techniques (~1-2 Mb). Since each chromosome is painted with a different 
fluorescent colour, inter-chromosomal rearrangements can be identified.  Not all types 
of abnormalities can be however discovered. Small deletions or amplification as well as 
inversions are missed.  
 
Microarray-based technologies offer much higher resolution for the detection of small 
genetic imbalances even at the level of single nucleotides. Two methods have been 
widely adopted: array comparative genomic hybridization (array-CGH) and single 
nucleotide polymorphism array (SNP array) (Solinas-Toldo et al., 1997; Peiffer et al., 
2006). The aCGH technology uses DNA arrays that contain bacterial artificial 
chromosome (BAC) clones, P1-derived artificial chromosomes (PAC) or yeast artificial 
chromosomes (YAC) covering the whole genome (Solinas-Toldo et al., 1997). The 
resolution of these arrays is higher and depends on the size and the spacing of the 
probes used. Initially, a collection of 2,400 BAC clones was used to cover the human 
genome at a resolution of approximately one clone per 1.4 Mb (Snijders et al., 2001). 
Later designs, using 30,000 BAC clones and reaching a full coverage resolution have 
been also reported (Ishkanian et al., 2004). For mouse, the early 3K BAC arrays 
contained 3080 mouse BAC clones spanning across chromosomes 1 to 19 and X with a 
1 Mb resolution (Chung et al., 2004). Additional improvements with the use of 
oligonucleotides instead of BAC clones have increased the resolution to ~100 Kb (van 
den IJssel, 2005). The technique is based on the competitive hybridisation of a test and 
control DNA sample differentially labelled with i.e. red and green fluorochromes. The 
relative fluorescence intensities of the two channels are calculated after the array is 
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scanned and imaged. The generated data can be then visualised in appropriate software 
packages and the intensity ratios can be analysed in order to identify regions of copy 
number variations (CNVs). In contrast to classical cytogenetic techniques, aCGH does 
not require the extra step of fixing the metaphase spreads and provides higher 
resolution. However, the equipment and reagents required are more expensive in 
comparison to conventional cytogenetic techniques.  
 
SNP arrays consist of attached short fragments of DNA (probes), usually of a 25 to 50 
nucleotides length, that are complementary to sequences around the SNP loci.  
Fragmented single-stranded DNA from the test sample is hybridised to the array and 
specialised equipment quantifies the signal intensity that results from the probe and 
the target DNA hybridization. Major commercial manufacturers of SNP arrays include 
Affymetrix and Illumina which employ slightly different methodologies but based on 
the same principles (see (LaFramboise, 2009) for a review). An advantage of SNP 
arrays is that they can be used for the identification of copy-neutral loss of 
heterozygosity (LOH) events, such as uniparental disomy (UPD), as well as CNVs. Of 
course, in the case of inbred organisms where all genomic loci are homozygous, SNP 
analysis can be only informative when performed across different inbred strains.  
 
The downside of the array-based cytogenetics is that they assess the genomic integrity 
of a population of cells. As a result, they may not be able to discover subtler patterns 
present only in a few cells nor report the frequency of an aberration across the whole 
population.  For example, a study has reported that an aberration present in 33% of the 
cells assessed by conventional karyotyping could not be detected by array-CGH, while 
the aberration became detectable when carried by 75% of the cells (Veltman et al., 
2003). The lower limit of the method for the detection of mosaicism in the cell 
population is not clear and specific experiments are needed to address this question.  
 
The techniques described in this section have different time, labour intensity, 
equipment and consumables requirements and thus they can be more appropriate for 
different types of experiments. To date, conventional cytogenetics and even simple 
metaphase counting is the method most routinely applied for the investigation of 




2.2.3. Culture Adaptation 
 
In the general sense, culture adaptation refers to the ability to establish, expand and 
maintain a cell population in vitro. In the context of pluripotent stem cells, Baker et al. 
(2007) has proposed an alternative definition according to which culture adaptation 
refers to the phenomenon where pluripotent stem cells exhibit decreased population 
doubling times, increased cloning efficiency and accumulation of karyotypic 
abnormalities after prolonged time in culture (Baker et al., 2007). For the remaining of 
this thesis, the definition of Baker et al. (2007) is adopted.  
 
The indefinite self-renewal observed in ESC cultures in vitro does not occur in vivo since 
during normal embryonic development the ES cell population is transient and rapidly 
gives rise to lineage-restricted progenies. It has been shown that pluripotent ICM cells 
and ESCs in culture, although broadly very similar, display different epigenetic 
silencing marks across key pluripotency regulators (O’Neill et al., 2006). These findings 
suggest that specific selection mechanisms may exist in vitro that favour growth in 
culture.  
 
An integral part of the culture adaptation process, in the context of Baker and 
colleagues’ definition, is the accumulation of chromosomal aberrations. Indeed there 
are numerous reports of such aberrations present in both human and mouse ESCs as 
well as iPSCs which are discussed in detail in the following sections (2.2.4 and 2.2.5). 
Chromosomal abnormalities may arise randomly upon cell division but specific 
recurring aberrations that have the ability to overtake the normal cell population 
premise a mechanism that confers selective advantage to the cells carrying them. This 
is more likely to occur through processes that regulate cell cycle control, resistance to 
apoptosis and differentiation (Herszfeld et al., 2006; Harrison et al., 2009). Some of the 
potential mechanisms are discussed in more detail in section 2.2.6. 
 
2.2.4. Genomic Integrity of Mouse Pluripotent Cells 
 
2.2.4.1. Mouse ES cells 
Although mouse ESC lines have been extensively used since they were first established 
in 1981 (Evans and Kaufman, 1981; Martin, 1981), surprisingly few studies have thus 
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far systematically assessed their genomic integrity in culture (Liu et al., 1997; Longo et 
al., 1997; Sugawara et al., 2006; Rebuzzini et al., 2008a; Rebuzzini et al., 2008b; Liang et 
al., 2008).  From these studies, only Liu et al. (1997) and Sugawara et al. (2006) 
reported the exact karyotype of a high number of cell lines (35 and 88 respectively).  
 
Liu et al. (1997) examined the relationship between the growth rate of ESCs, their 
ability for germ line transmission and the karyotypic integrity of the cells. It has been 
observed that higher passage cell lines have hindered efficiency to contribute to the 
germ line (Nagy et al., 1993). Liu et al. (1997) confirmed that colonies that demonstrate 
high growth rate often coincide with the presence of trisomy 8 which also reduces the 
germ line transmission rate. Clones from three independently derived ESC lines were 
analysed using G-banding and trisomy 8 was found to spontaneously arise in all three 
lines and eventually over-grow the cell population after six passages in culture. 
Trisomy 11 was also identified in 3 out of the 22 abnormal clones as well as other 
chromosomal changes. Longo et al. (1997) showed that somatic and germ line 
contribution highly correlates with the percentage of euploid metaphases in an ES 
clone and becomes limited when this percentage drops below ~40% (at about passage 
number 20). The study of Longo et al. (1997) comprised of three independently derived 
ESC lines from which 32 different ESC clones were cytogenetically analysed with the G-
banding method.  Unfortunately, the authors did not provide detailed information of 
the chromosomal mapping of the reported aberrations with the exception of a single ES 
clone whose karyotype was 41, XY, -13, -13, +10, +11, +19. 
 
An additional study from Guo and colleagues validated four different ES cell lines (E14, 
W9.5, 2A and KPA cells) at different passage points using multicolour FISH analysis 
(Guo et al., 2005). The authors examined 9-15 metaphases per cell line. Even though 
the E14.1 cells exhibited normal morphology and expression of ES markers (Oct4, 
Nanog), they had acquired a duplication of 14q (10/10 metaphases) and a trisomy 8 
(3/10 metaphases). Extending their analysis to the three additional cell lines W9.5, 2A 
and KPA, Guo et al. (2005) also identified a deletion of 6q in the W9.5 cell line (10/10 
metaphases) as well as a trisomy 8 (7/11 metaphases) and trisomy 14 (5/11 
metaphases) while the 2A and KPA cell lines were karyotypically normal.  
 
The study of Sugawara et al. (2006) is the most comprehensive cytogenetic study to 
date and includes the karyotypic validation of 540 mouse embryonic stem (ES) cell 
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lines obtained through the course of three years (2001 to 2004) from 20 different 
institutions in Japan. From the cell lines examined, 66.5% showed normal chromosome 
number while the rest displayed different modal chromosome numbers (assessed by 
fifty metaphases counting per cell line). The authors randomly selected 88 cell lines for 
in-depth karyotypic analysis by a modified Q-banding technique (Nesbitt and Francke, 
1973) and found that 60.2% of them were normal. The chromosomal changes of the 
rest 35 abnormal ES cell lines were predominantly trisomy 8 (51.4%), trisomy 8 with 
loss of a sex chromosome (14.3%) or combination of trisomy 8 and 11 (11.4%). In total, 
trisomy 8 in combination with other aberrations was present in 88.6% of the cell lines, 
and trisomy 11 in combination with other aberrations was present in 17.1% of the cell 
lines. In addition, 25.7% of the ES cell lines examined demonstrated a loss of a sex 
chromosome. Finally, the overall percentage of normal karyotypes was similar between 
the two different mouse strains analysed (58.3% for strain 129 animals and 58.8% for 
C57BL/6J × CBA) although a bit higher in the case of strain C57BL/6J mice (72.7%). 
 
Rebuzzini et al. (2008a) examined the chromosomal make-out of the UPV04 ES cell line 
(Neri et al., 2007) during different time-points in culture by C-banding (Sumner, 1972) 
or DAPI banding (Schnedl et al., 1980). The authors analysed metaphases from 
passages 6 to 34 (93 metaphases on average per passage) and found that the overall 
percentage of euploid metaphases was constant through the three month culture 
period (~55% to 65%).  For the aneuploid metaphases, there was a broad spectrum of 
chromosomal abnormalities that varied across the different passages. Contrary to Liu 
et al. (1997) and Sugawara et al. (2006), Rebuzzini et al. (2008a) did not identify 
trisomy 8 as the predominant type of aneuploidy (in fact, only a single case of trisomy 8 
was discovered). These results could indicate that random patterns of aneuploidy may 
arise frequently during culture in a dynamic fashion but only specific aneuploidies 
actually confer selective advantage to the carrying cells which are, as a result, able to 
out-grow the normal cell population in a selective environment. 
 
Importantly, the studies that have been discussed in this section refrain from providing 
any mechanistic hypothesis on the occurrence and prevalence of the genomic changes 
that they report and adopt a rather descriptive approach of the type of patterns they 
observe and their effect mostly on the ability for germ line transmission of the 
aneuploid cells. It is essential, therefore, to take these initials observations forward by 
delineating the processes that are involved in the accumulation of the observed 
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genomic aberrations and the selective advantage that it is believed they confer to the 
cells.    
 
To conclude, chromosomal instability of mouse ES cell lines appears to be a widespread 
problem. It has been suggested, however, that embryonic stem cells are less permissive 
to mutations and demonstrate a much lower spontaneous mutation rates than somatic 
cells (Cervantes et al., 2002). Cervantes and colleagues used the Aprt mouse model 
which is derived from a cross between the 129 strain mice homozygous for the 
targeted null Aprt allele and C3H mice with wild-type Aprt (Vrieling et al., 1999). By 
examining the Aprt loss of function in mESCs and MEFs, this study identified that in 
mESCs the most frequent spontaneous mutation resulting to Aprt loss is the loss of 
chromosome followed by reduplication resulting to uniparental disomy (UPD) and 
apparent euploidy. Intriguingly, the Aprt gene is found on mouse chromosome 8. This 
could suggest a possible mechanism for the high frequencies of chromosome 8 specific 
aberrations in mouse ESC studies. Cervantes and colleagues also hypothesised that the 
observed UPD is a result of a series of nondisjunction events, where the cells acquire a 
trisomic chromosome 8 and subsequently return to isodisomy. Consistent with this, 
they were able to identify trisomy 8 in the population of the heterozygous Aprt ESCs. 
While it can be argued that the observed rates of UPD are specific to chromosome 8, 
another study has found high rates of isodisomy also on chromosomes 2, 5, 10 and 17 
in mESCs (Lefebvre et al., 2001).  
 
2.2.4.2. Mouse iPS cells 
Since the first report in 2006 that mouse somatic cells can be reprogrammed to an ESC-
like state through the transfection by four transcriptional factors (Oct4, Sox2, Klf4 and 
c-Myc) (Takahashi and Yamanaka, 2006), the iPSC field has been the focus of great 
interest and intensive research. In the years that followed this important finding, many 
scientists have contributed to the significant advance of the field by improving the 
derivation process or generating iPSC from different somatic tissues (also refer to 
(Boué et al., 2010) for a list of pivotal publications). However, there seems to be a 
surprising lack of studies that investigate the genomic integrity of mouse iPSCs. Even 
though genetic changes in mESC lines have been reported by several independent 
laboratories, as reviewed in the previous section, and similar analysis has been 
performed extensively for their human counterparts, there is only a single study to date 
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that investigates the genomic integrity of mouse iPSCs during reprogramming (Quinlan 
et al., 2011) and no study that explores the effects of prolonged propagation in culture.  
 
Quinlan and colleagues used high-resolution whole genome paired-end DNA 
sequencing to investigate the presence of chromosomal structural variations (SVs) such 
as inversions, micro-duplications or deletions, complex rearrangements and 
retroelement transpositions, during reprogramming. Paired-end sequencing is a 
sequencing approach that provides information about the physical distance of two 
reads in the genome in addition to the actual sequence of the reads. The authors used 
MEFs from a mixed mouse strain (Pcdh21/Cre - Z/EG transgenic mouse lines originally 
derived from C57BL/6CrSlc and CD1 mice respectively)(Boland et al., 2009) to obtain 
three iPSCs lines and indentified SVs by comparing them to the C57BL/6J reference 
genome. Two of the three iPSC lines (iMZ-9 and iMZ-21) were derived from the same 
MEF donor cell after viral transduction while the third (iMZ-11) was obtained from a 
different cell. By performing pooled multi-sample data analysis, meaning by analysing 
simultaneously the reads from all three cell lines, the authors were able to identify 
germline SVs that were present in all cell lines and the MEFs as well as de novo SVs that 
were the result of cellular reprogramming and were not present in the parental MEFs. 
Intriguingly, the authors identified only one de novo SVs present in each iPSC cell lines 
that had probably arisen during reprogramming. Two of the SVs affected two genes 
(Plxna4 and Cssp1) while the third was in a nongenic region. In addition, no 
retroelement transpositions could be identified in any of the lines. The cells were fully 
reprogrammed and could generate viable mice. In the study of Quinlan et al. (2011), the 
iPSCs analysed were of a very low passage, suggesting that the process of 
reprogramming itself is not detrimental to the genomic integrity and careful selection 
of iPSCs could assure a normal karyotype. Of note, the mixed strain used in this 
experiment is not representative of the majority of mESC and miPSC lines currently in 
use and more experimental data are needed to investigate the effect of genetic 
background in the predisposition of certain pluripotent stem cell lines to demonstrate a 







2.2.5. Genomic integrity of Human Pluripotent Cells 
 
2.2.5.1. Human ES cells 
Rigorous karyotypic validation of human pluripotent cell lines during in vitro 
propagation is critical in order to assure their genomic integrity.  Since the necessary 
prerequisites for normal mouse ESCs and iPSCs, namely contribution to chimaeras and 
germ line transmission, cannot be assessed in human ES and iPS cell population for 
obvious reasons, the only way to establish that the cells have not been transformed is 
through karyotypic analysis. As a result, there are numerous studies that report the 
presence of aneuploidy and structural chromosomal aberrations in human pluripotent 
cells.    
 
After their initial derivation in 1998 (Thomson et al., 1998), studies have shown that 
hESCs can be cultured for prolonged periods of time retaining a normal karyotype 
(Amit et al., 2000; Reubinoff et al., 2000). However, in the recent years increasing 
evidence has demonstrated that this is not necessarily a global characteristic of all cell 
lines. In 2004, two independent studies were the first to report the presence of 
karyotypic abnormalities in human ESCs. Draper et al. (2004) investigated the 
chromosomal make-out of four different cell lines using FISH and G-banding: three of 
them were sublines of the H7 line (H7.S0, H7.S6 and H7.S9) and two of them from H14 
line (H14.S9 and H14.S14). The H7.S0 display normal karyotype and differentiation 
capacity for several months. However, the two sublines, H7.S6 and H7.S9, which were 
recovered from frozen batches, both acquired whole or partial chromosome 17 
amplifications after several months in culture. The H7.S6 line had a 46,XX, 
der(6)t(6;17)(q27;q1) karyotype after 6 months in culture (60 passages) with a 
translocation of 17q to 6q, resulting to a trisomic 17q. A percentage of the cells also 
displayed trisomy 12. The H7.S9 line acquired a trisomy 17 within four months in 
culture. A trisomy 17 was also observed in the H14.S9 subline. For the H14.S14 subline, 
although initially karyotypically normal, after 22 passages in culture 76% of cells 
acquired a trisomy 17 and after 39 passages the culture was relatively homogeneous in 
trisomic 17 cells (95%), suggesting a selective growth advantage of the specific 
abnormality.  Interestingly, 12p and 17q aberrations are often observed in the typically 
aneuploid human EC cells suggesting parallel mechanisms in these two closely related 
cell types (Atkin and Baker, 1982; Rodriguez et al., 1993; Skotheim et al., 2002). The 
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second study was the one of Inzunza et al. (2004) which used FISH and CGH to assess 
the genomic integrity of three female lines, HS181, HS235 and HS237, at passages 35-
39. All three lines seem to have a normal karyotype initially, but line HS237 showed an 
isodicentric X chromosome at passage 61. However, Buzzard et al. (2004) reported that 
persistent changes similar to the ones identified by Draper and colleagues were not 
present in the six hES cell lines (hES1–2, and hES3–6) of the study. The lines of Buzzard 
and colleagues had been frequently karyotypically analysed, for between 34 and 140 
passages, but only sporadic aberrations that could not overtake the cell population had 
been observed.  
 
Mitalipova et al. (2005) observed that the method of propagation may be highly 
connected with the occurrence of aneuploidy. For example, the hESC lines BG01 and 
BG02 maintained a normal karyotype for passages 41 to 105 when propagated by 
manual dissection of the hESC colonies. The authors then used two methods that can 
disaggregate hES cell colonies for bulk passaging, a nonenzymatic (cell dissociation 
buffer, CDB) and an enzymatic (collagenase/trypsin, CT). The change of propagation 
method resulted to the appearance of aneuploidy: the BG01 cell line developed trisomy 
12 and 17 (and sporadic appearance of trisomy X) as soon as 23 passages with the CDB 
method, while the BG02 line developed trisomy 12, 14, 17 and an extra copy of the X 
chromosome (and sporadic appearance of trisomy 20), after 56 passages with the CT 
method. Mitalipova and colleagues hypothesised that the difference in propagation 
methodology adopted by Draper et al. (2004) and Buzzard et al. (2004), that is 
enzymatic versus manual, could be the reason that the lines in the study of Draper and 
colleagues were more susceptible to karyotypic abnormalities.  
 
The first study using SNP-arrays to identify chromosomal aberrations in hESC was 
performed by Maitra and colleagues in nine pairs of early and late passage hESC lines 
(Maitra et al., 2005). The authors reported a range of subchromosomal aberrations, 
including a 17q amplification and a whole chromosome 13 deletion in two different 
lines. Imreh et al. (2006) also examined the HS181 cell line and found that after 11 
passages the 80% of the examined cells have acquired an abnormal karyotype (47, XX, 
del(7) (q11.2), +i(12) (p10)), again implicating chromosome 12. In addition, these cells 
showed impaired differentiation capacity when assessed by teratoma formation in 




Another study investigated the process of culture adaptation by comparing early 
passage normal samples and later passage adapted cell from a single cell line, H7 
(Enver et al., 2005). This study is particularly interesting because it examined the 
expression profiles of normal and adapted cells by further dividing the two types of 
cells into two subpopulations according to the expression of the surface marker SSEA3. 
SSEA3 is a marker of undifferentiated hESCs (Draper et al., 2002). The authors 
demonstrated that the karyotypic abnormalities of the H7 adapted hES cell line (46,XX, 
der(6)t(6;17)(q27;q1)) can be readily identified at the transcriptional level by using 
Affymetrix expression arrays. However, not all the genes in the affected region show 
altered gene expression levels nor the ones that are indeed up-regulated have the same 
fold-change in mRNA expression levels (i.e. the notch ligand, DLK1, showed a 7-fold up-
regulation). In addition, the majority of the differentially expressed genes were within 
the aberration coordinates and only a few were found in other genomic loci. As 
revealed by hierarchical clustering, both the SSEA3+ and SSEA3- adapted cells 
clustered closely to the SSEA3+ normal cells suggesting a shift of the adapted cells 
towards self-renewal. In addition, the adapted cells showed an enhanced cloning 
efficiency when compared to the normal cells (6-fold higher for the SSEA3+ adapted 
cells and 3-fold higher for the SSEA3- adapted cells) and reduced differentiation as 
assessed by colony morphology. 
 
Besides the recurring chromosome 12, 17 and X aberrations (Baker et al., 2007), other 
studies have revealed the occurrence of a 20q11.21 amplicon. Lefort et al. (2008) 
examined five hESC lines (SA01, H9, H1, VUB01 and VUB05-HD) that have been 
propagated by manual dissection, using BAC array-CGH, SNP arrays and FISH. They 
found that the 20q11.21 duplication arose as an inverted repeat during long-term 
culture in the SA01 (p83), H9 (p41) and VUB05-HD (p103) lines. In addition, an extra 
copy of the 20q11.21 was found inserted in the 1p36.3 region at the H1 cell line (p24, 
24% of the cells and p64, 47% of the cells). Similar results were reported by Spits et al. 
(2008), where 17 hES cell lines were tested by array-CGH and five out of the 17 carried 
a 20q11.21 duplication after several passages in culture. The 20q11.21 amplicon was 
also confirmed using array-CGH analysis by Wu et al. (2008) and by Werbowetski-
Ogilvie et al. (2009). The same region was identified by yet another study in the CCTL-
14 hESC line (Narva et al., 2010). Using high resolution SNP arrays, this study reports a 
range of CNVs present in otherwise karyotypically normal hESC lines, implicating 
chromosomes 4, 5, 10, 15, 18 and 20 (for larger CNVs of ~1-3 Mb). Collectively, these 
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findings suggest that the amplification of the 20q11.21 locus confers selective 
advantage to the affected cells. Since the specific aberration is quite small in length 
(~1.5 Mb) the number of encompassing candidate genes is also limited. All the above 
studies have proposed that two conspicuous candidates in the specific region may be 
driving the selection: the BCL2L1 gene, a member of the Bcl2 pro-survival family that 
inhibits apoptosis under some types of cytotoxic stress (Cory and Adams, 2002) and 
ID1, a member of the ID proteins family that regulate cell differentiation and cell cycle 
(Prabhu et al., 1997; Barone et al., 1994) and have been also found implicated in cancer 
(Cheng et al., 2011; Pillai et al., 2011).    
 
Importantly, two recent large-scale integrated analysis studies have investigated the 
largest collections to-date of human ES and iPS cell lines (Mayshar et al., 2010; Amps et 
al., 2011). Mayshar and colleagues performed transcriptional karyotyping to study the 
impact of underlying aneuploidies at the transcriptional profile of the affected cells 
using gene expression microarrays in combination with validation by SNP arrays. This 
study is closely related to the methodology adopted here and it’s discussed in more 
detail in section 4.1.2. Briefly, Mayshar et al. (2010) identified chromosomal aberration 
in 32% of the examined hESC lines, involving whole chromosomes or chromosome 
segments, and specifically implicated chromosomes 12 and 17 that were both observed 
with a frequency of 3 out of 38 lines.  
 
Finally, the study of Amps and colleagues is the most comprehensive study to date, 
consisting of 125 independent hESC lines and 11 reference iPSC lines derived from 38 
laboratories worldwide. These lines were examined in earlier and later passages using 
high-resolution SNP-arrays. The authors provide a comprehensive resource of 
karyotypic imbalances accompanied with structural variation of normal and adapted 





Figure 2.5 Genomic mapping  of hESCs chromosomal aberrations.  
Chromosomal mapping of identified aberrations in 125 hESC lines of which 42 were found 
abnormal specifically implicating chromosomes 1, 12, 17 and 20.  
[Image from (Amps et al., 2011)] 
 
 
Interestingly, from the 125 examined lines 42 (34%) had abnormal karyotypes. These 
included changes primarily in chromosomes 1, 12, 17 and 20 (almost half of the 
adapted lines), consistent with previous reports (Figure 2.5). In addition, late passage 
lines had a two-fold higher probability to carry chromosomal abnormalities. These 
changes were significantly more frequent in lines that have been enzymatically 
propagated for many passages. In the case of the 20q11.2 amplicon specifically, the 
pattern was present in 7 abnormal lines but more interesting, also in 22 of the 
karyotypically normal hESC lines as a structural variant. Among these 22 lines, five 
displayed the variant at an early passage and the rest 17 acquired it upon prolonged 
passaging. In addition, from the 17 lines that acquired the 20q11.21 amplicon in a later 
passage, three displayed extended karyotypic abnormality suggesting that the specific 
aberration may promote chromosomal instability. The authors identified the minimal 
overlapping region of the 20q11.21 gain to contain three genes expressed in hESCs. 
These were the HM13, ID1 and BCL2L1, and at least ID1 and BCL2L1 have been 
repetitively reported in literature as putative candidate genes that drive the selection 
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behind the specific aberration (Maitra et al., 2005; Lefort et al., 2008; Spits et al., 2008).   
 
2.2.5.2. Human iPS cells 
Several recent reports have uncovered genetic and epigenetic changes in human iPSCs 
raising an alarm for the scientific community (Mayshar et al., 2010; Gore et al., 2011; 
Laurent et al., 2011; Hussein et al., 2011; Ben-David et al., 2011; Amps et al., 2011). 
Mayshar and colleagues used a large-scale gene expression meta-analysis approach to 
analyse the genomic integrity of 66 iPSC lines from independent laboratories. The 
authors found that approximately one fifth of the lines contained a large-scale 
aberration (whole or partial-chromosome spanning, > 10 Mb). Chromosome 12 was 
found trisomic or partially duplicated in four of the adapted lines and the overlapping 
aberrant region spanned the GDF3-NANOG locus. Both these genes also demonstrated 
significantly elevated expression levels in the abnormal cell lines. In addition, cells that 
carry the specific duplication rapidly overtook the cell population, as assessed by 
karyotyping of early and later passages, suggesting that the specific aberration confers 
selective advantage to the cells. The authors also proposed that the rapid selection for 
the chromosome 12 specific aberration may be due to the enrichment of the specific 
chromosome in cell-cycle genes that could potentially contribute to accelerated growth. 
Similar genetic changes was also identified by Amps et al. (2011) in three out of the 11 
iPSC lines (27%) included in the study. Two of them carry a trisomy 12 and the third an 
inversion of chromosome 5.  
 
In another study, Laurent et al. (2011) performed SNP analysis in a large collection of 
human pluripotent ESC and iPSC lines as well as non-pluripotent cell populations. The 
overall frequency of subchromosomal aberrations was significantly more frequent in 
pluripotent cell lines. Interestingly, chromosomal gains were more prevalent in hESCs 
while deletions in hiPSCs. Large chromosomal aberrations implicated chromosomes 12, 
17, 20 and X as it has been previously reported. Furthermore, several lines carried 
small CNVs spanning pluripotency genes such as NANOG and OCT4 as well as related 
pseudogenes whose function remains unknown. The study also linked extended 
passaging of hiPSCs with the presence of amplifications of oncogenes while the process 
of reprogramming was associated with deletions of tumour-suppressors (Laurent et al., 




A separate study by Hussein and colleagues, using again high resolution SNP arrays, 
reported that a large number of CNVs appears de novo during reprogramming (two-
fold higher frequencies than the levels present in the parental fibroblasts or ESCs). 
Perhaps unexpectedly, the majority of these changes are selected against during culture 
and later passage iPSC lines demonstrated lower frequencies of mutation. In addition, 
recurring deletions was mostly observed in common fragile sites (CFSs) suggesting that 
the novel CNVs may be the result of replicative stress during cellular reprogramming 
(Hussein et al., 2011).  
 
Finally, Gore et al. (2011) performed exome sequencing on 22 human iPSC lines from 
seven different laboratories which have been derived using different reprogramming 
methodologies. The authors also used the parental fibroblasts to quantify the 
mutational load during reprogramming. They were able to validate 124 point 
mutations present in the iPSC lines but not the fibroblasts which averages to six coding 
mutations per iPSC line. The mutations were found to be enriched in cancer-related 
genes but no enrichment of specific pathways was present. Gore and colleagues suggest 
that the mutational load may not be the intrinsic effect of the reprogramming process 
but rather a result of the way colonies are picked and cells are propagated in culture.  
  
2.2.6. Mechanisms of culture adaptation and tumorigenicity 
 
Several studies have linked the events occurring during culture adaptation of 
pluripotent stem cells with tumorigenic transformation (Herszfeld et al., 2006; Baker et 
al., 2007; Harrison et al., 2007; Yang et al., 2008; Werbowetski-Ogilvie et al., 2009; 
Harrison et al., 2009; Blum and Benvenisty, 2009; Hovatta et al., 2010; Ben-David and 
Benvenisty, 2011). The “best” ESCs in culture, which most researchers would pick for 
propagation, are the cells that show higher proliferative rates, decreased differentiation 
and apoptosis and enhanced clonogenicity. The paradox is that the cells that 
demonstrate the above characteristics are also the ones that are most likely to carry 
karyotypic changes similar to the ones observed in tumorigenic transformation.  
 
Recurring chromosomal aberrations hint towards an underlying selective mechanism 
rather than random acquisition. For hESCs in particular, frequent genomic changes are 
similar to changes observed in cancer cell types. For example, the common 
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chromosome 12, 17 and X amplifications in human pluripotent cells, discussed in the 
previous section, are also present in germ cell tumours and EC cells (Baker et al., 2007; 
Blum and Benvenisty, 2009). In addition, the recurrent 20q11.21 amplicon has been 
also reported in lung cancers and giant-cell tumour of bone (Beroukhim et al., 2010).  
When analysed by teratoma formation, adapted hESCs gave rise to tumours containing 
more primitive types of tissues and OCT4-positive cells in contrast to teratomas from 
normal hESCs that showed a more differentiated phenotype (Herszfeld et al., 2006; 
Yang et al., 2008). Finally, Herszfeld et al. (2006) observed that the expression of the 
CD30 surface marker, an EC-specific surface antigen, is restricted to the adapted hESCs 
and it can be used to distinguish them from normal hESCs. However, this finding was 
not confirmed by Harrison et al. (2009), suggesting that CD30 expression is not a 
universal characteristic of adapted hES cell lines and different mechanisms can 
contribute to culture adaptation.  
 
Interestingly, initial findings suggest that ESCs demonstrate much lower spontaneous 
mutation rates than their somatic counterparts (10-6 in ESCs versus 10-4, assessed by 
the number of spontaneous mutations at the Aprt reporter gene) (Cervantes et al., 
2002). Since ESCs are endowed with the task to give rise to the whole developing 
embryo, a high mutation frequency cannot be tolerated. In fact, stringent mechanisms 
of DNA damage repair are present in order to assure their genomic integrity and cells 
with DNA damage are eliminated through apoptosis or differentiation (Tichy, 2011). 
For example, mESCs lack a G1 checkpoint following DNA damage and thus they are 
directly routed towards apoptosis (Hong and Stambrook, 2004). However, it has been 
found that the G2 decatenation checkpoint, which delays entry into mitosis if the 
chromosomes have not been sufficiently decatenated or disentangled, is error-prone in 
mESCs which could result to severe aneuploidy (Damelin et al., 2005).  
 
Nonetheless, genomic aberrations occur in pluripotent stem cells and more importantly 
in a non-random fashion. For iPSCs particularly, there are three potential types of 
aberrations: (i) mutations in the parental somatic cells, (ii) mutations arising during the 
reprogramming process and (iii) genomic aberrations linked to prolonged culture 
propagation (Mayshar et al., 2010; Ben-David and Benvenisty, 2011). The sequencing of 
three mouse iPSC lines and their parental MEFs showed no evidence of high mutation 
rates during reprogramming (Quinlan et al., 2011). Studies in human iPSCs reported 
different types and rates of mutation associated with reprogramming (Laurent et al., 
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2011; Gore et al., 2011; Hussein et al., 2011) but  one of these studies proposed that the 







The transcriptome is the total of all RNA molecules present in a cell, including mRNAs, 
non-coding RNAs and small RNAs. The study of the transcriptional state of a cell is 
referred to as transcriptomics in contrast to the term genomics which describes the 
analysis of the genetic content of the cell. While the genome is relatively constant for 
the cells of a given organism, the transcriptome is widely varying from cell to cell 
depending on the specific type of tissue and the specific circumstances.  The variations 
of the transcriptional state of a cell are depicted through different gene expression 
patterns. Gene expression is the process that begins from the transcription of a gene to 
produce a primary transcript (RNA molecule), continues with the processing of the 
primary transcript to obtain a mature RNA (mRNA) after intron removal (splicing) and 
finishes with the production of a functional protein.  
 
Recent technological advances have generated a set of methods that can be used for the 
analysis and the quantification of the transcriptome. These technologies can be grossly 
divided into two categories: hybridisation- and sequencing-based approaches. 
Hybridisation-based techniques mainly rely on the use of microarrays. The application 
of microarray technology for the identification of genomic abnormalities has been 
already introduced in section 2.2.2. In the following sections a brief introduction of the 
gene expression microarrays and the RNA-seq technologies is provided. In addition, 
section 2.3.3 describes the application of transcriptomics analysis for the validation of 
the genomic integrity of a cell population, a concept that is fundamental to this study.  
 
2.3.1. Gene Expression Microarrays 
 
Gene expression microarrays can quantify the expression levels of thousands of genes 
of an organism in a single reaction. In a typical microarray experiment, mRNA 
molecules are hybridised to DNA template molecules which are fixed on a solid surface 
(glass slides, silicon chips or nylon membranes). The DNA template molecules, referred 
to as probes, can be cDNA or synthesised oligonucleotides of known sequences that 
complement the target transcript and known location on the chip and thus allow the 
identification of the expression levels of a gene whose mRNA product hybridises to a 
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specific probe (Schena et al., 1995; Schena et al., 1996; Lockhart et al., 1996). Typically 
the sample mRNA is reverse transcribed into the more stable cDNA and mRNA or cDNA 
is labelled by the incorporation of a fluorescent nucleotide. Hybridisation to the array is 
then performed and complementary sequences quantitatively bind depending on the 
abundance of each mRNA or cDNA molecule. The resulting fluorescent signal from each 
spot of the array gives a measure of the relative abundance of the target transcript in 
the test sample. These fluorescent signals are recorded by a laser scanner or CCD 
camera and computer image analysis outputs the final raw intensities for each 
transcript.  
 
In cDNA microarrays, PCR-amplified DNAs (usually longer than 1 Kbp) are immobilised 
on the array chip. In oligonucleotides arrays the probes are shorter. Affymetrix 
GeneChip® arrays made by photolithography in situ include nucleotides of about 25 bp 
length (Lipshutz et al., 1999). In the Affymetrix GeneChip technology, multiple 
independent probes are designed to hybridise to different complementary sequences of 
the 3’ end of each transcript in an attempt to minimise the signal-to-noise ratios and 
cross-hybridisation effects. Arrays based on this design are called 3’ expression arrays 
and include some of the most popular arrays such as the Human U133 Plus 2.0 or the 
Mouse 430 2.0 array. In 3’ expression arrays, probes are designed in pairs that differ 
only in one base pair in the middle of the sequence. The perfect match (PM) probes 
have a perfect complementary sequence to the target, while their partner mismatch 
(MM) control probes differ in the middle base of the sequence. Thus, the MM probes are 
used to control for background and cross-hybridisation noise. Recently, Affymetrix has 
released a new technology, the Exon arrays, that specifically interrogate gene 
expression at the exon level. Contrary to the traditional 3’ expression arrays which use 
the MM probes to account for non-specific hybridisation, Exon arrays do not include 
MM probes but use instead a set of probes designed to measure cross-hybridisation 
noise due to pure background.  
 
Another popular manufacturer, Agilent Technologies, produces arrays of longer 
oligonucleotides (~60 bp) manufactured in situ by use of ink jet printing technology 
(Hughes et al., 2001). Oligonucleotides arrays have the advantage over cDNA 
microarrays that they do not require the generation and management of clone libraries. 
In addition, it has been reported that the longer oligonucleotides provided in the 
Agilent platform give better sensitivity due to the larger surface available for 
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hybridisation (Hardiman, 2004).  
 
Besides the actual abundance of a given transcript, several other factors can influence 
the intensity measurements from a microarray experiment. These include the sample 
preparation protocol, the array type, the sensitivity of the hybridisation process and 
the signal quantification (Hartemink et al., 2001). Because of the presence of this 
technical variation between different microarray samples, it is necessary to apply 
sample normalisation before performing data analysis. One of the most widely-used 
methods for Affymetrix GeneChip arrays normalisation is the Robust Multi-array 
Average (RMA) method described by Irizarry et al. (2003a). The RMA method includes 
three basic steps: an array-specific background adjustment, quantile normalization to 
ensure that the distribution of the expression values of each array in the comparison is 
the same and, finally, summarization to generate the normalised measurement for each 
probe (Bolstad et al., 2003; Irizarry et al., 2003b). The RMA method does not 
incorporate the PM/MM information which is available in the 3’ expression arrays 
since it has been shown that subtraction of the MM signal from the PM signal can be 
problematic in the lower quantile of expression values due to noise (Irizarry et al., 
2003b). One downside of the method is that it can be applied for the normalisation of 
samples from the same type of gene chip only. In the present study the RMA method 
has been used for the normalisation of samples from the Mouse 430 2.0 array. In 
addition, the PM/MM information has been used for the generation of the 
Present/Absent flags (further discussed in section 3.5) using the MAS5.0 algorithm 
(Hubbell et al., 2002). 
 
The microarray methods are at the moment one of the most widely adopted tools for 
transcriptomics analysis due to their relative low cost and the high throughput they 
provide. Their popularity is depicted in the ever increasing number of publications to 
date using this technology. Accordingly, there is a wealth of readily available datasets 
deposited in public data repositories such as the NCBI’s Gene Expression Omnibus 
(GEO) (Edgar et al., 2002) and the EBI’s ArrayExpress (Brazma et al., 2003). 
Researchers can easily access this data in order to re-analyse or compare results and 







The recent advances in the next-generation sequencing technology have also been used 
in the context of transcriptomics. Providing the highest resolution achieved to date, 
RNA-seq (RNA sequencing) can generate hundreds of millions of reads that can be 
analysed to provide an even more comprehensive image of the transcriptome. Briefly, 
the RNA-seq protocol consists of the collection of the sample RNA, which is 
subsequently used to generate a collection of cDNA fragments with adaptors ligated at 
one or both ends of the short sequence. The cDNA collection is typically amplified and 
high-throughput sequencing is performed to obtain reads from either the one end of 
each fragment (single-end sequencing) or from both ends (paired-end sequencing). 
Sophisticated algorithms are then used to perform quality control, align the reads to 
the reference transcriptome and identify differentially expressed transcripts or 
investigate other types of non-coding RNAs and microRNAs. Different sequencing 
technologies exist (i.e. Illumina (Solexa), Applied Biosystems, 454 Life Sciences) and 
each of them has specific limitations that render it more suitable for different types of 
applications. Nonetheless, RNA-seq presents several advantages over microarray 
technology including the wider range of expression it can capture (avoiding the caveat 
of decreased sensitivity in the lower and higher expression range that is present in 
microarrays) as well as the important ability to detect novel transcripts. A detailed 
discussion of the method, its advantages and limitations is provided by Wang et al. 
(2009).  
   
2.3.3. Identification of Aberrant Genomic Regions at the 
Transcriptional Level 
 
Concordant changes in gene expression levels across whole chromosomes or 
subchromosomal regions could be the result of underlying genomic or epigenetic 
alterations. Several studies from the field of cancer biology, where genomic aberrations 
are frequently observed, have demonstrated that the expression levels of a substantial 
number of genes in regions of chromosomal amplifications or deletions are altered in 
accordance with the DNA copy number of these regions (Pollack et al., 2002; Hyman et 
al., 2002; Kahlem et al., 2004; Myers et al., 2004; Schoch et al., 2006). For example, 
studying the correlation between gene expression levels and DNA copy numbers in 
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human breast tumours, Pollack et al. (2002) have shown that 62% of the genes in 
amplified regions have corresponding elevated levels of expression (at least 2 fold 
change) and a two-fold change in DNA copy numbers manifests as an average 1.5 fold 
change in gene expression levels. In addition, Mayshar et al. (2010) has successfully 
applied this approach in human pluripotent stem cells (discussed in detail in section 
4.1.2).   
 
Of note, the analysis of microarray data for the inference of regions of genomic 
abnormalities has several major benefits. First of all, there is a plethora of gene 
expression microarray data that is not accompanied with the equivalent genomic data. 
Ideally the analysis of genomic and transcriptional data should be combined; 
nonetheless, the mere amount of available transcriptional profiles provides a wealthy 
source of information that can be used to infer recurrent chromosomal abnormalities in 
large-scale meta-analysis approaches. Furthermore, it is to be expected that not all the 
genes in the affected genomic region, in fact only very few of them, will be functionally 
related to the mechanisms that confer selective advantage to the aneuploid cells. These 
key regulators need to be distinguished for genes in the affected region that also 
frequently have an aberrant copy number due to linkage. These genes would appear 
frequently altered in meta-analysis approaches, albeit as a result of their physical 
proximity with the key regulators rather than their functional consequences. The use of 
transcriptional data could thus potentially help in distinguishing the driver genes from 
the functionally unrelated bystanders, at least in the case where they do not 
demonstrate significant changes in their expression levels. Finally, this approach allows 
the simultaneous examination of the downstream effects of an aberration in a genome-
wide scale by providing information about putative targets that are not necessarily 
located in the aberrant region.  
 
The downside of the approach is the fact that it is not always clear if the observed 
pattern is a result of underlying genomic abnormality, or epigenetic alteration or even 
transcriptional regulation, especially in the case of genomic regions that only contain a 
small number of genes with altered gene expression. In addition, sophisticated 
bioinformatics analysis must be applied in order to infer the precise coordinates of the 
affected regions because of the noise introduced by genes whose expression is not 
necessarily changed by the presence of aneuploidy. For example, genes whose 
regulatory elements are not present, or are not generally expressed in the specific 
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tissue won’t appear differentially expressed even if they are found in the 
amplified/deleted region. In addition, some genes may even appear differentially 
down-regulated while in an amplified region (or over-expressed while in a deleted 
region) if they demonstrate dramatically different expression levels in the control 
sample (i.e. dramatically over-expressed genes in a control without a gain may appear 
differentially down-regulated in the test sample carrying the gain due to the relative 
differences in the microarray measurements).  
 
Several tools have been developed for the discovery of genomic clusters of 
differentially expressed genes that can be diagnostic of underlying aneuploidies. 
However, the use of these tools is not often reported in literature especially in the field 
of stem cell research. In section 3.1.2, a detailed presentation of the available methods 





2.4. Machine Learning and Pattern Recognition in Gene 
Expression Data 
 
2.4.1. Clustering Techniques 
 
Cluster analysis consists of a set of unsupervised machine learning techniques that seek 
to group data that fall in distinct categories (clusters), with members within each group 
being similar to each other according to some scoring function and dissimilar from 
members of other groups (Hand et al., 2001).  
 
Clusters analysis has been widely applied in biological studies where the researcher 
aims, for example, to group types of tissue samples based on the expression levels of   
sets of genes. (Eisen et al., 1998) have demonstrated how cluster analysis can be used 
to group genes with similar expression profiles across a range of samples, visualise the 
results in an intuitive way and potentially identify functional categories related to 
specific clusters. Given that the original publication of Eisen et al. (1998) has been cited 
by ~11,400 authors (source: Google scholar), the popularity of clustering among the 
biology scientific community cannot be doubted. In some cases, however, it has been 
regarded with scepticism since clustering results of microarray experiments are often 
not reproducible, especially where the number of analysed samples is small (<50) 
(Garge et al., 2005).  
 
Different clustering techniques have been developed thus far that can identify different 
kinds of clusters. Some of the widely used clustering methods are hierarchical 
clustering (Sokal and Michener, 1958), k-means clustering (MacQueen, 1967) and self-
organising maps (SOMs) (Kohonen, 2001).  Among them, the hierarchical clustering is 
one of the most (if not the most) widely adopted method for gene expression 
microarray analysis (Allison et al., 2006). Here, a brief description of the agglomerative 
hierarchical clustering approach is provided. Detailed description of other methods 
that can be used for clustering is not in the scope of this thesis.  
 
Hierarchical clustering gradually merges similar points (agglomerative) or divides 
super-clusters (divisive). In addition, it offers an intuitive graphical representation of 
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the entire merging (or splitting) of the clusters in a tree-like plot, called the 
dendrogram. Clustering can be also simultaneously performed for both the samples in 
the study and the genes under measurement (Figure 2.6). In the agglomerative 
hierarchical clustering samples and, subsequently, clusters of samples are merged 
according to some distance measure. Initially, samples that have the smallest distance 
are merged and then each two clusters that are nearest are merged until the whole 




Figure 2.6 Heatmap of ALL data after filtering. 
The rows of the heatmap correspond to genes and the columns to samples. Here, hierarchical 
clustering has been performed simultaneously to genes and to samples as depicted by the plotted 
dendrograms on the left and on the top of the heatmap. Class members are indicated by blue or 
purple under the samples dendrogram [figure from (Tarca et al., 2007)]. 
 
Common distance metrics for agglomerative hierarchical clustering include the: 
 Euclidean distance,                 
 
  
 Manhattan distance,                  
 Mahalanobis distance,                 where   is the covariance matrix, 
and 
 Pearson correlation coefficient,      
               
 
   
         
, which is the metric of 
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choice in the present study and it is presented in detail in section 4.3.2. 
 
Euclidean and Pearson correlation-based distance are the most widely applied metrics 
in gene expression microarray analysis. There are however differences between the 
two metrics. Given three genes A, B and C, if we assume that the vector of expression 
values for gene A is closer to that of gene C but the expression of genes A and B changes 
in a similar way, then using the Euclidean distance will result to merging genes A and C, 
while using the Pearson correlation will result in merging genes A and B. Different 
distance metrics can, therefore, differentiate but there is not a consensus on which 
method is most appropriate for a specific dataset (Allison et al., 2006).  
 
Another concept that arises in hierarchical clustering is the type of linkage to be 
applied for cluster merging. There are three typical variants to calculate the distance 
between two clusters while forming the dendrogram (Figure 2.7): 
 Average linkage 
The distance between two clusters is the average/median pair-wise distance 
among all the members of the clusters. 
 Single linkage 
The distance between two clusters is the smallest pair-wise distance between 
all the cluster members. 
 Complete linkage 
The distance between two clusters is the maximum pair-wise distance between 
all the cluster members. 
 
 
Figure 2.7 Three different types of clusters distance definitions used in hierarchical clustering.  
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2.4.2. Classification Techniques 
 
Predictive models for classification are a set of supervised machine learning techniques 
that allow us to identify a mapping from a vector of measurements to some categorical 
value. The categorical value to be predicted is typically called the class of the data. A 
typical classification task consists of the creation of a prediction rule based on the 
measurements  of a variable (attribute, feature) in samples with a known class label 
and the estimation of the performance of this rule in samples that has not been used to 
construct the rule (Hand et al., 2001). A classification problem can be perceived, 
therefore, as the construction of a class assignment function. This function will map the 
input space   to the categorical class space  . In deterministic classification, examined 
here, the sample is assigned to the correct class (contrary to the probabilistic 
classification where the sample is assigned to the most probable class). The class is 
known for the samples used in training the model (creating the prediction rule) and the 
class of the rest of the sample space needs to be estimated by applying the most 
accurate model.  
 
The classification problem can be formulated as following: each sample is a pair         
where   is a  -dimensional vector of the measured attributes (features), usually but not 
necessarily real-valued variables, and   is the class label of the sample, typically taken 
from a definite set of categorical labels            . The input of the classifier is a 
set of         pairs, namely the training set, which is used to construct the prediction 
rule. After the training phase is over, the classifier can be used to predict the class label 
of a new test vector  . 
 
A closely related concept is the decision boundary (or decision region) of the prediction 
rule. If, for the sake of simplicity, we consider a classification model with only two input 
variables    and    and two output classes    and   , the prediction rule will identify a 
piecewise constant surface in the (  ,  ) space that is partitioned according to    and 
  . That is each point in the space will only belong to one of the two classes. So another 
way of defining the classification task is the learning of these decision boundaries 
(Hand et al., 2001). Given how different classification methods have different ways of 





The majority (if not all) of classification models have one or more free parameters. A 
free parameter is a variable of the model that can be used to tune the model towards a 
more accurate prediction. Ideally, models with the lowest number possible of free 
parameters that can still produce accurate predictions should be preferred. That is 
because in models with a small number of free parameters (equal or less than the 
attributes used as input), over-fitting is less likely to occur. The term over-fitting refers 
to the ability of a model to perfectly describe the training data but lacks generalisation 
capacity to data that have not been used in the training process. Of course, this is 
exactly the requirement of a good classification model: its ability to perform well in 
unseen data. In the case of datasets where the number of input features is so much 
greater than the number of available samples (which is normally the case in microarray 
gene expression experiments for example), over-fitting can be a common and limiting 
problem.  
 
Classification has been widely used in many fields of biology and especially in 
microarray gene expression analysis. For microarray gene expression classification, 
each sample consists of thousands of measured features (gene transcripts) and belongs 
to a specific class (i.e. different tumour types) (Tarca et al., 2007). The great 
dimensionality   of the input vector   in the case of a gene expression microarray (that 
is the high number of input features measured in each microarray sample) and the low 
number of samples that is commonly available in a biological experiment makes the 
danger of over-fitting prominent in this type of analysis. In order to minimise this 
problem, it is required to select a small sub-set of features whose expression best 
correlates with the class of the sample and, therefore, is more likely to be informative 
during the creation of the prediction rule. This process is referred to as feature 
selection.  
 
2.4.3. Feature selection for classification 
 
Feature selection is commonly applied in order to identify a subset of features that can 
most efficiently distinguish between the two (or more) classes of the samples. Feature 
selection can be performed in two quite distinct ways: either by choosing the most 
appropriate features or by eliminating the most irrelevant features (Cristianini and 
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Shawe-Taylor, 2000).  
 
Feature selection methods broadly fall into two categories: filter models and wrapper 
models. In filter models, feature selection is a pre-processing step, independent of the 
type of the classifier used. The computational cost of this approach is less but it can 
result to loss of information through the removal of features that could prove valuable 
for the creation of the prediction rule under a specific classification model. An example 
of feature selection through filtering was performed by Golub et al. (1999) where only 
genes with a high correlation with a specific cancer class were used as input. A 
repository of different filter methods for feature selection can be found in (Zhao et al., 
2010). In wrapper approaches, the feature selection step is highly dependent on the 
classification model. Subsets of features are iteratively chosen and the accuracy of the 
classifier is evaluated. In this scenario, the classifier can be perceived as a “black box” 
that is being used to evaluate the predictive power of a specific feature subset (Guyon 
and Elisseeff, 2003). The set of features that results to the highest accuracy levels is 
subsequently chosen. The downside of these methods is that the identification of the 
optimal subset of features is an NP-hard problem: a problem that it is believed that it 
cannot be solved in polynomial time and, thus, it is extremely difficult to solve (Amaldi, 
1998). A detailed discussion of different wrapper methods and definitions of the 
optimal feature set can be found in (Kohavi and John, 1997).   
 
2.4.4. Validation in classification 
 
There are different techniques that can be used in order to estimate the accuracy of a 
classifier and different measures that can be used to report it. From the methods that 
give an estimation of how well a classifier can generalise to new datasets, the following 




The original dataset is split into two subsets: the training data and the test data. The 
training data are used to generate the prediction rule, while the test data are used to 
estimate the error rates of the classification. The downside of this method is that part of 
the information that can be used to train the classifier is lost as it is being used to test it. 
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In the case where the number of available samples is limited it may not be desirable to 
set aside part of the dataset for testing.  It is also possible that the error rates obtain are 





Cross-validation is another commonly applied technique. It can be divided in three 
categories: random subsampling, K-fold cross-validation and leave-one-out cross 
validation (LOOCV). In the random subsampling, a fixed number of samples are 
randomly selected to constitute the test data. The remaining data are used to train the 
classifier. This process is repeated   times and the average error rate obtained from 
each run represents the true error estimate. In the K-fold cross-validation, the     
first sub-samples are being selected for training in the first fold, the next     sub-
samples for the second fold and so on until all samples have been used for training. It is, 
in reality, very similar to random subsampling with the exception that the use of all 
samples as part of the test data is guaranteed. The true error rate is again calculated as 
the average of all error rates obtained at each fold. Finally, the LOOCV is a special case 
of K-fold cross-validation where    . Typically, a good choice for   is    . In the 
case of datasets where few samples are available LOOCV may be a better choice since 




Bootstrapping is random resampling with replacement. This means that from a dataset 
of   samples,   samples are chosen with replacement for training and the remaining 
are used for testing. The process is repeated for   folds and the true error rate is again 
estimated by the average of the error rates obtained from each test subset.  
 
Three-way data partitioning  
 
In the three-way data partitioning method, data are divided in three subsets: the 
training, the validation and the test group. The training data is used to train the 
classifier and the validation data is used to choose the classifier with the lowest error 
rate. Next, the test data is used to report the true error rate of the model. In this way, 
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the true error rate is less biased since it has been calculated on data that have not been 
used in any way for the selection of the best-scoring classifier. Given that depending on 
the availability of samples may not be affordable to limit the number of samples used 
for the training of the classifier, another approach is to merge the training and 
validation datasets after choosing the best performing classifier and re-train the 
classifier with the merged dataset. The true error rate of the test dataset is then 
reported. The latter is the approach adopted for the training and validation of the SVM 
classifiers discussed in section 5.3.3.  
 
Finally, as mentioned in the beginning of this section different measures can be used to 
perform error estimation. Most commonly in literature, the F-score and the Area Under 
the ROC Curve (AUC) have been applied. The AUC measure is used in the case of cross-
validation experiments. In the present study, the F-score and the accuracy measures 
have been used to describe the error rates of the classification models. These are 
defined as following: 
 
         
     
           
            
  
      
        
  
     
 
           
                




                                  
                                   
 
F1 score gives a balanced estimation between Precision and Recall and it is the most 
popular metric in cases of unbalanced classes (when instances of the one class are far 
more abundant than instances of the other). Accuracy, on the other hand, tends to 
under-estimate the ability of the classifier to predict smaller classes (Forman and 








2.4.5. Some considerations for the classification of microarray data 
 
In a typical microarray experiment replicate samples are collected from each condition. 
The common practice is to represent each replicate group with a single averaged 
instance. Since the number of available samples can be limited this results to a loss of 
important information that could have been used to better train the classification 
model. An alternative to this problem has been proposed by Karpievitch et al. (2009) 
with the use of subject-level bootstrapping in Random Forest (RF) classification.  In any 
case, it is evident that the expression profiles of replicate samples are highly correlated 
and, thus, including replicate samples from the same study in both the training and the 
test datasets will introduce significant bias. It is a prerequisite, therefore, to partition 
the data in such a way that samples from the same study belong to only one of the 
partitioned groups, namely the training, the validation or the test data.  
 
An additional consideration, highlighted in the study of Simon et al. (2003), is that the 
data used for testing and estimating the error rate of the classification model should 
not be included in the process of feature selection. For example, when cross-validation 
is used for the estimation of the error rates, feature selection has to be performed anew 
for each fold. If this important consideration is overlooked the estimated error-rates 
might be highly biased due to over-fitting to the specific dataset. Detailed description of 




2.5. Research Objectives 
 
The recurrence of specific abnormalities in pluripotent stem cells and their potential 
link to mechanisms that promote selective growth in culture raises three important 
questions: (i) how the presence of such aberrant patterns can hinder the validity and 
reproducibility of experimental results, (ii) what is the transcriptional footprint of 
these genomic changes and (iii) what information can we extract from these signatures 
to get insights into the normal biological functions of stem cell biology.  
 
In order to address the above questions, this study will be focusing on: 
 
 The development of sensitive bioinformatics tools that can be used for the 
identification of chromosomal aberrations from gene expression profiling data 
(i) at a single experiment level (DI.S.C.O. application) and (ii) in a large-scale 
integrated type of analysis,   
 The application of the proposed methodologies for the assessment of a large 
collection of published transcriptional profiles from mouse pluripotent stem 
cell studies in order to quantify the overall frequency of aneuploidy and the 
recurrence of specific patterns, 
 The identification of transcriptional signatures that are linked to aneuploidy,  
and, finally,    
 The exploration of different classification models that can predict underlying 




3. DI.S.C.O.: A Genomic View of Transcription 
 
 
Figure 3.1 The DI.S.C.O. logo 
 
This chapter introduces a novel computational tool for the analysis of gene expression 
data in the context of genomic position. DI.S.C.O. (DIscovery of Subtle Clustered 
Organization) can be used to identify regions of non-random transcriptional activity in 
the genome by a combination of visualisation and statistical techniques. The DI.S.C.O. 
application, an example dataset and the application’s user manual is provided as part of 






As it has been highlighted by many independent studies (see section 2.2), the 
accumulation of chromosomal abnormalities in human and mouse pluripotent stem 
cells upon prolonged propagation in culture is a frequent phenomenon. These findings 
stress the need for karyotypic testing of pluripotent cell lines which is most commonly 
performed by chromosome counting, a quick and inexpensive technique that lacks 
however the ability to capture subtle chromosomal abnormalities such as partial 
chromosome gains or losses or complex events such as translocations. G-banding or 
chromosome painting by fluorescence in situ hybridization (FISH) or microarray-based 
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techniques, such as array comparative genomic hybridization (aCGH) and single 
nucleotide polymorphism (SNP) arrays, have higher resolution but they are not 
routinely performed since their cost becomes prohibitive when used for continuous 
testing of many cell lines over many passages. 
 
Importantly, it is also possible to identify chromosomal imbalances by studying the 
genomic localization of gene expression levels. Chromosomal intervals of non-random 
transcriptional activity can be diagnostic of underlying aneuploidies which 
concordantly affect the expression patterns of the genes in the aberrant region. This 
approach has been already applied by two recent studies in order to identify patterns 
of chromosomal aberrations in human hESCs, hiPSCs and other multipotent cell types 
(Mayshar et al., 2010; Ben-David et al., 2011).  
 
In the field of cancer biology, where genomic instability is prevalent, some of the 
developed methods specifically examine the relationship between gene expression 
levels and DNA copy numbers, using paired datasets, and have shown the high 
correlation between these two types of genomic data in the affected regions. These 
studies have examined a variety of disease and tumour profiles varying from breast 
cancers (Pollack et al., 2002; Hyman et al., 2002; Myers et al., 2004; Buness et al., 2007), 
head and neck squamous cell carcinoma (Masayesva et al., 2004), renal cell carcinomas 
(Cifola et al., 2008),  trisomy 21 in Down syndrome patients and its equivalent mouse 
model (Kahlem et al., 2004; Lyle et al., 2004) or acute myeloid leukaemia datasets 
(Schoch et al., 2006; Hertzberg et al., 2007) among others. Alternatively, the emergence 
of chromosomal patterns of aberrant transcription could also be related to the 
perturbation of normal epigenetic regulation, such as the failure of XCI or even large 
region epigenetic silencing, present in cancer (Stransky et al., 2006; Frigola et al., 
2006). 
 
Given the relative abundance of gene expression microarray data compared to aCGH 
and SNP data, assessing genomic integrity at the transcriptional level can provide an 
easy and efficient way to validate pluripotent cell lines and identify problematic 
genomic regions which could potentially otherwise passed unnoticed and, therefore, 
confound the analysis of the experimental results. Furthermore, it can lead to the 
identification of candidate genes that have a causal role in the emergence and 




A number of methods have been thus far made available for this type of analysis, 
typically applied in the field of cancer biology (Toedling et al., 2005; Levin et al., 2005; 
Callegaro et al., 2006; De Preter et al., 2008; Nilsson et al., 2008). Even though the 
developed methods could also be used in a broader spectrum of applications, such as 
the karyotypic validation of pluripotent stem cells, their use has not been widely 
adopted by the biological community, as shown by the small percentage of published 
stem cell studies that include this type of test.  This could be potentially due to a 
number of limitations in the currently available tools that render them inaccessible to 
biologists. For example, algorithms or scripts that require previous familiarization with 
specific statistical environments or programming experience can be limiting to the non-
expert user. In the following sections, a detailed analysis of the related methods and 
their limitations is presented and how each one of them was dealt with during the 
development of DI.S.C.O.  
 
It should be also noted that the usefulness of the approach is not necessarily limited to 
the identification of chromosomal abnormalities. Other applications include the 
discovery of a broad range of general structural genomic features such as the non-
random genomic organisation in the eukaryotes (Michalak, 2008), the regional 
clustering of “housekeeping” genes (Lercher et al., 2002), of genes belonging to the 
same functional pathways (Lee and Sonnhammer, 2003) and of genes with 
spatiotemporal expression patterns in specific tissues or organs (Yamashita et al., 
2004). Finally, concordant changes in the transcriptional levels of genes within a 
genomic region have also been identified around transgenic insertions within cell lines 
(Valor and Grant, 2007).  
 
3.1.2. Related Tools and Limitations 
 
The computational tools currently available for the identification of genomic clusters of 
differentially expressed genes can be roughly divided in three main categories:  
 
(1) segmentation/ clustering algorithms or scripts,  
(2) visualisation tools with no computational detection integration,  




It is immediately evident that the first two categories both suffer from the lack of either 
the visualisation or the computational component. The importance of the graphical 
representation cannot be overstated and it bears a great significance for the user since 
it gives a quick and intuitive first level overview of the data that is complementary to 
the algorithmic analysis. On the other hand, the acceptance or rejection of any scientific 
hypothesis and the reproducibility of the results should be based on proper statistical 
significance which can only be measured with the generation of appropriate p-values 
or defined computational scores. Thus, any tool that fails to incorporate both these 
aspects of the analysis immediately limits its general usability.   
 
In Table 3.1, a detailed list of related visualization tools and/or algorithms for the 
identification of regional enrichment is presented. Highlighted are aspects of each tool 
that can restrict broader application. For example, implementations that are available 
through R (Ihaka and Gentleman, 1996) require a specialised knowledge of the R 
statistical environment which can be challenging for the non-specialised biologist user 
(such as the R scripts E-CHaRGE, MACAT, LAP and PREDA in Table 3.1). In addition, 
complex algorithms with a high number of parameters that need to be adjusted for 
individual datasets require an in-depth understanding both of the algorithm itself and 
the type of patterns that might be present in the dataset, which is not, in the majority of 
cases, a priori known (such as the TV minimization method) (Nilsson et al., 2008).  
 
Another potential drawback under specific experimental hypothesis is the type of data 
that the method can process. Tools that typically accept only gene lists could potentially 
pose a limitation to the detection power of the methodology since they heavily rely on 
the method and the assumptions used for the gene list generation and do not reflect the 
continuous change of the transcriptional levels across the chromosomes (examples of 
such applications are the tools REEF, PGE and CROC in Table 3.1).  
 
Another issue of importance is the capacity of the method to process high-throughput 
sequencing data such as RNA-seq data. Since next generation sequencing technologies 
are currently becoming increasingly popular and a large number of datasets is being 
constantly generated, there is an immediate need for tools that are able to examine data 
derived from this type of technologies. Where indicated, the methods presented in 
Table 3.1 could be potentially adjusted for RNA-seq data, relatively effortlessly by the 
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user without a need to adjust the algorithm itself.  
 
As it is evident in Table 3.1 there are two popular approaches for the identification of 
regional enrichment: (i) the use of sliding genomic window of either fixed (i.e. the 
ChroCoLoc, REEF, CROC and TRAM methods), or adaptive size (PGE method), and (ii) 
the use of a kernel regression smoother (i.e. the E-CHaRGE, MACAT, LAP and PREDA 
scripts).   
 
Almost all the methods of the first type of approach (genomic window) measure the 
enrichment within the window boundaries with the hypergeometric distribution. The 
hypergeometric distribution test gives the probability of having as many enriched 
genes in a specific window size and is defined as: 
 
          
  
 
     






   
 
 
where   is the total number of genes,   the genes in the specific window,   the number 
of differentially expressed genes within   and    the total number of differentially 
expressed genes in  . 
 
In addition, the methods that use the sliding window-hypergeometric distribution 
strategy either test enrichment only in predefined genomic intervals such as the 
cytobands (ChroCoLoc) or require from the user to define the size of the window and 
the offset between subsequent windows (REEF, CROC, TRAM). The PGE method uses an 
improved concept of an adaptive size sliding window which overcomes the need for 
user-defined window properties (also see section 3.7.3 for detailed description). 
 
DI.S.C.O. is addressing the limitation present in current available tools by providing a 
powerful and intuitive graphical user interface and a platform for the analysis of 
transcriptional data in terms of regional enrichment. DI.S.C.O. is particularly designed 
to facilitate the non-expert user. It includes three different computational methods and 
provides a framework for the integration and comparison of additional methods in the 
future. Furthermore, it can be easily used with next-generation sequencing RNA-seq 







Table 3.1: Comparison to related tools.  
List of relevant software applications, visualization tools or algorithms/ scripts that can be used for the identification of regional enrichment of differentially 
expressed genes and distinguishing features.  
Tool Graphical 
Output 
GUI Statistical Test or Algorithm Data input NextGen 
applicable 
Part of complete 
analysis engine 
Platform Publication 
Caryoscope Yes Yes N/A GEP1 No No Java (Awad et al., 2004) 
E-CHaRGE Unknown No Compound Poisson Process 
model-based scan statistic 
GEP No No Requires R (Levin et al., 2005) 
MACAT Yes No Kernel functions GEP No  No Requires R (Toedling et al., 2005) 
ChroCoLoc Yes  Yes Hypergeometric 
Cytobands 






(Blake et al., 2006) 
LAP Yes No Local variable bandwidth kernel 
estimators 
GEP No No Requires R (Callegaro et al., 2006) 
REEF Yes Yes Hypergeometric 
Fixed size sliding window 
Gene lists Yes No Requires 
Python 
(Coppe et al., 2006) 
PGE Yes Yes Hypergeometric 
Adaptive size sliding window 
Gene lists Yes No Web-based (De Preter et al., 2008) 
TV Yes No Total variation minimization GEP Yes No Standalone (Nilsson et al., 2008) 
                                                             
 
 









GUI Statistical Test or Algorithm Data input NextGen 
applicable 
Part of complete 
analysis engine 
Platform Publication 
minimization (segmentation method)  
GeneSpring 
GX 
Yes Yes N/A GEP Yes N/A Standalone Agilent Technologies  
CROC Yes Yes  Hypergeometric 
Fixed size sliding window 
Gene lists Yes No Web-based (Pignatelli et al., 2009) 
TRAM Yes Yes Hypergeometric 
Fixed size sliding window 
GEP No Yes Windows, 
Macintosh 
(Lenzi et al., 2011) 
PREDA Yes No Non-linear kernel regression 
smoothing with adaptive 
bandwidth – Improvement of 
LAP method 
GEP No Yes Requires R (Ferrari et al., 2011) 
DI.S.C.O. Yes Yes Includes PGE, TV minimization 
and Nearest Neighbour 
(clustering approach) methods 






Skylaki et al.,  
In preparation 
 




3.1.3. Previous Work 
 
The fundamental concepts upon which DI.S.C.O. was based were first defined during my 
MSc Thesis in Bioinformatics (Skylaki, 2007). The aim of the project then was to 
develop a software tool that would plot gene expression data from microarray 
experiments as a function of genomic position. It was greatly focused on the 
visualisation aspect and aimed to overcome the main drawbacks of the tools that were 
available at the time. Even though the field has progressed a lot since then, and new 
methods have emerged, many of the limitations identified at that stage are still 
prominent as previously mentioned.   
 
This initial stage of development (hereafter called DI.S.C.O. v1.0) resulted to the 
creation of a prototype application. By the end of the sort time available for the 
completion of an MSc thesis, however, the essential future steps for the transition from 
a prototype application to a complete computational solution became clear. The 
current version of the DI.S.C.O. application, presented here, has indeed moved a long 
way forward in terms of enhanced visualisation functionalities, incorporating multiple 
data analysis options and finally, including statistical detection methods. During this 
process, it has given rise to three more complementary MSc projects whose 
contributions would be also stated where appropriate (Sarantidis, 2008; 
Sveinbojornsson, 2010; Matzavinos, 2011). 
 
The following sections present the fundamental concepts and functionality in the 
current DI.S.C.O. version. In the interest of facilitating the reader, a brief description of 
the original implementation, DI.S.C.O. v1.0, is given in section 3.10, after the 
introduction of the necessary basic principles of the application.  




3.2. System Requirements 
 
The following sections list the requirements that must be met by the DI.S.C.O. 
application during the development phase.  
 
3.2.1. Technical requirements 
 
The programming language chosen for the implementation of the application must be 
supported by all widely used operating systems in order to facilitate the development 
phase and maximise the effectiveness of the tool. The tool must be platform agnostic 
and should require only the minimal effort from the user to install and run. In addition, 
DI.S.C.O. should be a stable and reliable application with reasonable memory 




The visualisation component must offer an intuitive and powerful representation of the 
data which shall be on its own a valuable aspect of the data analysis process. It is 
essential that the initial plotting of the data must be automated and the optimal 
parameters for the visualisation must be data-driven in a sample-specific manner. This 
will enhance the pattern discovery ability of the user and establish the optimal 
parameters for effective visualisation at least at the very first stage. Subsequently, the 
user should be encouraged to explore different visualisation options and tune the 
visualisation parameters at will.    
 
3.2.3. Detection Power 
 
There are certain significant criteria that need to be met to ensure the high detection 
power of the integrated statistical methods: 
 
Detection performance is the accurate identification of clusters of differentially 
expressed genes when they are present in the genome.  








The end users of the application are presumed to be mainly biologists from the 
academic community with no expert knowledge of computational or statistical analysis. 
Therefore, DI.S.C.O. must be freely accessible through the internet and should not 
dependent upon the availability of specialised resources. The installation and set-up 
procedure must be straight forward and the user’s ability to interact with the tool 
should require no previous familiarisation with any programming or statistical analysis 
interface.  
 
The GUI component has to be clear and intuitive and it should facilitate the navigation 
through different options and features. This can be achieved by the use of 
comprehensive and contextual menus and actions as well as the integration of detailed 
documentation and help files. At any given step, the analysis must be transparent and 
the underlying data structures accessible to the user for further examination and 
exporting. In addition, the user must have easy access to summary tables for the 
different analysis steps performed and the type and attributes of the data processed.  
 
Finally, the statistical analysis should require the minimum amount of user 
configuration with initial suggestion of optimal parameters that the user can 
subsequently choose to adjust if desired.       
 
3.2.5. Extended Functionality for the Analysis of Gene Expression Data 
 
The objective of the application presented here is to implement a genomic visualisation 
of the transcriptome while providing computational tools for the discovery of 
statistically significant chromosomal regions of aberrant gene expression levels. Along 
with the realisation of this goal, it is also recommended to enhance the user experience 
by supplying extensive functionality for the analysis of gene expression data in the 
context of genomic position.  
 




commonly applied during gene expression analysis. This includes data transformation 
and normalisation techniques, identification of differentially expressed genes, 
generation of gene lists with specific characteristics, generation of concise reports after 
the completion of the data analysis or data exports in different formats, both tabular 
and image, and finally, direction and representation of the results in independent 
genomic browsers of choice. Furthermore, the user should be able to import custom 
data tracks for the visualisation of different data types, such as array-CGH or SNP data, 




3.3. System Architecture & Implementation 
 
3.3.1. High-level System Architecture 
 
An overview of the high-level system architecture can be found in Figure 3.2. A 
breakdown of the separate components is as follows: 
 
 
Data Input  Required and optional data files for the initialisation of the 
analysis. Further discussion in section 3.4. 
 
Data Processing The core processing machinery of DI.S.C.O. The principal data 
analysis tasks and additional functionalities are presented in 
section 3.5. 
 
Data Plotting The main visualisation component of DI.S.C.O., namely the 
Genome Canvas. Different options to improve the visualisation 
quality. Detailed discussion can be found in section 3.6. 
 
Cluster Analysis This component consists of the automatic calculation of the 
appropriate thresholds for the identification of differentially 
expressed genes as well as the three statistical methods 
integrated in DI.S.C.O. It will be further discussed in section 3.7. 
 
Data  Output Export of the results and saving of the data structures used in 


















DI.S.C.O. has been implemented as a Java Web Start application in order to allow easy 
(cross-platform) access online, using Java 2 SDK standard edition version 1.6.0. Java 
Web Start can be used by any client system that supports the Java 2 platform and 
virtually all browsers. Java Web Start can be run on Windows 98/NT/2000/ME/XP, 
Linux, and the SolarisTM Operating Environment. Macintosh provides a version for their 
OS X release2. The current DI.S.C.O. implementation has been tested on Windows XP 
SP3 and Linux (CentOS release 5.7).  
 
There are a total of 124 classes which are organized in 15 packages as shown in Figure 
3.3. A detailed description of each class relationships, operations, attributes, and 
interfaces will not be attempted here in the interest of brevity. The functionality 
performed through the implementation will become however clear in the following 
sections. A brief explanation of each package and corresponding components is: 
 
Disco.Reader contains the classes that read and validate the input files 
either of the user or of a middleware component. It 
performs error checking and ensures the consistency 
between different data types.  
Disco.Organizer contains the classes that organise the input data into a 
hierarchical logic that follows the order chromosome, 
genome, experiment, normalisation and viewer.   
Disco.Viewer is responsible for all the visualisation operations. 
Disco.Analyzer consists of classes that perform the main analytical tasks. 
The calculation of Present/Absent flags, the replacement of 
replicate probe sets, the gene density estimation and the 
normalisation of the data are executed here.   
Disco.Plotter contains classes responsible for the creations of 
supplementary plots and graphs.  
Disco.Writer is responsible for all data exporting operations. 
                                                             
 
 




Disco.Tools contains various help classes utilised in specific tasks.    
DISCOhelp implements the DI.S.C.O. help system. 
Clustering.common contains the classes that are commonly used from all 
clustering methods.  
Clustering.stats includes all the necessary statistical operations for the 
clustering methods. 









3.4. Data Input 
 
The data files supported by DI.S.C.O are tab delimited text files. There are five data files 
that can be imported at the initiation of the DI.S.C.O. analysis: (i) the genome annotation 
file, (ii) the gene expression file, (iii) the Present/Absent flags file, (iv) the cytobands 
file and finally (v) the normalisation scheme file. The genome annotation and the gene 
expression files are essential for the analysis while the cytoband, the Present/Absent 
flags and the normalisation scheme files are optional. The content and format of each of 
these files is described as follows:  
 
The Genome Annotation file 
 
The genome annotation file provides information about the genes that are included in 
the analysis and their physical mapping on the genome. It consists of three columns: 
the transcript identifier, the common name of the corresponding gene and the mapping 
position in the genome and as many rows as the genes included in the experiment. The 
transcript identifier can be i.e. the probe set ID provided in Affymetrix microarray 
chips, the Illumina Probe ID in Illumina BeadChip arrays or any custom identifier (key) 
defined by the user as long as it is unique for each row.  
 
When two (or more) mapping positions are assigned to the same transcript, only the 
first one will be considered for plotting. In addition, transcripts not assigned to a 
specific chromosome will be excluded from the analysis.  
 
The Gene Expression file 
 
The gene expression file provides the information about the expression levels of each 
gene in each sample included in the analysis. There is an 1-to-1 correspondence 
between each row of the gene expression file and the genome annotation file. The first 
column represents the transcript identifier while any subsequent column (as many as 
the samples included in the analysis) contains the normalised gene expression values 
for each transcript in each sample. The transcript identifier is matched between the 
gene expression file and the genome annotation file. When the two files are largely 





The P/A flags file 
 
This file is particularly relevant for the analysis of Affymetrix microarrays. As it has 
been briefly mentioned in section 2.3.1, the MAS5.0 algorithm (Hubbell et al., 2002) 
uses the measurements from the pairs of PM and MM probes in Affymetrix GeneChips 
to calculate a p-value reflecting the confidence that a gene is present in a sample. It then 
attributes a flag (or call) for each gene that can either be Present (P), Absent (A) or 
Marginal (M) (Liu et al., 2002). A probe set with an Absent flag has an expression 
intensity near to zero which can be due to the absence of expression of the 
corresponding transcript or problematic hybridisation. If, in the control sample, the 
same probe set has a higher expression intensity but still close to zero, it might appear 
differentially expressed. In reality, there is no confidence that the gene is present and it 
should be filtered out of the analysis.  
 
The Present/Absent (P/A) calls file format is similar to the expression values file 
format where for each probe set P stands for Present and A for Absent for each sample. 
In the case where neither P or A is present in a column (for example M for Marginal) 
the gene is considered present for that sample. The user can generate this file using the 
MAS5.0 algorithm. In the case where the experiment is not performed with the 
Affymetrix platform, a custom threshold can be used to exclude Absent transcripts (i.e. 
transcripts in the range of the lower 50% of intensities per sample could be called 
Absent) (McClintick and Edenberg, 2006) or any other measure of choice (i.e. variance; 
Hackstadt and Hess, 2009). In addition, for RNA-seq data a user-defined threshold of 
minimum number of reads per transcript can be applied for the generation of the P/A 
flags file.  
 
The Cytoband file 
 
The cytoband file follows the BED format (standard UCSC Browser format) and can be 
directly downloaded from the UCSC site or from our server for human, mouse or rat 
(http://disco.stembio.org/). It describes the Giemsa stain bands of each chromosome in 






The Normalisation Scheme file 
 
At this point, it is necessary to make the distinction between the normalisation of the 
raw gene expression intensities using an appropriate normalisation method such as 
RMA (as described in section 2.3.1) and the normalisation of samples in order to 
identify differentially expressed genes, which is the focus of this section. The initial 
normalisation of the raw expression values must be performed by the user before data 
input. It is essential because it corrects for sample-specific background noise and 
brings the distribution of the expression values of each sample in the same range 
rendering them comparable.  
 
The normalisation scheme, described here, refers to the way the samples are grouped 
and compared in order to identify the set of genes that show significant difference in 
their expression levels between the groups.  Each sample can be assigned a set of 
attributes as for example replicate id, normal or tumour, time collected or type of 
strain. These parameters can be used to group the samples and subsequently compare 
them in a meaningful way, i.e. normal versus tumour, in order to find the genes that 
change between the two conditions.  
  
The normalisation scheme file consists of as many rows as the number of samples for 
the specific experiment and as many columns as the number of parameters the user 
wishes to include. The sample names must match the sample names used in the 





3.5. Data Processing 
 
3.5.1. Typical workflow 
 
After the data input step, the internal DI.S.C.O. data processing functionality begins. A 




Figure 3.4 A typical workflow of the initial data processing of a new experiment.  
It starts at the top left corner with the creation of a new experiment and finishes at the bottom right 
corner with the visualization of the data in the Genome Canvas window. The human icon indicates 







A detailed breakdown of each step follows: 
 
a. Load new experiment 
 
b. Import files (as described in section 3.4) 
 
c. Verify annotation 
 
The fold change (FC) of each gene is calculated based on the measurements provided in 
the gene expression file. The information of the physical position of the gene is found in 
the genome annotation file. Therefore, in order to assign the fold change (FC) of each 
gene at its respective genomic position, an 1-to-1 relationship must exist between the 
gene identifiers of the genome annotation file and the gene expression file. This step 
verifies the consistency between these two files. Transcripts that are not represented in 
both files are excluded and the processing continues as long as at least 80% of the 
genes are matched between the two files. Otherwise an error exception is thrown and 
the user is prompted to review the files. In addition, transcripts with no genomic 
mapping available are removed from the analysis.  
 
d. Estimate gene density 
Gene density across the chromosomes is calculated by a fixed size sliding window of 1 
Mbp and a step size of the same size. Gene density is defined by the number of genes at 
any given genomic window divided by the expected number of genes if they were 
equally distributed on the chromosome.  
 
e. Calculate Present/Absent flags 
As it has been mentioned in the previous section, the P/A flags file can be imported by 
the user if it is already available. If, however, this file is not available to the user, P/A 
flags can be internally calculated in DI.S.C.O. They are assigned according to the lower 
percentile of the raw expression values that are considered to be expressed at 
background noise levels, as defined by the user during the data input step. The filtering 
out of the lower 50% of genes has been shown to eliminate most of the unreliable 






f. Identify replicate probe sets 
 
In the Affymetrix GeneChip arrays, a single gene may be represented with multiple 
probe sets on the chip. In the present study, probe sets that measure the expression 
levels of the same gene are referred to as replicate probe sets. As an example, in the 
mouse moe430_2 chip, 40% of the genes are represented by more than one probe set 
and almost 20% of the genes are represented by more than two probe sets per chip, in 
some cases reaching the number of ten replicate probe sets per gene (Li et al., 2008). 
Replicate probe sets exist for three reasons: (i) improved annotation has revealed that 
some cDNAs that were initially attributed to different loci are in reality the same gene, 
(ii) additional probe sets have been designed in case where the cross-hybridisation 
quality of a probe set was poor and (iii) different probe sets have been designed to 
capture alternative splicing of a single gene (Li et al., 2008). However, there is not a 
consensus on how replicate probe sets should be treated and different studies have 
chosen different approaches such as arbitrary selection of a single probe set per gene 
(Liao and Zhang, 2006) or selection of the probe set with the maximum intensity 
(Jordan et al., 2005).  
 
The identification of replicate probe sets that correspond to a single gene is an 
important step in the data processing pipeline. At the Data Input step, DI.S.C.O. groups 
identifiers that are assigned to the same gene under this gene’s name. At the Data 
Visualisation step, the user can choose to replace replicate probe sets (in case of 
Affymetrix data) or replicate genes (for any other type of data) by the maximum, 
minimum, average or median FC value of all the transcripts in the group. This 
replacement is quite important as it can eliminate clusters (visual or statistical) that 
simply correspond to the probe sets of a single gene being simultaneously up- or down-
regulated and, of course, all mapping to the same genomic position. The downside of 
this replacement is that it introduces some information loss in the case where replicate 
probe sets actually represent different isoforms of the same gene. As a result, none of 
the proposed replacement options (max, min, average or median) is an ideal metric of 








g. Define normalisation scheme 
 
The aim of a typical microarray experiment it to examine the relative changes of gene 
expression at a genome-wide scale and identify genes whose expression levels are 
significantly altered between two different states. For this purpose, samples are 
collected that correspond to different types of tissue, different drug treatments, knock-
out and wild-type cell lines etc. In addition, to allow sufficient power for the subsequent 
statistical analysis, microarray experiments should include at least 3 replicates per 
condition/comparison. This information is provided by the user in the normalisation 
scheme. At this step, it is defined how the samples are to be grouped and compared to 
each other. An example normalisation scheme is presented in Figure 3.5. 
 
 
Figure 3.5 An example normalisation scheme.  
The Sample Name column contains the samples that are present in the gene expression file. Each 
additional column of the table represents a parameter that can be used for the grouping and the 
normalisation of the samples (in this example there is only one parameter: the Replicate Group). 
The user can add or subtract parameters by clicking on the +/- buttons on the top right corner of 
the table. The available parameters can be found in the list with the indication “All” and the user 






h. Calculate FC values from normalisation scheme 
 
After the normalization scheme has been designed by the user, the FC values between 
the groups of samples to be compared can be calculated. Fold change can be defined as 
the gene expression ratio between two groups of samples, named hereafter the 
condition and the control. In DI.S.C.O., the expression levels of each group can be 
summarised by either the average or the median of the group. Alternatively, if the user 
chooses to omit the normalisation scheme designing, each sample will be compared to 
either the average or the median of all samples in the experiment.  
 
i. Calculate FC values distribution per sample and identify colouring 
thresholds 
 
The FC values that have been generated at the previous step are next loge transformed 
and modelled as a normal distribution as shown in Figure 3.6. FC coloured red signify 
over-expressed genes, yellow no change and blue down-regulated. The gradient from 
red to yellow to blue represents different levels of FC values varying from high to low. 
For the initial distribution and colour gradient, the maximum red and blue values 
correspond to ±1.5 standard deviations from the mean (86.6% of FC fall in the 
gradient). These thresholds can be also manually changed by the user after the initial 
data plotting.     
 











3.6. The DI.S.C.O. Visualisation 
 
3.6.1. The DI.S.C.O. main window 
 
Figure 3.7 The main window of the DI.S.C.O. application 
 
Figure 3.7 presents the main parts of the DI.S.C.O. application main window after data 
loading. In the Genome Canvas, a visual representation of the transcriptome is plotted. 
The Genome Canvas of Figure 3.7 is at the Full View mode, meaning that all the 
chromosomes of the organism are plotted on the screen in a way that the user can have 
a full overview of the genome. More details on the different view modes of the Genome 
Canvas will be given in section 3.6.9. In Figure 3.7, the 21 tracks representing the 21 
mouse chromosomes are displayed.  The Group Comparisons panel contains the list of 
comparisons between different sample groups as it has been defined during the 
normalisation process. In the Data panel, the core datasets used by DI.S.C.O. during and 
after data loading as well as a summary of the input data can be viewed and exported. 
The Memo panel gives a brief summary of the colouring scheme and the underlying FC 
distribution used to generate it. The Summary icon, at the bottom left corner of the 
main window, directs the user to obtain a summary of the datasets used for plotting. 
Finally, on the bottom right corner, the indication of the current zoom level of the 




3.6.2. Memo and Genome Canvas interpretation 
 
The Memo panel guides the user to interpret the visualization of the gene expression in 
the Genome Canvas. In the Genome Canvas, each line represents a chromosome and 
each rectangular, either over or under the chromosome line (forward or reverse strand 
respectively), represents a gene. There are three types of information regarding each 
gene: its genomic position in terms of physical coordinates on the chromosome, the fold 
change of the gene relative to the control as depicted by the colour assigned to the gene 
and, finally, the raw expression value of the gene in the condition group as depicted by 
the height of the gene. Figure 3.8 and Figure 3.9 give an example of how the Memo 
panel can be used to understand the plotting conventions of the Genome Canvas.  
 
 
Figure 3.8 An example of a genomic region with zoom level x9 in the Genome Canvas.  
Each gene, represented by a rectangular, is assigned a colour that corresponds to its fold change 
value. The height of the gene represents its expression value in the condition group (averaged 
across all samples in the condition group). The gene is plotted on its physical (or rank) position on 
the chromosome and over or under the chromosome line depending on the forward or reverse 




Figure 3.9 The Memo panel for the comparison presented in Figure 3.7.  
The horizontal axis corresponds to fold change levels. The gradient represents the colour of the 
genes in that range. All genes with fold change values less than 0.67 are coloured blue while all 
genes with fold change values higher than 1.49 are coloured red. The remaining genes are assigned 
a colour from the gradient as depicted in the Memo panel. The vertical axis represents the intensity 
value (average of the condition group). The biggest height is assigned for genes that have an 
average intensity value equal or higher than 9.24 and accordingly the lowest for genes that have an 








Figure 3.10 The physical view of a single chromosome 
 
 
Figure 3.11 The rank view of a single chromosome 
 
 
There are two different ways of plotting each gene on its mapping chromosome: the 
Physical view and the Ranking view.  In the Physical view each gene is plotted on its 
actual physical chromosomal coordinates (from start position to end position) as 
indicated in the genome annotation file. In the ranking view, however, each gene is 
plotted according to its rank position on the chromosome. In this case, an arbitrary 
gene size of 100bp is assigned to all genes; the first gene on the chromosome occupies 
the position 1 to 100 bp, the second the position 101 to 200 and so on, until all genes 
are plotted on the chromosome. Therefore, the length of the chromosome is also 
converted to ranking coordinates depending on the number of genes that have been 
mapped to the chromosome. In this way, nongenic regions (gene deserts) can be 
removed and the distribution of genes on each chromosome is identical. The exclusion 
of gene deserts achieves a more compact visualisation for the identification of 
interesting patterns. In addition, there is no need to make assumption in order to 
model the gene distribution on the chromosomes for the computational processing of 
significant clusters.  
 
In Figure 3.10 and Figure 3.11, there are four tracks: 
i. The chromosome track 
ii. The clustering output track 
iii. The gene density track 
iv. The cytoband track 
v. Custom tracks (not shown here) 
 
3.6.3. The Chromosome track 
 




the chromosome track is relative to the actual size of the chromosome in the genome 
(the size is defined from the genome annotation file by the base pair of the last gene on 
each chromosome). Each rectangular plotted on the track represents a gene. The height 
of the rectangular corresponds to the raw intensity value for this specific gene and the 
colour to the fold change of its expression level when compared to the control (after the 
normalisation). The fold change magnitude colour scale ranges between deep blue to 
deep red (with red being over-expression and blue under-expression). When zooming 
in the chromosome track after a certain level, the common names of the genes are also 
displayed below/above the gene depending on their orientation (forward/reverse 
strand).    
3.6.4. The Clustering Output track 
 
As soon as one of the clustering algorithms has been executed and has identified 
clusters of differential gene expression levels on a chromosome, its output will be 
plotted in the clustering track right below the chromosome track. This is represented 
by a coloured bar (red for clusters of over-expressed genes and green for clusters of 
under-expressed genes) that spans from the starting base pair of the first gene in the 
cluster to the ending base pair of the last gene in the cluster. The intensity of the colour, 
either red or green, corresponds to the confidence level of the particular cluster as 
indicated by the significance metric of each algorithm (such as p-value or significance 
score). For the NN algorithm the confidence level is also indicated by three (high), two 
(medium) or one (low) dots next to the bar.  
3.6.5. The Gene Density track 
 
The next track to be plotted is the gene density track with a grey-to-white colour range 
(white for highly dense chromosomal areas and dark grey for sparse chromosomal 
areas). For the physical view, the gene density track does not provide additional 
information as the density of genes on the chromosomal locus can be directly identified 
by the user. In the ranking view, however, it is a very important feature because it 
highlights the gene “deserts” and “islands” and it links back to the physical view.      
3.6.6. The Cytoband track 
 




relation to the chromosome bands (i.e. Giemsa stain bands obtained from the USCS 
genome browser) and the centromere location (centromeric and pericentromeric 
aberrations have been often described in tumours, for example see (Deng et al., 2010)). 
3.6.7. Custom tracks 
 
Custom tracks can also be imported by the user. The custom track can contain any type 
of genomic feature that can be plotted along the chromosomes and it will appear under 
the Cytoband track when available or under the Gene Density track when the Cytoband 
track is not available.  
 
3.6.8. DI.S.C.O. Quick Menu 
 
The DI.S.C.O. Quick Menu is located on top of the Genome Canvas. It represents a 
selection of the most common functionalities of the application for quick access by the 
user. In Figure 3.12, a short description of each button that appears in the Quick Menu 
can be found.  
 
 
Figure 3.12: The DI.S.C.O. Quick Menu.  
Brief description of each button included in the Quick Menu. These buttons represent the most 








3.6.9. Different Views  
 
In Figure 3.13 to Figure 3.16, the different views implemented in DI.S.C.O. are 
presented. The Full Genome view (Figure 3.13) displays the whole genome (all 
chromosomes) in a single window. It offers a comprehensive overview of the whole 
transcriptome in a genomic context. The Chromosome view (Figure 3.14) gives a more 
detailed view of each chromosome including the additional tracks which are not visible 
in the Full Genome view. In Figure 3.14, the Chromosome View is plotted in terms of 
physical position of the genes (Physical view). In Figure 3.15, the same data are plotted 
in terms of Rank view. The Rank view helps improving the visualisation since it 
effectively removes any genomic regions with no mapping genes. Finally, in Figure 3.16, 
the same data are presented with two extra plotting options: i) the Absent probe sets 
are no longer plotted on the chromosome and ii) replicate probe sets have been 
replaced with their median value. The succession of the following figures clearly 
demonstrates how the visualization efficacy can be greatly improved with the 
















Figure 3.14 The Chromosome view in Physical view mode.  






Figure 3.15 The Chromosome view in Rank view mode. 




Figure 3.16 The Chromosome view in Rank view mode with Absent flags removal. 
Rank view mode with additional absent flags removal and replacement of replicate probe sets with 





3.7. Integrated Algorithms for the Identification of Genomic 
Regions of Non-Random Transcriptional Activity 
 
This section provides the description of the three integrated computational methods 
that constitute the cluster analysis module: the PGE method (De Preter et al., 2008), the 
TV minimisation method (Nilsson et al., 2008) and the NN method (Tomlinson, 
unpublished). All of the three methods were originally implemented in different 
programming languages and translated in Java by Ioannis Sarantidis as part of his MSc 
thesis (Sarantidis, 2008). The methods were then integrated in DI.S.C.O. in 
collaboration with I. Sarantidis. The histogram shape-based thresholding method was 
developed by Liao et al. (2001) based on the work of (Otsu, 1979). I have adapted the 
code provided by Yasunari Tosa (version Feb. 19th, 2005) that can be found in the 
plug-ins collection of the Image Processing and Analysis in Java (ImageJ) program3.  
 
3.7.1. Histogram shape-based thresholding of FC values 
 
A typical task in computer vision and image analysis is the separation of the image in 
regions of interest, which represent objects, and regions that bear no relevant 
information and represent the background (image segmentation). Intensity-based image 
segmentation is commonly performed by examining the intensity of pixels and 
identifying thresholds that can distinguish between regions with high and low pixel 
intensity. During this process, it is presumed that relevant regions occupy a different 
range of intensity values from the background. The image can be then transformed into 
a binary representation where each pixel that falls below the identified threshold is 
assigned a value of zero and each pixel that is above the threshold a value of one.  
Alternative ways for image segmentation include clustering methods (k-means), 
entropy maximization methods, mixture modelling and region growing. A detailed 
review can be found here (Pal and Pal, 1993).     
 







A way to find the appropriate thresholds for image segmentation is to examine the 
histogram of pixel intensities in order to determine whether two or more distinct 
modes are present – corresponding to the foreground and the background respectively. 
In DI.S.C.O., the distribution of FC values is represented by a histogram which is also 
used to define the colouring thresholds. Therefore, an intuitive way of identifying the 
thresholds for gene expression levels that correspond to up- and under-regulation is by 
taking advantage of the properties of the FC values histogram distribution as well (also 
see section 3.5.1i). Contrary to grey-scale image processing where the pixels are 
separated in background and “relevant”, in this case there are two “relevant” classes, 
namely over- and under-expressed while the no-change genes represent the 
background. 
 
The Otsu method is a non-parametric method that identifies the optimal thresholds for 
grey-scale image segmentation by calculating the thresholds that maximise the 
between-class variance using an exhaustive search (Otsu, 1979). It has been adapted 
for multi-level thresholding using a faster recursive algorithm by Liao et al. (2001). The 
implementation proposed by the latter has been integrated in DI.S.C.O. to perform 
multi-level threshold identification for the three classes of gene expression previously 
described. A brief description of the original Otsu method follows: 
 
The Otsu Method  
Given a grey-scale image with  number of pixels each one having an intensity value of 
  where        . The number of pixels having an intensity level of   is denoted by    
and the probability of an intensity value   is given by  
        
Let us denote the two classes, foreground and background,    and    with    taking 
intensity levels from       and    from        . The weights of the classes,    and 
  , are defined the number of pixels per intensity level over the total number of pixels 
N: 
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While the class mean    and variance    are defined by: 
     
  
   
 
   
 
   
 
      
  
   
 
     
 




         
 
  
   
 
   
 




          
 
  
   
 
     
 
     
 
The within-class variance can be computed as: 
  
      
      
  
Τhe within-class variance needs to be calculated for all possible values of   and the 
value of    that yields the minimum   
  is chosen as the optimal threshold by this 
method.  
The algorithm can be easily extended to multi-level thresholding in a similar way as 
described in (Liao et al., 2001). The implementation available in DI.S.C.O. is largely 
based on the code of Yasunari Tosa (Feb. 19th, 2005) from the algorithm of Liao et al. 
(2001) and further adapted to work with gene expression data. In the proposed 
implementation, the histogram of FC values is used to identify the optimal thresholds 
for up- and down-regulation and no change. The histogram consists of all FC values 
after filtering of outliers (FC values that lie after three standard deviations of the 
mean).  
 
3.7.2. The NN algorithm 
 
The Nearest Neighbour (NN) algorithm was originally implemented by Dr Simon R. 
Tomlinson in the programming language C++. In the NN algorithm, clusters are defined 
by using the distance between two neighbouring differentially expressed genes along 
the chromosome. For this implementation, every gene (or probe set) is assigned a 
change-call: up-, down-regulated or no change according to the specified thresholds. 




the distance between them is smaller than a predefined threshold, namely the allowed 
gap    , (ii) the number of genes with a different change-call within that distance is 
also smaller than  . In addition, the distance between neighbouring genes is defined in 
terms of the rank rather than the physical position of the genes in order to eliminate 
any positional bias from the underlying genomic distribution of genes on the 
chromosomes.  
 
A graphical representation of the algorithm can be found in Figure 3.17.  Initially, each 
chromosome is scanned in a linear fashion and adjacent genes with the same change-
call are grouped together. The distance between each pair is calculated and pairs that 
fail the gap criteria are discarded. The remaining pairs are forming the clusters and 
each gene that falls within the cluster boundaries is assigned the change-call of the 
specific cluster. Clusters are always examined in an ordered fashion depending on the 
distance between the included genes. Thus, in case of conflict, where a gene of a pair 
has already been assigned a different change-call in a cluster of a smaller distance/gap 
but falls within the boundaries of a cluster of its original change-call with a larger 
distance/gap, the second cluster will be discarded.  After this initial grouping, 
chromosomes are again scanned and clusters of genes with the same change-call, 
rather than pairs, are now grouped after considering the distance   between them. 
Each cluster is assigned a score   : 




where:                                                        
and                                                               
 
In order to establish the null distribution of the score statistic, a user-defined number 
of random permutation is performed (proposed at least 1000). Permutations are 
performed by randomly shuffling the chromosomal position of the genes (using the 
MersenneTwister pseudorandom number generator (Matsumoto and Nishimura, 
1998)) and run the algorithm in the resulting random dataset. The empirical p-value of 
score    can then be computed by observing how often a random score exceeds   . A 
user-defined p-value          is used as the threshold for significant clusters. As an 
additional step, the hypergeometric distribution (see section 3.1.2) is used to further 






Figure 3.17 The NN algorithm 
 
Finally, the algorithm assigns each significant cluster from the original data a 
confidence level: high, medium or low. A cluster is high confidence if its score exceeds 
the highest obtained score from the permutation data, medium confidence if its score 
lies between the median score and the top score obtained from the permutation data, 
and finally low if its score is below the median score and over the lower score obtained 
from the permutation data for significant clusters of the same change-call.  
 
3.7.3. The PGE method 
 
The Positional Gene Enrichment method (PGE) was first implemented as a Perl script, 
publicly accessible through a web interface by De Preter et al. (2008)4. The original 
implementation typically accepts gene lists, namely genes of interest, from five 
organisms (Homo sapiens, Mus musculus, Rattus norvegicus, Arabidopsis thaliana and 







Saccharomyces cerevisiae). A gene list may contain i.e. over-expressed genes between 
two conditions, differentially expressed genes in an experiment or genes sharing a 
common characteristic such as members of the same pathway. In the DI.S.C.O. 
implementation of PGE, two gene lists are submitted, the one containing all over-
expressed genes and the other consisting of all down-regulated genes.  
 
PGE uses the hypergeometric distribution to identify significantly enriched regions 
(and in case where the total number of genes in the dataset is significantly larger that 
the size of the query, the cumulative binomial distribution). Again, the rank position of 
the genes is considered for the cluster formation. The candidate regions are defined 
using an adaptive size sliding window and must comply with the following set of rules 
(De Preter et al., 2008): 
 
1. The region must contain at least two genes of interest 
2. The region must not include a smaller region with the same number of genes of 
interest 
3. There is not a bigger region that contains more genes of interest and the same 
number of genes of no interest 
4. There is not a bigger region, containing the region in question, that includes a 
higher percentage of genes of interest 
5. The region must not include a smaller region with a lower p-value 
6. The region does not include any smaller region with less than expected genes of 
interest 
 
These rules address the problem of region redundancy resulting by the use of the 
adaptive size sliding window. Specifically, rules 1 to 3 are enforcing the pertinence 
definition described in (Barriot et al., 2007) for any type of gene set enrichment 
analysis. The three additional rules proposed by De Preter et al. (2008) are introduced 
in order to further reduce redundancy especially in the context of chromosomal gene 
enrichment. 
 
Figure 3.18 demonstrates how the PGE method initially tests all possible windows of all 
possible sizes ( 
      
 
  windows where   is the number of genes of interest). Each 




aforementioned rules. In Figure 3.18 the input gene list consists of down-regulated 
genes while the list of over-expressed genes is submitted separately and processed in a 
similar way.  
 
 
Figure 3.18 The PGE algorithm  
(adapted from (De Preter et al., 2008)) 
 
 
3.7.4. The TV method 
 
The Total Variation (TV) minimization method (Nilsson et al., 2008) is based on a 
technique that has been classically applied to the task of signal restoration or image 
recovery in the presence of noise. Contrary to the NN and PGE algorithms, TV uses the 
FC values (or alternatively the raw expression values), rather than the gene’s change-
call, to segment the chromosomal regions with biased gene expression. The original 
motivation for the development of this method was the discovery of regions of 
transcriptional deregulation as a result of underlying genomic or epigenetic events, 





Figure 3.19 The TV algorithm.  
Graphical representation of a chromosomal region with biased gene expression levels. The TV 
method assumes that the expression profile of a region with an increased/decreased average 
transcriptional activity can be represented as a constant signal as indicated by the black line. Genes 
whose expression levels deviate from the bias profile of the region are regarded as noise.  
 
In the context of transcriptional data, the TV method considers gene expression levels 
as a piece-wise constant signal corrupted by noise. The noise corresponds to the 
inherited variability of gene expression and it is also linked to the observation that not 
all genes in a region of a chromosomal gain or loss will be necessarily affected by the 
underlying genomic change. The purpose of the method is to recover the constant 




Let          be the expression level of genomic position   in a chromosomal interval 
 . The TV method regards      as the sum of two signal components: the piece-wise 
constant signal              where    represents a plateau level for the interval   
and a high-frequency component       that represents the noise. The original signal can 
then be recovered by minimizing: 
                 
 
 
The first term, the    norm of   , prevents over-segmentation while the second term is 
an    fitting term that corrects for under-segmentation. The regularisation parameter   
balances the effects of these two counteracting terms. Therefore, for     the constant 
bias profile will simply represent the average expression levels of the interval  , while 




discrete-form objective can be represented by the following formula: 
 
  
              
                                  
 
where    
  is the optimal segmentation value for the objective function of a closed 
interval       where   is the left boundary of the interval (after discretisation).  In 
addition,          is the starting point of the last segment in the optimal segmentation 
and            is the starting point of the last interval of the optimal segmentation. In 
addition,        is the average gene expression levels of a region       while        is 
the sum-of-squares about the average for      . The proposed solution also follows the 
dynamic programming formulation since the optimal segmentation of a region can be 
explicitly calculated given the optimal segmentations of all previous regions.   
 
The performance of the algorithm largely depends on the selection of the regularisation 
parameter  . It is impossible, however, to define a single value for   that will effectively 
reflect the optimal degree of segmentation for all genomic regions simultaneously. 
Therefore, Nilsson et al. (2008) propose a scheme that uses a range of   values in order 
to capture small regions of altered gene expression levels and still keep larger regions 
intact from over-segmentation. In other words, the algorithm implementation starts by 
    where a whole chromosome is considered as a relevant segment (a relevant 
segment is defined as a segment whose plateau    exceeds a predefined threshold). 
Then, the    value is iteratively increased in order to obtain higher resolution, where 
   
 
     
 
With    being the size of candidate segments to be examined for relevancy and    . 
For example,   
 
  
 allows for the consideration of segments with average gene 
expression levels around 10, which can reflect a segment of 10 genes with plateau level 










3.7.5. Typical workflow for cluster analysis 
 
Typically, the initial data plotting is followed by cluster analysis. Figure 3.20 
demonstrates the necessary steps for cluster analysis. It should be noted that for any of 
the clustering techniques, only the rank position of the genes/ probe sets is considered 
and genes that have an Αbsent flag in the condition group are filtered out.  
 
Initially, the user can either accept the automatically calculated thresholds for over- 
and under-expression, as identified by the Multi-Level Otsu algorithm, or manually 
provide constant thresholds for all comparisons. Secondly, the user has to choose the 
preferred cluster analysis method and provide the necessary parameters for the 
specific method (or proceed with the default values). Table 3.2 provides a short 
description of the set of parameters required from each one of the three clustering 
methods. DI.S.C.O. is launched with the default set of values that can be used as an 
initial guideline. Of course, different datasets have different characteristics and the user 
is encouraged to explore different set of values in order to improve the performance of 
the algorithm of choice for the specific dataset. The meaning and the effect of each 
parameter has been already described in the sections presenting each algorithm. The 
effect of the parameters presented in Table 3.2 will be additionally described in section 
3.11, where the validation of the methods is performed with synthetic and biological 
data. Ideally, a computational model that can achieve high prediction with a lesser 















Table 3.2 Short description of the required parameters of each one of the three clustering methods 
integrated in DI.S.C.O. 
Parameter Description 
Nearest Neighbour method (NN) 
False positive rate The desirable percent of false positives (0..1). 
Number of permutations Number of permutations for the randomisation step. 
Blank spaces extent  The largest allowed gap between two over-expressed or under-
expressed genes/probes. 
Parameter Description 
Total Variation minimization method (TV) 
Smallest Lowest number of probes expected in a segment times the 
average value of the segment. 
Largest Starting point of the regularization loop. The larger it is the 
larger are the initial clusters which the algorithm searches for. 
It should be set to the highest number of probes expected in a 
segment times the average value of this segment.  
Threshold Threshold for a cluster to be considered relevant. 
Step Parameter that controls the range of   values to be considered 
and influences the execution time of the TV algorithm. Higher 
values mean lower execution times but also lower resolution to 
identify clusters.  
Positional Gene Enrichment method (PGE) 
P-value threshold Threshold for a cluster to be considered significant.  
Average significance ratio Threshold for p-value significance when compared to 
enrichment. The higher its value, the more important p-values 






Figure 3.20 A typical workflow to perform cluster analysis.  





3.8. RNA-seq analysis 
 
Thus far, the description of the application has been focusing on the analysis of gene 
expression data obtained using the DNA microarray technology. However, in the era of 
next-generation sequencing, it is essential to also account for data that have been 
generated using the emerging high-throughput sequencing technique of RNA-seq.  
 
RNA-seq data analysis in DI.S.C.O. is quite straight-forward. It is presumed that the 
initial processing of the RNA-seq dataset is already performed before data input in 
DI.S.C.O. This includes i) obtaining the raw sequencing data, ii) performing quality 
control, iii) aligning to a reference genome or assembling a transcriptome de-novo, iv) 
identifying the expression levels of different genes or isoforms and v) normalization of 
different samples. There is a wealth of tools that can address each separate task which 
exceed the scope of this thesis (for a detailed review of current tools and challenges 
please refer to (Garber et al., 2011)).   
 
In addition to the normalised raw data obtained from a typical RNA-seq analysis 
pipeline, the user can easily generate a custom Present/Absent flags file by deciding on 
a threshold of counts (reads) per gene over which the gene is considered to be 
expressed. Finally, the data can be imported, the FC values between the groups of 
samples to be compared can be calculated and the cluster analysis can be performed as 




3.9. Accessing Remote Datasets 
 
DI.S.C.O. is primarily designed to address the data analysis of a single experiment as a 
standalone client application. Recently, it has been implemented as a module for the 
integration in the GeneProf workflow engine (Halbritter et al., 2012) for the analysis of 
next-generation sequencing data. The development and integration of the GeneProf 
DI.S.C.O. module has been conducted in collaboration with Florian Halbritter and 
Panagiotis Matzavinos as part of the MSc thesis in Bioinformatics of the latter 
(Matzavinos, 2011). 
 
GeneProf is a web-based workflow system that contains modules for the analysis of 
RNA-seq and ChIP-seq experiments. There is a selection of predefined workflows in the 
engine, while the user can also design custom workflows. In addition, the GeneProf 
database is a valuable resource of a great number of publicly available analysed 
datasets that can be further examined and re-processed by the user in order to gain 
biological insights.  
 
Figure 3.21 demonstrates the DI.S.C.O. module in the GeneProf workflow designer (PGE 
algorithm implementation as described in section 3.7.3). The module typically accepts 
four input datasets (gene expression values, genome annotation, Present/Absent flags 
and normalisation scheme) from RNA-seq experiments processed as discussed in 
section 3.8. The output results of the analysis consist of the identified intervals (along 
with information such as size, p-value, start and end position of cluster) as well as an 
image representation of the Genome Canvas plot for the specific comparison. The 
integration of the DI.S.C.O. component guarantees an automated way of examining 
available datasets for positional enrichment of differentially expressed transcripts and 
highlights to the user experiments where clusters of high significance are present for 
further consideration. Finally, it offers a quick and easy incorporation of this type of 











3.10.  DI.S.C.O. v1.0 
 
As already discussed in section 3.1.3, the current version of the DI.S.C.O. application 
builds upon the work that was performed during my MSc project (Skylaki, 2007). 
Figure 3.22 presents a screenshot of the first prototype application that was submitted 
as part of the requirements for the completion of the MSc in Informatics. DI.S.C.O. v1.0 
was a tool with functionality restricted to the visualisation of the transcriptional data 
on the genome. From the implementation described in the previous sections of this 
chapter, the features that were also available in this earlier version are as following:  
 
 Display of the Physical View 
 Display of the Ranking View 
 Plotting of the Gene Density and the Cytoband tracks 
 Display of significantly enriched intervals by importing the output of 











In summary, the improvements that have been introduced in the current DI.S.C.O. 
version are the following: 
 
 Integration of computational methods for the identification of significantly 
enriched genomic regions, 
 Extended functionality of the Genome Canvas, including zooming, available 
annotation on mouse-over and export of analysis in an image format, 
 Automatic choice of thresholds for over- and under- expressed genes, 
 Automatic choice of the colouring thresholds for the visualisation of the genes, 
 Custom colouring schemes, 
 Import and plotting of custom tracks, 
 Creation, import and export of custom gene lists, 
 Creation of line plots from the expression levels of a gene or a gene list across 
samples,  
 Creation of analysis reports in Portable Document Format (PDF) format, 
 Integrated functionality for the designing of the Normalisation scheme, 
 P/A flags calculation and integration in the visualisation, 
 Replicate probesets replacement, 
 Extensive Help files and documentation, 
 Extensive error detection and correction functionality during data input, 
 Option to redirect the user to online Genome Browsers such as Ensembl5 or 
UCSC6. 
 
For more information, see also the DI.S.C.O. Application User Guide, provided as part of 
the Supplemental Information in the attached CD.  
 








3.11. Validation of the Integrated Clustering Methods 
 
This section discusses the methodology applied for the evaluation of the DI.S.C.O. 
application, specifically the performance of the integrated clustering methods. Two 
different types of data can be used for the validation: artificially generated data, where 
clusters are a priori positioned in selected intervals on the chromosomes, and real 
biological datasets, where the presence of a cluster has already been identified by 
classic cytogenetic techniques at the DNA level.  
 
The validation of the algorithms requires benchmark data where the underlying 
distribution of clusters is known. This can be only achieved by the use of synthetic data 
that need, however, to adequately model the various properties of the gene expression 
profile of a real biological dataset. In reality, the use of artificial data for validation has 
been often criticised as synthetic data may represent an over-simplification of the real 
gene expression profile that prohibits effective evaluation. In addition, there is the 
danger that the artificially generated data implicitly match the assumptions that have 
been used to generate the model in the first place rendering the validation biased in 
favour of the specific model. On the other hand, there is a common problem with the 
use of experimental data for the evaluation of the performance of an algorithm: in most 
cases, this approach is limited to the confirmation of previously characterised features 
in the dataset in question. As a result, it is not feasible to penalise false positive clusters 
that have not been previously experimentally discovered.  
 
The proposed validation methodology consists of a combined evaluation of both 
synthetic and experimental data and, therefore, aims to present a comprehensive 
measurement of the detection power of the methods. In addition, particular care has 
been taken in the designing of the artificial data in order to achieve the highest 
potentially accuracy in representing the complexity of a real biological gene expression 
profile. A detailed description follows in sections 3.11.1 and 3.11.2. This work builds 







3.11.1. Artificial data 
 
The artificial data generated for the evaluation of the visualization and the 
computational methods integrated in DI.S.C.O. has been directly generated from real 
biological datasets in order to adequately model the complexity of a real biological 
transcriptional profile. For this purpose, the previously described dataset of (Kim et al., 
2008b) has been used, which consists of neural stem cells (NSCs) reprogrammed to 
iPSCs using two factors (Oct4 and Klf4) and four factors (Oct4, Sox2, c-Myc and Klf4) and 
the wild-type ESC line (three replicates per cell type, GSE10806). The samples have 
been normalised using the Multiple-Array Average (RMA) (Irizarry et al., 2003a) and 
genomic data mapping was based on the Affymetrix GeneChip Mouse Genome 430 2.0 
Array mapping annotation. 
 
In order to obtain the FC values for the validation of the methods the following 
normalisation scheme has been applied: i) a comparison between the iPSC-four factors 
(iPSC4) and ESC group of replicates and ii) a comparison between NSC and ESC groups 
of replicates. The specific normalization schema was chosen in order to model two 
different categories of comparisons: i) samples that are still quite similar in terms of 
transcriptional profiles, such as it would be expected for iPSC and ESC lines and ii) 
samples that are quite different, since they represent distinct cell types, and a higher 
number of differentially expressed genes is present. In these comparisons, each gene is 
represented with the median value of all its corresponding replicate probe sets when 
applicable. Annotation has been obtained from the Affymetrix website (version 
Mouse430_2 Release 25 (3/19/08)). From the total number of 45101 probe sets on the 
Mouse Genome 430 2.0 Array, 43109 had available genomic mapping annotation. After 
replacement of replicate probe sets the final dataset comprised of 26930 probe sets 
each one representing a single gene. Table 3.3 reports the statistical summary of the 











Table 3.3 A statistical summary of the two validation artificial datasets.  
The iPSC vs ESC dataset is derived by comparing the median of the group of the 
three iPSCs samples to the median of the group of the three ESCs samples and the 
NSCs vs ESCs dataset is derived in a similar manner for the groups of NSC samples 
and ESC samples. Each gene is represented with a single value after replacement 
of its replicate probe sets with their median value. The table also presents the 
number of genes that have a FC value higher than (i) 1.5 FC, (ii) 2 FC or (iii) as 
defined by the Multi-Level Otsu Thresholds.  
 
Statistical Properties of the three validation datasets 
Statistic metric iPSC vs ESC NSC vs ESC 
Total number of probe sets 26930 26930 
Average 0.012 -0.039 
Standard deviation 0.386 1.054 
Max value 5.577 10.188 
Min value -4.024 -9.301 
FC  1.5 1110 3933 
FC  1.5 1310 3978 
FC  2 313 2475 
FC  2 393 2224 
FC  Multi-Level Otsu Thr. 738 953 







Figure 3.23 The histogram of the FC values of the two datasets used for validation.  
The coloured lines indicate the three different pairs of thresholds used in the evaluation process. 
 
 
The generation of the artificial data has been performed as following: firstly, the FC 
values of the probe sets within a dataset were assigned randomly to probe sets of a 
different genomic location in order to assure that all biologically relevant clusters have 
been disrupted. Then, for each dataset, five random genomic locations (chromosomes 
1, 14, 8, 17, 11, Table 3.4) were chosen as the starting position of artificial clusters of 
sizes 200, 100, 50, 20 and 5 probe sets. In every cluster, 85% of the probe sets in the 




threshold, 1.5 FC and 2 FC). In this way, both clusters of relatively milder changes and 
greatly affected clusters can be modelled. Numerous studies, examining the correlation 
of gene expression levels and DNA copy numbers in regions of chromosomal 
aneuploidies, have shown that a high percentage of genes in the region are affected but 
not necessarily all. For example, 83% of genes in a region of gain showed more than 1.5 
FC in yeast (Torres et al., 2007). By using a similar percentage (85%), it is possible to 
also model the “noise” introduced by genes that are present in a region but not affected 
by the underlying genomic change as a result of the gene dosage compensation 
mechanisms of the cell or the absence of expression of the regulatory inputs of the 
specific genes. In these comparisons the lower 45% of probe sets was considered to 
have a PMA flag of A (Absent) and multiple probe sets have been replaced with their 
median values.  
 
Table 3.4 Genomic position of artificially generated clusters.  
Chr Start Size 
1 89110488 200, 100, 50, 20, 5 
14 4437801 200, 100, 50, 20, 5 
8 19990620 200, 100, 50, 20, 5 
17 13117241 200, 100, 50, 20, 5 
11 52209964 200, 100, 50, 20, 5 
 
In each validation step, 10 artificial clusters were generated at the genomic positions 
presented in Table 3.4, with varying sizes (200, 100, 50, 20, 5 probe sets). In total, 50 
artificial datasets were tested for each algorithm/parameter/threshold configuration 
as described in the following sections. 
 
In each validation configuration, the following attributes were altered: 
 Algorithm of choice 
 Set of parameters for the specific algorithm 
 Type of clusters (gain or loss) 
 Thresholds used for differential expression 
 
More specifically, to assess the detection power of each algorithm under each specific 
parameters configuration, three different types of clusters have been generated and 




greater/lower than the Multi-Level Otsu thresholds (Figure 3.23), clusters whose 
expression levels are greater/lower than 1.5 FC and finally, than 2 FC. In addition, the 
detection ability of the algorithms was tested when the provided thresholds are 1.5 or 2 
FC over clusters generated with the respective thresholds, or in the case of Multi-Level 
Otsu thresholds, over clusters generated with all three possible ways.  
 
To access the performance of each validation configuration, the sensitivity statistic has 
been chosen, defined as:  
            
  
     
 
with 
                                    
where TP is the number of genes correctly identified in a cluster, and FN the number of 
genes wrongly identified as not belonging to a cluster. Furthermore, the number of 




The PGE algorithm uses the average significant ratio parameter (Table 3.2) to 
determine the balance between cluster with low p-values (which are biased towards 
larger clusters) and clusters which are smaller but have a better enrichment. Larger 
clusters with significant p-values may actually include smaller clusters with high 
enrichment (but not necessarily lower p-value) and this information may still be useful. 
In order to access the effect of the average significance ratio parameter of the PGE 
algorithm, validation was performed in 250 random datasets for a set of values ranging 
from 1 to 3 with a step of 0.5. The p-value threshold was kept constant at 0.01.  
 
Figure 3.24A presents the average sensitivity of the different configurations for over-
expressed clusters in the iPSC vs ESC dataset. Figure 3.24B displays the effects of the 
average significance ratio parameter in cluster fragmentation which reflects the degree 
that the cluster has been split in more than one sub-clusters. Fragmentation is denoted 
here as: 
               
 






It is evident that the best sensitivity is achieved when the thresholds for differential 
expression match the average gene expression levels of the artificially generated 
clusters. The Multi-Level Otsu method’s performance drops for clusters generated with 
an average of 1.5 FC (since the method estimates the thresholds at the 1.62 FC) and 
performs equally well in the case of clusters generated with 2 FC average gene 
expression within the cluster. In all configurations, the method’s sensitivity drops at 
clusters with a small size of only 5 probe sets. Moreover, there is no great difference in 
the sensitivity of the algorithm for each examined threshold configuration for the 
average significant ratio parameter. However, this parameter does affect the 
fragmentation of the clusters. For values lower or equal to 1.5, the clusters are severely 
fragmented indicating that even the smallest amount of noise causes the method to 
stop extending the cluster boundaries. This could be problematic in cases of noisy 
clusters such as the ones encountered in the majority of real biological datasets. A value 
between 2 and 2.5 seems to perform better under all configurations tested.  
 
In terms of false positive (FP) clusters (Figure 3.25B), all configurations have 
comparable performance but it improves when the average gene expression of the 
genes across the artificial clusters is in accordance with the thresholds used for 
detection. It is clear, nevertheless, that the number of FP decreases as the average 
significance ratio parameter increases with values between 2 and 2.5 showing the 
lowest FP rates. Thus, for the rest of the evaluation, the average significance ratio was 
chosen as 2.5. 
 
In Figure 3.26, the same results are presented for the NSC vs ESC dataset. Again, best 
sensitivity is achieved by the Multi-Level Otsu thresholds using the Multi-Level Otsu 
method. However, the detection power of the method drops significantly when the 1.5 
FC thresholds have been used for the generation of the clusters. This is due to the fact 
that for the NSC vs ESC dataset, where many genes are differentially expressed between 
the two cell types at the 1.5 FC level, the Multi-Level Otsu method has placed the 
thresholds for differential expression at the tails of the histogram distribution. Thus, 
the number of altered genes between the two configurations is quite different and the 
ability of the Multi-Level Otsu method to identify patterns is affected. For the case of 
clusters with gene expression over 2 FC, the sensitivity of the two methods is 





 It is intuitive to consider a higher threshold for the NSC vs ESC dataset, since positional 
patterns will be obscured if a great percentage of the genome is differentially expressed 
independently of chromosomal position. By increasing the thresholds, as done by the 
Multi-Level Otsu method, it is possibly to identify regions that are enriched in 
differentially expressed genes more than a random genomic region.  Finally, these 









Figure 3.24 Sensitivity and fragmentation of the PGE algorithm with the average significant ratio parameter in a range from 1 to 3 (step 0.5).  
A) Sensitivity of the five configurations used: Multi-Level Otsu defined thresholds with clusters of average gene expression varying from 1.5 to 2 FC (including the 
Multi-Level Otsu threshold which is placed at 1.62 FC). B) Cluster fragmentation denotes the number of sub-clusters included in a single cluster (a single cluster 









Figure 3.25 Number of genes in FP clusters and number of FP clusters with the average significant ratio parameter in a range from 1 to 3 (step 0.5).  
A) Number of genes in FP clusters of the five configurations used: Multi-Level Otsu defined thresholds with clusters of average gene expression varying from 1.5 to 





Figure 3.26 NSC vs ESC dataset validation for the PGE method.  
Sensitivity, number of FP clusters and number of genes in FP clusters for the five threshold 





Firstly, the performance of the algorithm was assessed with various values for the gap 
parameter                 with a constant significance p-value at 0.01 and 500 
random permutations.   
 




to drop for clusters equal or smaller than 20 probe sets. This effect aggravates as the 
gap parameter augments. This is particularly prominent in Figure 3.28 where the 
number of genes in FP clusters and the number of FP clusters is displayed. The actual 
number of FP clusters is low but the clusters are quite large encompassing a high 
number of genes. Again, higher values of the gap parameter display higher rates of FP 
discovery and a gap value of 5 seems to demonstrate the best performance. In addition, 
the clusters are not fragmented in smaller sub-clusters (data not shown).   
 
 










Figure 3.28 Number of genes in FP clusters and number of FP clusters with the gap parameter taking the values 5, 10, 50 and 100.  
A) Number of genes in FP clusters of the five configurations used: Multi-Level Otsu defined thresholds with clusters of average gene expression varying from 1.5 to 





Figure 3.29 NSC vs ESC dataset validation for the NN method.  
Sensitivity, number of FP clusters and number of genes in FP clusters for the five threshold 
configurations for the NN method in the NSC vs ESC dataset (gap=5). 
 
It is possible however that a gap parameter value of 5 is in fact too stringent and does 
not reflect the noise encountered in actual biological datasets although it seems ideal in 
the artificially generated clusters. In reality, as it was discovered during the validation 
with biological datasets, a gap value of 20 is more realistic as a value of 5 fails to 








As described previously, the TV method requires four parameters as user input. These 
control the maximum and minimum value of the denominator of the regularization 
parameter λ, the step for decreasing the denominator to allow searching for clusters of 
different sizes and finally, a threshold, the plateau μ, which denotes the average gene 
expression levels that a cluster should exceed in order to be regarded as over/under-
expressed. Initially, the detection performance of the algorithm was accessed by using a 
range of values for the max and min λ denominator values (max, min) and the threshold 
(t) parameters while keeping the step constant with a value of 1. For the initial 
exploration of the parameters’ space, the iPSC vs ESC dataset has been used with a 
range of               and                 .  
 
Figure 3.30 shows the results for the three different thresholds (t): 1.2 FC that 
represents clusters of a subtle change in the expression levels, 1.5 FC for medium 
change, and 2 FC for highly affected clusters. The performance of the algorithm was 
measured in terms of sensitivity, number of FP clusters and number of FP genes in the 
FP clusters since it is important to examine both the number of FP clusters and their 
sizes.  
 
From Figure 3.30 it becomes clear that the best prediction rate is achieved by the 
combination of                             . For the 2 FC threshold, the 
performance of the algorithm drops since the clusters are formed with the Multi-Level 
Otsu threshold (1.62 FC) and, as a result, the average expression level of the genomic 
clusters is below the detection threshold of the algorithm. It is still possible however to 
detect mild changes at the 1.2 FC level. For the remaining of the validation analysis the 
results from the combination of                        will be presented. It 
should be noted that a value of 100 for the λ denominator can correspond to a cluster of 
50 genes with 2 FC average gene expression, for example, or a cluster of 200 genes with 














Figure 3.31 Sensitivity, number of FP clusters and number of genes in FP clusters for the five 
configurations for the TV method in the NSC vs ESC dataset 
                      . 
 
In addition, the method showed equal performance when tested at the NSC vs ESC 
dataset where the number of differentially expressed genes is dramatically different 
both for the 1.5 FC level and the 2 FC level. Figure 3.31 shows the three metrics for the 
NSC vs ESC data using the three different thresholds and highlights the effectiveness of 
the Multi-Level Otsu method in terms of reducing the FP rates both in terms of 
identified FP clusters and in terms of keeping their size minimal and thus producing 








A realistic response time is a necessary prerequisite for every effective method 
implementation. If Figure 3.32 the average response times of each algorithm under 
each threshold configuration are displayed for both the iPSC vs ESC and NSC vs ESC 
datasets. In the general scenario, the PGE method demonstrates the quickest 
performance, taking less than 2 sec when the number of differentially expressed genes 
is low. The execution time increases dramatically, however, when a large percentage of 
the genome is differentially expressed such as in the case of the NSC vs ESC dataset 
with relatively low thresholds. The NN method is comparably fast and its execution 
time does not greatly vary between different runs. Finally, the TV method is 
significantly slower in most cases although, like the NN method, its execution time does 
not correlate with the number of differentially expressed genes.  
 
 
Figure 3.32 Average response times of the three algorithms for the two types of artificial datasets. 
 
 
3.11.2. Characterised biological datasets 
 
For the evaluation of the methods with real biological data, a range of datasets that 
have been previously characterised with conventional cytogenetic techniques have 
been used. The datasets included in this analysis have been selected so as they can 




patterns at the transcriptional level has been assessed. The mapping of gene expression 
levels was performed with the Affymetrix U133 _Plus2 chip for human and the 
Affymetrix GeneChip Mouse Genome 430 2.0 Array mapping annotation for mouse 
data.  
 
Table 3.5 presents the results for the three methods across the different datasets. 
Where indicated by the symbol (¥), the method attributed more than one clusters to 
the region in question, resulting to a failure to identify the correct boundaries of the 
cluster and fragmentation.   
 
According to this analysis, the PGE method was the most successful in identifying the 
underlying genomic patterns using the parameters defined at the validation step with 
artificial data (average significant ratio=2.5).  
 
For the NN method, it was clear that the outperforming gap parameter of 5 at the 
artificial data validation could not adequately capture the complexity of real biological 
datasets and the parameter was set to 20. With a more relaxed gap threshold, the 
method identified most of the clusters but, also, suffered from over-fragmentation.   
 
Finally, the TV method demonstrated the lower prediction rates, missing the localised 
expression patterns in 5 out of 16 datasets and only partially locating the cluster in 5 
more. Again, the parameters had to be re-adjusted and the configuration that could 
identify the underlying signal was                  with a threshold varying 
from 1.3 to 2 FC. This adjustment was possible since the underlying pattern was known 
for the specific datasets. However, it reveals a serious drawback of the method that 
requires a prior knowledge of the type of cluster to be found. Since the model used by 
the TV method requires four different input parameters from the user, it is not possible 
to assume that the correct set of parameters could be easily identified in 
uncharacterised datasets. In addition, in order to exclude the possibility that this 
observation is related to the integration of the algorithm in DI.S.C.O., Sarantidis (2008) 










Table 3.5 Method validation with real biological datasets, already characterized by cytogenetic analysis (¥ cluster is segmented to smaller sub-clusters) 
Name Description Karyotype PGE NN TV Accession 
chHES-3 hESCs (p=53) 46,XX,dup(1)(p32p36) dup(1)(p32p36)¥ - - GSE7234 





- - GSE7234 
H14 hESCs (p=25) 48,XY,+12,+der(17) 
del(17)(p12p13.3)hsr(17)(p11.2) 





p-hiPS01 hiPSC line 1 Ts1, Ts9 Ts1, Ts9 ¥ Partial dub(1) and dub(9) ¥ - GSE16093 
p-hiPS02 hiPSC line 2 Ts1, Ts9 Ts1, Ts9 ¥ Partial dub(1) and dub(9) ¥ - GSE16093 
hfT18 cell free mRNA  Ts18 Ts18 Ts18 - GSE25634 
MEF89 MEFs Ts16 Ts16 - Partial dub(16) GSE12501 
MEF92 MEFs Ts16 Ts16 Partial dub(16) Ts16 GSE12501 
MEF776 MEFs Ts13 Ts13 Ts13 Partial dub(13) ¥ GSE12501 
MEF780 MEFs Ts13 Ts13 Ts13 ¥ Partial dub(13) ¥ GSE12501 
MEF666 MEFs Ts13 Ts13 Ts13 ¥ Ts13 GSE12501 
MEF1113 MEFs Ts19 Ts19 Ts19 ¥ Partial dub(19) ¥ GSE12501 
MEF836 MEFs Ts1 Ts1 Ts1 Partial dub(1) ¥ GSE12501 




















Up-regulated X ¥ 
dub(17) (27-
34Mb) ¥ 
Up-regulated X ¥ 
GSE7306 







This chapter has presented the DI.S.C.O. software application for the identification of 
genomic clusters of differentially expressed genes. This part of the project was mainly 
focused on the development of a user-friendly and powerful tool that integrates 
intuitive visualization of the transcriptional data with computational methods that can 
identify statistically significant genomic regions of aberrant transcriptional activity.  
 
DI.S.C.O. aims to overcome the limitations that are present in the related tools as 
described in section 3.1.2 by providing an automated and intuitive analysis platform for 
the user (or semi-automated when it cannot be avoided). It can be, therefore, easily 
used as a first level quick and inexpensive test for the validation of the genomic 
integrity of many published datasets, especially in biological fields where chromosomal 
aberrations are frequent, such as the case of pluripotent stem cell lines. The limitations 
addressed here could be potentially the reason why the scientific community has not 
yet routinely adopted this type of methods. In the following chapter, the extent of this 
widespread problem is going to be discussed in more detail.    
 
Importantly, DI.S.C.O. is organism agnostic and platform independent as long as a 
genome annotation file is available for the specific organism and technology (tested 
with Affymetrix, Illumina and Agilent expression arrays as well as RNA-seq generated 
expression data). It can integrate and display different types of genomic features as 
additional custom tracks. It integrates and strengthens previously proposed methods 
(De Preter et al., 2008; Nilsson et al., 2008) and provides a framework for the 
comparison of novel methods, such as the NN method. The methods included in the tool 
have been extensively validated with both artificial and real biological datasets and 
their detection power and limitations have been discussed in section 3.11. 
 
Finally, DI.S.C.O. is extended to the analysis of high-throughput sequencing data for the 
newly emerged next-generation sequencing technologies and it is implemented as a 




4. Large-scale integrated search for aberrant 
transcriptional intervals in mouse pluripotent stem 
cells 
 
This chapter presents an optimized methodology for the large-scale analysis of 
transcriptional data for the identification of recurrent chromosomal clusters of 





As it has been already discussed in chapter 2.2, the accumulation of chromosomal 
imbalances in pluripotent stem cell populations is a frequent phenomenon, closely 
linked to the process of culture adaptation (Baker et al., 2007; Draper et al., 2004; 
Enver et al., 2005). The majority of the karyotypic validation of pluripotent stem cell 
lines has been performed by the use of conventional cytogenetic techniques or array-
based methods such as aCGH and SNP genotyping. However, it has been already shown 
that this type of analysis can be also done at the transcriptional level due to the high 
correlation between gene dosage and gene expression that a high percentage of the 
genes in the affected region demonstrate (Pollack et al., 2002; Hyman et al., 2002; 
Hertzberg et al., 2007). Two recent studies were based on this principle in order to 
perform transcriptional karyotyping in human pluripotent and multipotent stem cells 
(Mayshar et al., 2010; Ben-David et al., 2011).  
 
Interestingly, recurrent chromosomal aberration often map to specific genomic 
locations which correspond to chromosomes 12, 17, 20 and X in human (Draper et al., 
2004; Baker et al., 2007; Inzunza et al., 2004; Mitalipova et al., 2005; Amps et al., 2011) 
and chromosomes 8 and 11 in mouse (Liu et al., 1997; Longo et al., 1997; Sugawara et 
al., 2006). Recently, it has been also shown that iPSCs tend to demonstrate a 
compromised genomic integrity during reprogramming and after establishment of the 
cell line in culture (Mayshar et al., 2010; Laurent et al., 2011; Hussein et al., 2011; Gore 




they confer a selective growth advantage to the cells in vitro. Selection for particular 
genomic changes could occur for many different reasons, namely because they confer 
resistance to apoptosis, enhanced self-renewal through loss of cell-cycle control or 
limited differentiation capacity (Harrison et al., 2009). When aneuploidies are present 
in a rapidly dividing self-renewing cell in a selective environment, the affected cells can 
potentially outgrow normal cells and eventually dominate the cell population. 
Consistent with this hypothesis, it has been demonstrated that mouse ESCs with a 
trisomy 8 outgrow normal cells with a diploid karyotype in competitive cultures (Liu et 
al., 1997). 
 
This chapter presents a large-scale integrated approach for the identification of 
recurrent abnormalities in pluripotent stem cell populations using gene expression 
data. The significant advantage of using transcriptional profiling data for this type of 
analysis lies in the wealth of available datasets in public repositories that can be readily 
downloaded and re-analysed. In addition, the detection of these patterns at the 
transcriptional level can also potentially reveal candidate genes that drive the selection 
process. While gene expression analysis has been used to predict aneuploidies in 
human ESCs and iPSCs as well as other adult stem cell types this is the first 
comprehensive study in mouse to date. Therefore, it is important for both 
understanding data for this model system and also offers the opportunity for 
comparative analysis to existing human data. 
 
4.1.2. Related Approaches and Challenges 
 
Recently, Mayshar et al. (2010) used global gene expression meta-analysis in a 
collection of 66 hiPSC and 38 hESC samples from different passage numbers from 18 
independent studies in order to assess the chromosomal integrity of human pluripotent 
stem cell lines. The study was also able to validate the results of the analysis by 
examining the corresponding DNA data that were available for 50% of the studies 
included in the meta-analysis.  
 
At the first step of the analysis, Mayshar et al. (2010) obtained the FC values for each 
sample by dividing each gene with the median of the expression levels of the gene 




probe set (after random selection) that was Present in more than 80% of the samples. 
In addition, Mayshar and colleagues averaged profiles with similar expression levels 
after performing hierarchical clustering of the whole dataset. Then, for the 
identification of chromosomal enrichment of up-regulated genes only (>1.5 FC), the 
authors used two gene expression analysis software: Expander (Sharan et al., 2003) 
and EASE (Hosack et al., 2003) that both measure enrichment in chromosome 
cytobands or whole chromosomes. In order to further examine spatial patterns that do 
not necessarily overlap with predefined chromosomal intervals such as the cytobands, 
the authors used an application developed for aCGH data, CGH-explorer (Lingjaerde et 
al., 2004), using the program’s piecewise constant fit (PCF) algorithm with a constant 
set of parameters (Least allowed deviation = 0.3; Least allowed aberration size = 80; 
Winsorize at quantile = 0.001; Penalty = 10; Threshold = 0.01).  
 
Mayshar et al. (2010) identified high occurrences (6 hiPSC cell lines, 9% of samples 
examined) of chromosome 12 related aberrations (partial gains or full trisomies) and 
hypothesized that this could be due to the over-expression of the cluster of 
pluripotency genes Nanog and Gdf3 at the 12q.   
 
Ben-David et al. (2011) used the exact same methodology to interrogate human 
multipotent stem cells (208 samples of pluripotent stem cells, 144 samples of 
mesenchymal stem cells (MSCs), 97 samples of neural stem cells (NSCs) and 177 
samples of hematopoietic stem/progenitor cells (HSPCs), from 58 independent 
studies). The authors were able to identify multipotent cell type-specific aneuploidies, 
recurring with a similar frequency (NSCs) or lower frequency (MSCs) than the one 
reported for pluripotent stem cells. These finding stress once more the necessity for 
rigorous karyotypic testing of pluripotent and multipotent cell lines.  
 
Although, the results from the studies of Mayshar et al. (2010) and Ben-David et al. 
(2011) highlight an important problem, there are several limitations in their analysis 
pipeline. The use of a globally averaged expression profile can be limiting for the 
identification of subtler patterns of aberrations since it makes the assumption that a 
“normal” transcriptional stem cell state can be adequately represented by the global 
average of many different states. Given the heterogeneity of this type of data collections 
(derived from different labs, under different culture conditions and experimental 




interest. A detailed description of how the use of the global average expression profile 
may hinder the ability to predict aberrant regions follows in section 4.4. 
 
Furthermore, both these studies assessed positional enrichment in predefined 
chromosomal intervals (cytobands or whole chromosomes) submitting gene lists of 
only up-regulated genes and using a constant threshold across the whole dataset, 
factors that could also be limiting for the analysis. The continuous change across the 
chromosome was investigated using an algorithm designed for aCGH data (CGH-
explorer) which could identify highly affected regions but may lack the specificity to 
highlight milder changes. The CGH-explorer (Lingjaerde et al., 2005) is a moving 
window mean smoothing technique. The main criticism for mean smoothing is that it 
increases the signal-to-noise ratio with a cost of blurring the ends of the sequence 
which could result to over- or under- segmentation (Lai et al., 2005; Wineinger et al., 
2008). In addition, the choice of an appropriate window size is not straight forward: 
larger windows result to smoother curves and possibly lower sensitivity, while smaller 
window sizes may introduce a large number of false positives (Chari et al., 2006). 
Finally, the method does not take into account the spatial distribution of probes on the 
chromosomes. It is not clear how the differences in gene density of different genomic 
regions could affect the prediction power of the approach.    
 
The methodology proposed here addresses these potential problems by applying a 
sample-centric analysis with sample-specific thresholds in an iterative way across the 
whole dataset. In addition, the PGE algorithm (discussed in section 3.7.3) has been 
used, a method specifically designed for gene expression data and whose predictive 
ability has been demonstrated by extensive validation with both artificial and 





4.2. Data Collection and Data Normalization 
 
The initial dataset of the present study consisted of 481 public domain gene expression 
data (373 ESC and 108 iPSC samples from 64 experimental designs) for the Affymetrix 
GeneChip Mouse Genome 430 2.0 Array from the Gene Expression Omnibus (GEO)7 and 
ArrayExpress8 public databases (the complete list of the analysed samples and their 
annotation is available as part of the supplemental material in the attached CD, Table 
S1).  
 
The raw CEL files obtained from this table were globally normalized using the Robust 
Multiple-Array Average (RMA) (Irizarry et al., 2003a) and P/A flags were extracted by 
the MAS5.0 algorithm (Hubbell et al., 2002), both from the “affy” package of the 
Bioconductor suite9 in the R statistical environment (Ihaka and Gentleman, 1996).  
 
In order to identify differentially expressed genes, all the probe sets for which mapping 
positions were available have been considered (43109 probe sets). In addition, each 
gene was represented with a single value after averaging replicate probe sets with their 
median values, resulting to a final sum of 26930 probe sets. 









4.3. Establishing the appropriate baseline for FC values 
generation 
 
4.3.1. The need for an appropriate baseline discovery method 
 
Gene expression microarrays measure simultaneously the relative activity of every 
gene in the genome. In a typical microarray experiment, RNA is obtained from a control 
sample and a condition sample (which is by some criterion different from the control). 
The raw intensity values of each sample are then measured and compared in order to 
investigate the differences between these two conditions. The term baseline refers to 
the sample that is chosen to represent the control, that is the sample which establishes 
the cell state the deviation from which we wish to measure.  
 
It is not uncommon that, in a single experiment type of analysis, the control sample is 
obtained from the parental cell line while the condition sample is derived from the 
same cell line after some kind of genetic manipulation. For example, a common 
experimental set-up is the creation of a conditional gene knock-out cell line in order to 
study the pathways affected by the lack of expression of the specific gene of interest. In 
this scenario, if the parental cell line relatively homogeneously carries a chromosomal 
aberration, there is a high chance that this aberration will be also present in the knock-
out cell line. The relative change between the two samples will be unable to reveal the 
presence of the aneuploid chromosome. On the other hand, if the chromosomal 
imbalance only occurs in the derived knock-out cell line (either as a result of the 
genetic manipulation or because it is random but still counteracts and balances some 
process that is necessary for the cell and disturbed through the genetic manipulation), 
then it will be detectable with the above comparison.  
 
So even if the validation of the samples at the transcriptional level is performed (with 
tools such as DI.S.C.O.), it is not necessarily the case that the underlying chromosomal 
imbalances would be discovered depending on the normalisation scheme used and the 
availability of karyotypically normal control samples. This problem can potentially 




samples are analysed and it can lead to the under-estimation of the rate of recurrent 
aneuploidies in the examined dataset.  
 
Ideally, samples from a cell line should be compared with a karyotypically normal 
instance of the same cell line in order to improve the detection power of any positional 
enrichment method. If such normal samples are not available, the next most 
transcriptionally similar sample can be used to reveal potential chromosomal 
imbalances manifested at the transcriptional level.  
 
In order to address this problem, the present study uses a similarity measure of the 
transcriptional profiles of the different samples included in the analysis, and defines 
the comparisons to be performed using this similarity in an iterative way. The approach 
proposed is described in detail in the following section.  
 
4.3.2. Hierarchical Clustering of Microarray Profiles 
 
Firstly, the distance matrix of the different samples was calculated using the Pearson 
correlation. The Pearson correlation gives a measure of the similarity (linear 
dependence) of two variables, which is represented with a value ranging from -1 to 1. 
Typically, values between 0.7 and 1 denote high correlation (or -1 to -0.7 for high anti-
correlation) while a value close to zero denotes no correlation between the two 
variables. Pearson's correlation coefficient is defined as the covariance of the two 
variables divided by the product of their standard deviations: 
 
     
               
 
   
         
 
 
The distance matrix based on Pearson correlations has been used to perform 
agglomerative hierarchical clustering with average linkage in order to obtain a measure 






Figure 4.1 The resulting dendrogram after the agglomerative hierarchical clustering of the 481 
samples included in the study.  
The precise structure of the dendrogram of the present analysis can be found in Table S2 in the 
Supplemental Material provided in the attached CD.  
 
The lower level nodes of the dendrogram in Figure 4.1 (referred to as leaf-nodes) 
represent the different samples, while the remaining nodes represent the clusters to 
which the samples belong according to the distance matrix.  Clusters are formed by 
joining individual leaf-nodes or existing clusters and each joining point is a node. Each 
node (except the leaf-nodes), consists of a right and left sub-branch of clusters. In 
addition, the y-axis represents the distance between samples or clusters of samples in 
an incremental fashion. Therefore, samples that are highly correlated will have a low 
distance (close to zero) and will be represented by nodes nearer the bottom of the 
dendrogram. While clusters become gradually dissimilar, their distance is higher and 




4.4. Dendrogram-based Positional Enrichment Analysis 
 
The dendrogram produced by the hierarchical clustering of the samples can be used to 
define the normalisation scheme (the comparisons to be performed), between samples 
and groups of samples. Error! Reference source not found.A shows a schematic 
representation of the branch-wise iterative comparisons logic. Firstly, comparisons are 
being performed at the first level of the dendrogram (at the leaf-nodes). The leaf-nodes 
consist of pairs of samples that are most similar to each other within the whole data 
matrix. In the majority of the cases, these will be replicate samples or samples from the 
same cell line cultured in a similar way. The median across all samples consists of the 
trim mean (0.05% of outliers) of the raw expression values of each gene. These values 
are used in order to identify the direction of the aberration (gain or loss). In the case of 
gain, for example, we would expect a higher number of genes in the affected sample to 
have higher raw expression levels than their trim mean values. This step is necessary 
since it is otherwise impossible to determine if the identified cluster is the result of a 
gain in the condition sample or a deletion in the control sample (Figure 4.2BError! 
Reference source not found.Error! Reference source not found.).  
 
Figure 4.2Bshows a scenario that will result in the identification of the enriched cluster. 
In this scenario, the identified cluster can be either a gain in Sample 1 (the condition, 
red) or a loss in Sample 2 (the control, green). The region will be identified but the type 
of the cluster (under the assumption that this is a genomic aberration) can be only 
assigned after comparing the trim mean expression of each specific gene in the cluster 
with the expression levels of the respective gene in the specific sample. For this 
assignment, the hypergeometric distribution (see section 3.1.2) is used in order to 
identify whether the cluster is enriched in up-regulated or down-regulated genes. The 
two probabilities are calculated and the type of cluster is assigned according to the 






Figure 4.2 Dendrogram based positional enrichment. A) The branch-wise iterative comparison 
design. B) Level 1 comparisons of the dendrogram where a cluster is present at one sample. The 
chromosomal cluster can be identified since it appears in the one of the two samples being 
compared. C) Level 1 comparisons of the dendrogram where a cluster is present in both samples. 
The chromosomal cluster cannot be identified since it appears in both samples being compared. D) 
Level 2 comparisons of the dendrogram. The chromosomal cluster can now be identified since the 






Figure 4.2C, on the other hand, presents a scenario where the cluster is present in both 
samples (condition and control) and it cannot be identified at the first level 
comparisons step since it does not result in a relative change of the FC values of the 
samples being compared. However, as it is depicted inFigure 4.2D, the cluster will be 
discovered at the next level comparisons, where the median of the two samples is being 
compared to the next most similar sample that does not bear the specific aberration. As 
a result, it is possible now to correctly predict the presence of the underlying gain or 
loss in both samples 1 and 2. By iterating across the whole dendrogram in a branch-
wise manner, it is feasible to obtain, in a sample specific manner, an accurate estimate 
of the patterns of aneuploidy present.  
 
For this analysis, the PGE method has been used with an average significant ratio of 2.5 
(discussed in section 3.7.3). The PGE algorithm is the method of choice since it was able 
to predict correctly the majority of patterns during the validation with previously 
characterised biological datasets (see section 3.11.2). In addition, the Multi-Level Otsu 
method has been used for the calculation of the sample-specific thresholds in each 
branch-wise comparison (average of thresholds used across the hierarchical tree: >1.56 
FC and <0.66 FC). In Figure 4.3, the enhanced detection power of the methodology is 
presented. A single sample (GEO ID: GSM517044) is firstly compared to the global trim 
mean (panel A) and secondly, to the group of samples indicated by the dendrogram 
(GSM517041, GSM517042, and GSM517043 - series GSE20576) (panel B). The up-
regulated cluster across chromosome 8 can be partially identified in (A) but it becomes 
much prominent in (B) while an up-regulation of the first part of chromosome 1 is also 
revealed which was not identified in (A). The distance of the transcriptional profiles 
between sample GSM517044 and the global trimmed mean obscures the ability to 
evaluate the transcriptional profile of GSM517044 in (A). Therefore, this approach can 
reveal the unique subtle changes of each sample that differentiate it from its most 
similar neighbour(s). It deviates from previous methodologies (Mayshar et al., 2011; 
Ben-David et al., 2011) in that it avoids the use of a globally averaged profile as a 
definition of a “normal” stem cell state to represent complex stem cell expression 






Figure 4.3 Improved detection of the proposed method.  
An example of the enhanced detection power of the approach which is based on the “branch-wise 
comparisons” across the dendrogram. (A) Visualization of the transcriptional profile from sample 
GSM517044 (series GSE20576) when compared to the global Trimmed Mean (Chromosomes 1-10). 
(B) Visualization of the transcriptional profile from sample GSM517044 when compared to samples 
GSM517041, GSM517042, and GSM517043 (series GSE20576) as indicated by the hierarchical 
clustering derived dendrogram. The comparison is presented in Table S2 of the Supplemental 





4.5. The large-scale integrated search workflow 
 
Figure 4.4 summarizes the proposed methodology, which consists of the following 
steps: 
 
(A) Global normalization of 481 public samples using RMA.  
(B) Pearson correlation derived distance matrix and agglomerative hierarchical 
clustering with average linkage of the normalised data.  
(C-D) PGE analysis with Multi-Level Otsu thresholding for identification of recurrent 
aberrant localized expression across the dendrogram. 
 
In addition, for each comparison of the samples, the PGE algorithm corrects the 
enrichment p-value for multiple testing using False Discovery Rate (FDR) (Benjamini 
and Hochberg, 1995). An additional adjustment to the p-values to correct for multiple 
testing over the whole dendrogram was performed using 1,000 random permutations 
of data generated from randomised genomic mappings of the FC values. The resulting 










4.6.1. A Catalogue of Predicted Aberrant Intervals in Mouse ESCs and 
iPSCs 
 
The PGE analysis of the clustered gene expression samples generated a large set of 
predicted regions of chromosomal change (the complete list is available as part of the 
supplementary files provided with the attached CD, Table S2). The most prevalent 
recurring intervals that have been observed map to chromosomes 6, 8, 11, 14 and most 
commonly in chromosome X (Figure 4.5, constructed using Circos (Krzywinski et al., 
2009)). It is plausible that a percentage of the observed clusters on chromosome X 
correspond to varying states of X chromosome inactivation (XCI), while others to DNA 
copy number (CN) alterations. However, it should be noted that in mouse ESCs, all lines 
for which annotation was available (~70%) were annotated as male. Larger intervals 
covering extensive regions of the autosomes are likely to reflect underlying 
aneuploidies since co-regulation of large genomic regions is not commonly observed as 
the result of transcriptional regulation. Interestingly, 75.43% (binomial, p-value=3.8E-
50) of the identified intervals are predicted gains, which implies that amplifications or 
activation events are much more frequent than deletions or coordinated down-
regulation. A strikingly similar percentage of copy number variations (CNVs) in human 
ESCs has been reported to correspond to amplifications (72%) (Narva et al., 2010). The 
tendency towards a higher frequency of gains rather than losses in pluripotent stem 
cell lines has been also reported by Amps et al. (2011) where 39 ES cell lines (~31%) 
demonstrated gains of chromosomal material versus 20 lines (~16%) that showed a 
loss. In addition, Laurent et al. (2011) has suggested that time in culture correlates with 






Figure 4.5 Identified aberrant intervals presented on a circular karyotype.  
The circular karyotype of all predicted significantly over-expressed (red) and under-expressed 
(blue) intervals in the matrix and the genes that are differentially expressed between predicted 
normal and aberrant samples (red for up-regulated genes and blue for down-regulated). Larger 
effects observed in chromosomes 8, 11, 14 and X. Figure generated in Circos (Krzywinski et al., 
2009). 
 
In addition, Figure 4.6 (constructed using Circos (Krzywinski et al., 2009)) gives a 
graphical overview of the chromosomal intervals that seem to appear simultaneously 
aberrant. In the circular karyotype plot, each line connects two different genomic 
regions that have been predicted abnormal in the same sample. Therefore, with this 
type of representation, it is possible to summarize the complex patterns of recurrence 






Figure 4.6 A connectivity map of jointly re-occurring clusters with major hubs at the chromosomes 
1, 8, 11, 14, 19 and X. Figure generated in Circos (Krzywinski et al., 2009). 
 
 
4.6.2. Expression of pluripotency markers 
 
The PGE analysis resulting clusters were visually inspected using DI.S.C.O. and samples 
with whole- or partial-chromosome spanning clusters were classified as “Aberrant”. 
The rest of the samples were categorized as “Normal” even if they included small 
clusters since the genomic or transcriptional origin of smaller aberrant intervals cannot 
be distinguished at the transcriptional level.   
 
By examining the expression levels of hallmark pluripotency genes such as Nanog, 
Pou5f1 (Oct4) and Sox2 (Chambers et al., 2007; Silva et al., 2009; Nichols et al., 1998; 
Niwa et al., 2000; Schöler et al., 1990; Nichols et al., 1998; Avilion et al., 2003), it was 
possible to reveal distinct differences of the expression levels of these markers 





In Figure 4.7, samples of the two groups (Normal and Aberrant) have been plotted 
according to the Nanog expression levels in an ascending order. It becomes clear that 
the Aberrant group largely consists of samples with Nanog high expression levels (86% 
of the samples) while the percentage drops to 47% in the Normal group. The 
expression of the pluripotency genes Oct4 and Sox2 correlates with the Nanog 
expression levels at the high expression range, with the exception of the group of 
samples at the far right of the graph where the Oct4 suppression is induced by 
tetracycline after the targeted inactivation of the endogenous alleles (ZHBTc4 cell line) 











Figure 4.7 Expression levels of pluripotency markers (Nanog, Pou5f1 (Oct4) and Sox2) in the normal and aberrant groups of samples.  
Pie charts of the percentage of samples in each group that demonstrate high and low Nanog expression levels. The collection of samples at the far right section of 




By using a combination of the available annotation of the samples and the expression of 
the pluripotency markers Nanog, Oct4 and Sox2, it was possible to identify that the 
majority of the samples with Nanog low expression levels are either differentiated cells, 
cells in various time-points of a differentiation protocol or partially reprogrammed 
cells. Even though Nanog expression is not necessary to sustain pluripotency 
(Chambers et al., 2007), it can be hypothesised that samples with low levels of Nanog 
expression potentially have higher percentages of differentiating or partially-
reprogrammed cells. This was highly consistent with the obtained sample annotation. 
Given the highly unbalanced percentages of homogeneously pluripotent cell lines 
between the Normal and Aberrant groups of samples, the ability to detect the 
transcriptional changes due to aneuploidy can be obscured by the transcriptional 
changes linked to the differentiating signature in half the samples of the Normal group. 
In order to be able to distinguish between the differentiation signature and the 
aneuploidy signature, the samples included in the study were divided in two groups 
based on the criterion of Nanog expression levels: the Nanog-high group, which 
consists of pluripotent stem cell populations (315 samples) and the Nanog-low group, 
which consists of their differentiating or partially-reprogrammed counterparts (166 
samples).  
 
The extent of aneuploidy in the Nanog-high group and the Nanog-low group is 
presented in Figure 4.8. The percentage of aberrant samples in the Nanog-low subset is 
much lower (30%) than the ones in the Nanog-high subgroup (57%). This difference 
may reflect differences in the frequency of pluripotent cells in cultures or the ability to 
detect these subtle signatures in mixtures of differentiating cells. 
 






4.6.3. Comparison to published cytogenetic studies in mESCs 
 
A detailed discussion of the findings of the various studies that have assessed the 
genomic integrity of mouse ESCs in culture has been presented in section 2.2.4. The 
small number of available studies assessing systematically the phenomenon of culture 
adaptation in mouse pluripotent stem cells is however surprising. The majority of these 
studies have reported an alarming range of chromosomal abnormalities (Liu et al., 
1997; Longo et al., 1997; Guo et al., 2005; Sugawara et al., 2006; Rebuzzini et al., 2008a; 
Rebuzzini et al., 2008b; Liang et al., 2008). From these studies, only (Liu et al., 1997) 
and (Sugawara et al., 2006) included a high number of cell lines (29 and 88 
respectively) and provided the detailed karyotype of the analysed cells. Frequent 
genomic changes seem to be non-random and mainly involve chromosomes 8, 11 and X 
(Liu et al., 1997; Longo et al., 1997; Sugawara et al., 2006). The study of Guo et al. 
(2005) has also implicated chromosome 6 and 14.  
 
 Figure 4.9 presents a comparison between the present study and the studies of Liu et 
al. (1997) and Sugawara et al. (2006). These studies were chosen because they provide 
the most comprehensive analysis to date. The percentage of abnormal karyotypes (any 
type of aberration) is 57% for the current study, 75.86% in Liu et al. (1997) and 
39.77% in Sugawara et al. (2006). Trisomy 8 is the most frequent chromosomal change 
in all three studies and trisomy 11 is the second most frequently observed aneuploidy. 
Instances of chromosomal aberrations in chromosomes 6 and 14 were much more 
predominant in the present study but they constitute partial chromosomal gains or 
losses rather than trisomies or whole chromosome losses. The identification of 
frequent patterns on chromosomes 6 and 14 could reflect the ability of the proposed 
method to detect subtler changes. Nonetheless, high percentages of chromosome 6 and 
14-specific aberrations have been also identified by multicolour FISH by Guo et al. 
(2005) (10/10 metaphases had a 14q duplication and 11/11 a loss of 6q in the E14.1 
and W9.5 ES cell lines respectively). 
 
In the case of the sex chromosomes, the instances of chromosome X specific 
aneuploidies identified by the present study could reflect different states of XCI 
between different ESC samples. Alternatively, it is possible that the detected up-




two active X chromosomes and male ES cell lines. It is worth noting however that the 
majority of ES cell lines for included in the study have been annotated as male (~70% 
of lines for which annotation was available). It has been reported previously that the 
derivation of male ES cell lines is more efficient and they maintain better genomic 
stability than female ES cell lines (Robertson et al., 1983; Huynh and Lee, 2003). 
Information for the sex chromosome constitution of the iPSC samples examined here 




Figure 4.9 Comparison to published large-scale cytogenetic studies.  
Comparison of the frequencies of predicted abnormalities per chromosome in the present study 
and two independent cytogenetic studies of mouse ESCs (Liu et al., 1997; Sugawara et al., 2006). 
 
Growth advantage of ES cells in culture has also been linked with sex chromosome 




Sugawara et al. (2006), 9 of the 35 aberrant cell lines were XO with 2 of the 9 lines 
containing a small sub-population of XY karyotypes, 1 of XX karyotypes and the rest 
were homogeneously XO. Y-chromosome loss has also been reported at an average 
frequency of 2% of subclones from 40,XY ES cell lines (Eggan et al., 2002). Cell lines are 
typically sexed by PCR analysis of the male-specific Sry gene on chromosome Y 
(Lambert et al., 2000). A similar analysis at the transcriptional level was not possible 
since Sry transcripts were only detected in very low levels in the ESCs of this study. The 
expression of four more genes transcribed from Y chromosome was analysed in order 
to investigate the possibility of a chromosome Y loss. These were the genes Ddx3y 
(Dby), Eif2s3y, Ube1y1 and Uty located at the male-specific region of the gene-poor 
mouse Y chromosome. Their expression levels in the annotated as male only ES cell 
lines (221 samples) was analysed and compared to each gene’s trim-mean expression 
(0.05% of values removed). Since the average percentage of XO male ES cell lines has 
been reported to be around 2% (Eggan et al., 2002), it can be hypothesised that the 
trim-mean across the male sub-group will be representative of the baseline expression 
of these genes in male samples. Samples were divided in three categories: up-regulated 
Y chromosome, down-regulated Y chromosome and no change in Y chromosome, based 
on the expression of the four genes. A sample was assigned to the one of the two 
aberrant categories if more than two of the four Y-specific genes were differentially 
expressed when compared to their trim-mean value (>1.5 FC).  
 
The analysis of the occurrences of a deregulated Y chromosome (over- or under-
expression of more than half the Y-linked genes examined) revealed that 28.96% of the 
male samples show a down-regulation of Y-chromosome while 12.67% show an up-
regulation.  Interestingly, an up-regulated Y-chromosome coincides in 76.92% of the 
samples with a trisomy 8 (p-value<0.01, hypergeometric). This could indicate a 
regulatory role of elements on chromosome 8 that can affect the expression of the 
chromosome Y-specific genes. In the study of Sugawara et al. (2006), 6 out of the 9 XO 
lines had also a trisomy 8. In the present study, 25% of male ES cell lines with predicted 
trisomy 8 showed a down-regulation of chromosome Y (p-value<0.01, 
hypergeometric). Figure 4.10 displays a heatmap representation of the expression 
levels of the four Y-linked genes examined in combination with the presence of a 
predicted chromosome 8 – specific aneuploidy. However, there is no way to 
conclusively infer whether the deregulation of the Y-chromosome linked genes is a 




regulation event. These preliminary data could be further investigated only with the 




Figure 4.10 Comparative analysis of Chr8 aberrations and expression levels of four Y-linked genes. 
Heatmap representation of the expression levels of the four Y-linked genes Ddx3y (Dby), Eif2s3y, 
Ube1y1 and Uty in male mouse ES cell lines in relation to the existence of a predicted chromosome 8 
specific aneuploidy.  
 
 
4.6.4. Chromosomal breakdown of patterns 
 
The aberrant clusters from the PGE dendrogram-based analysis described in section 
4.4 were visually inspected using DI.S.C.O. and statistically significant large whole- or 
partial-chromosome spanning clusters were further examined. It is reasonable to 
hypothesise that large expression domains are characteristic of underlying aneuploidy 
rather than transcriptional regulation. Large-region epigenetic silencing has, however, 
been reported in cancer (the largest region observed thus far has been reported by 
Frigola et al. (2004) which consisted of a 4 Mb methylated region in colorectal cancer). 
Figure 4.11 presents the chromosomal breakdown of the resulting clusters for the 
Nanog-high subgroup of 315 ESC and iPSC samples specifically. 179 samples (56.83%) 
of the Nanog-high subgroup contained whole or partial-chromosome spanning clusters 
while the percentage of aberrant samples in the Nanog-low subset is much lower 






Figure 4.11 Breakdown of percentages for the aberrant chromosomes and the associated aberrant 
chromosome pairs for the Nanog-high subset of 315 pluripotent cell lines. 
 
In Figure 4.11, chromosome 8 is most often affected either solely (9% of samples) or in 
combination with chromosomes 11 and 14 (27% and 12% of aberrant samples 
respectively). Chromosomes 8 and 11 are the chromosomes most frequently affected 
by aneuploidy and, in fact, 70% of the predicted aberrant samples carry whole or 
partial-chromosome aberrations on at least one of these two chromosomes.  
 
Frequently recurring pairs of predicted chromosome anomalies which tend to recur 
across many different experiments were also discovered. These include chromosomes 
8 and 11 (hypergeometric, p-value=0.001), chromosomes 8 and 14 (hypergeometric, p-
value= 3.20E-06), chromosomes 11 and 6 (hypergeometric, p-value= 0.019) and 
chromosomes 14 and 17 (hypergeometric, p-value= 4.00E-11). A detailed breakdown 






Figure 4.12 Venn-diagram representing the co-occurrence of aberrations between chromosomes 6, 
8, 11 and 14. 
 
 
Finally, a detailed comparison between ESC and iPSC-specific aberrations of the 
autosomes revealed that in both cases more than half of the samples are predicted to 
carry one or more chromosomal aberrations (Figure 4.13). However, chromosome 11 
patterns are mostly present in ESCs. Chromosome 8 and 14, in contrast, account for a 
large number of aberrations in both populations. In iPSCs, the chromosome X changes, 
which are predicted gains, could reflect differences between male and female lines such 
as different states of XCI. Unfortunately, annotation for the sex of the line for the 
majority of iPSC samples studies was not readily available online and thus, sex 






Figure 4.13 Genomic changes in ESCs versus iPSCs.  
Detailed comparison between ESC and iPSC-specific patterns with overall percentages of predicted 






4.7. Chromosome 14 & 17 complex recurring patterns 
 
4.7.1. Identification of chromosome 14 and 17 recurring patterns 
 
In one of the first aCGH studies performed in mouse ES cells, Hall described a complex 
pattern of aberration involving chromosome 14 and 17 (Hall, 2008). This pattern 
included a deletion on chromosome 14 of 36.9 Mb followed by an amplification of the 
distal part of chromosome 14 of around 28.1 Mb in the ZHBTc4.1 cell line. In addition, a 
small deletion in the chromosome 17qE1.3-qE3 locus was identified (11.3 Mb) in the 
same cell line. In this experiment, the ZHTBc4 cells were compared to the CGR8 male 
cell line (derived as described in (Nichols et al., 1990)). Hall reported one more 
chromosome 14 related amplification in the B6 PD1 cell line (wild-type C75BL/6 
mouse derived ES cell line), namely an amplification of 14qD1-qE4 (aCGH analysis).  
Interestingly, a duplication of 14q has also been reported in W9.5 and trisomy 14 in 
E14.1 mouse ES cells after multicolour metaphase FISH analysis (Guo et al., 2005).  
 
In Figure 4.14, the complex aberration of chromosomes 14 and 17 described by Hall is 
presented in DI.S.C.O (in-house gene expression data from the Affymetrix GeneChip 
Mouse Genome 430 2.0 Array). The relative gene expression changes between the 
ZHBTc4 and CGR8 cell lines is clearly depicted at the transcriptional level and the PGE 
algorithm identifies both the deletion followed by the amplification of the distal end of 
chromosome 14 as well as the deletion on chromosome 17 as indicated by the 









Figure 4.14 The ZHBTc4.1 cell line gene expression compared to the CGR8 mESCs in DI.S.C.O.  
The complex aberration pattern in chromosomes 14 and 17 is highlighted by the output track of the PGE algorithm under the aberrant regions (green for down-



















Figure 4.16 Mapping of the chromosome 14 specific aberrations across the specific genomic region of chromosome 14 (USCS browser).  
Red tracks represent amplifications and green tracks represent deletions as indicated by the dendrogram-based PGE analysis. Samples included in the analysis: 
iPSC_Oct4 (Kim et al., 2009), iPSC_Oct4_Klf4 and iPSC_4Factors (Kim et al., 2008a), E14TG2a (Loh et al., 2006), R1,CGR8 (Chen et al., 2010), ZHBTc4_H and 





Figure 4.17 Mapping of the chromosome 17 specific aberrations across the specific genomic region of chromosome 17 (USCS browser).  
Red tracks represent amplifications and green tracks represent deletions as indicated by the dendrogram-based PGE analysis. Samples included in the analysis: 




The recurrent chromosome 14 amplifications in two independent ES cell lines in the 
study of Hall (2008) and two more ES cell lines in the study of (Guo et al., 2005) were 
intriguing. Chromosome 14 specific aberrations were also frequent in the present 
study, commonly in combination with chromosome 17 aberrations. Therefore, it was 
intuitive to attempt to identify a common region that could possibly reveal the gene or 
genes under selection. In Figure 4.15, a summary of the samples with a predicted 
chromosome 14 and/or 17 aberration is presented. With the exception of the iPSC 
samples of (Kim et al., 2008a) and (Kim et al., 2009), the rest of the data are ES cell 
lines. In more detail, both Hall (2008) and (Endoh et al., 2008) used the ZHBTc4 cell 
line. In the ZHBTc4 cell line, Oct4 expression is sustained from a tetracycline (Tc)–
repressible transgene on an Oct4 null background (Niwa et al., 2000). Upon Tc 
treatment, Oct4 is rapidly silenced and cells start to differentiate. The G6GR cell line in 
(Endoh et al., 2008) is generated by random integration of the linearized Gata6-GR 
expression vector into E14TG2a-derived EB5 ES cells (Shimosato et al., 2007; Kawasaki 
et al., 2000; Niwa et al., 2000). Loh et al. (2006) also uses E14TG2a mouse embryonic 
stem cells transfected with Nanog RNAi or Oct4 RNAi. Finally, Chen et al. (2010) uses 
two ES cell lines, the CGR8 and R1, but the specific origin of the sub-clones used is not 
provided.  
 
Table 4.1 gives a detailed description of the ES cell lines with an identified chromosome 
14 and/or chromosome 17 aberration and traces their parental cell lines. One initial 
observation is that the chromosome 14-17 specific pattern seems to be related to the 
CGR8 and E14TG2a cell lines and their genetically modified sub-clones, ZHBTc4 and 
G6GR.  However, there is an instance of the R1 cell line carrying the exact same pattern 
in the study of Chen et al. (2010). No other chromosome 14/17 aberrations at the 
specific loci were discovered in the remaining R1 and CGR8 cell lines included in the 
present study. However, an overlapping amplification of chromosome 14qE1-qE2.3 
(87816437-103476845) was also discovered in three subclones of the D3-pOct4 cell 










Table 4.1 Description of ES cell lines carrying a chromosome 14 and/or a chromosome 17 
aberration and their parental ES cell lines. 
ES Cell Line Description 
CGR8 129/Ola-derived wild-type ES cells (Nichols et al., 1990). 
D3 129/Sv blastocysts derived ES cells (Doetschman et al., 1985). 
D3-pOct4 D3-derived ES cells by electroporation of the linearized p-Oct4-eGFP-
pgk hygro plasmid (Tejedo et al., 2010). 
E14TG2a 129/Ola-derived HPRT-negative ES cells (Hooper et al., 1987). 
EB5 E14TG2a ES cells carrying IRES-BSD in one of Oct4 locus, which 
allows selection of Oct4-positive undifferentiated stem cells (Niwa et 
al., 2000). 
G6GR EB5-derived ES cells by random integration of the linearized Gata6-
GR expression vector (Shimosato et al., 2007). 
R1 Hybrid of two 129 substrains (129X1/SvJ and 129S1/SV-+p+Tyr-cKitlSl-
J/+) (Nagy et al., 1993).  
ZHBTc4 ZHTc6-derived ES cells maintained by tetracycline-regulatable Oct4 
transgene. Both of Oct4 locus are disrupted by IRES-zeocin and IRES-
BSD KO vectors (Niwa et al., 2000). 
ZHTc6 CGR8-derived ES cells carrying tetracycline regulatable Oct4 
transgene and IRES-zeocin cassette in one of Oct4 locus, which allow 
selection or elimination of Oct4-positive stem cells (Niwa et al., 2000). 
 
Upon closer examination, the following observation can be made: the majority of ES cell 
lines that demonstrate the specific chromosome 14-17 aberrant pattern have at some 
point undergone a genetic manipulation of the Oct4 locus by integration of an IRES-BSD 
or IRES-zeocin cassette (ZHBTc4 and G6GR), or the p-Oct4-eGFP-pgk hygro plasmid 
(D3-pOct4) with the exception of the CGR8 and R1 cell lines of Chen et al. (2010). In 
addition, the E14TG2a cell line used in the study of Loh et al. (2006) has been targeted 
with Nanog and Oct4 RNAi. However, even the pSUPER-puro empty vector samples that 
have been used as a control in this study carry the deletion on chromosome 14, thus, it 
seems that the aberration had already been present before induction of RNAi.  
 
Why the same complex pattern of chromosome 14-17 concordant aberration would 
appear in three different ES cell lines and their derivatives remains unclear. The 




manipulations of the Oct4 locus which may have resulted in suboptimal levels of Oct4 
expression in a past time-point of the ES cell line (no other genetically engineered Oct4 
cell line was available in the present analysis). One hypothesis could be that this 
complex pattern of aberration confers an advantage to the cells that can potentially 
compensate for the low Oct4 expression levels. This scenario might also explain the 
presence of the deletion of distal chromosome 14 observed in the iPSC cell lines. If such 
a hypothesis is true, it specifically implicates the region of deletion of chromosome 14 
which is overlapping in all samples examined with the exception of the CGR8 and R1 
cell lines of Chen et al. (2010).  However, it does not explain the presence of the 
chromosome 14 amplification and/or the chromosome 17 deletion in parental cell lines 
such as CGR8, R1 and E14TG2a where no targeting of the Oct4 locus has been 
performed.  
 
Another possibility is that the deletion on chromosome 14 and the amplification on 
chromosome 14 coupled with the deletion on chromosome 17 are two independent 
events that happened to simultaneously occur in specific cell lines. The cell lines can be 
actually divided into three groups: the ones that carry only the chromosome 14 partial 
deletion (iPSC cell lines and E14TG2a), the ones that carry the chromosome 14 partial 
deletion followed by amplification at the chromosome’s distal end and chromosome 17 
partial deletion (ZHBTc4, G6GR, CGR8 and R1) and finally the ones that carry the 
chromosome 14 distal end amplification only (D3-pOct4).  
 
It is also possible that some of the recurring pattern are mirroring a single event that 
occurred at the paternal cell line, which giving a selective advantage to the cells, 
propagated through serial passaging and outgrew the subsequent sub-clones or new 
cell line derivatives. This could be specifically the case for the ZHBTc4 cell line, which 
carries the exact same pattern in all clones examined in the course of this project, 
including an additional study by Sharov et al. (2008) using the NIA Mouse 44 K 
Microarray v2.1 and v2.2 (Agilent Technologies) (data not shown). 
 
Finally, it should be noted that complex genomic events such as translocations would 
not be identified with aCGH analysis but they could potentially be identified at the 
transcriptional level if they result in concordant changes of the expression levels of the 
genes in the affected region. Therefore, the possibility of a recurrent complex 




regions cannot be excluded. Even though the exact nature of the chromosome 14/17 
pattern, i.e. translocation, sequential events in culture, remains unclear, it has been 
validated with aCGH analysis at the genomic level (Hall, 2008). The performed 
validation provides strong additional support for the effectiveness of the proposed 
methodology to infer patterns of abnormalities at the transcriptional level.  
 
4.7.2. Determination of the minimal overlapping regions of recurring 
chromosome 14 and 17 aberrant patterns and candidate genes.  
 
Given the high frequency of recurrence of the specific pattern of aberration in 
chromosome 14 and 17, it was interesting to identify the minimal overlapping region 
that is common to all affected pluripotent cell lines. Locating the common interval and 
the genes that are consistently differentially expressed in the region could potentially 
reveal the gene or genes that play a role in the selective advantage conferred to the cell 
by the presence of the specific genomic change(s).  The obvious caveat with this 
approach is that the selection mechanism and the chromosomal aberration may not be 
the same. In addition, not all the genes that are differentially expressed in the aberrant 
region are necessarily linked to the selection mechanisms but they could rather be 
differentially expressed because of the underlying DNA CN change. In fact, it is possible 
that the key candidates whose deregulation has contributed to the selective advantage 
of the cells are no longer differentially expressed upon the domination of the abnormal 
cell population and the abolition of the competitive environment. However, the 
identification of consistently differentially expressed genes within a region that is 
recurrently aberrant may shed light to the composition and functionality of the 
aberration.  
 
In order to narrow down to the minimal overlapping genomic region that is aberrant 
across all the samples with a chromosome 14-17 abnormality, the STAC (Significance 
Testing for Aberrant Copy number) method has been applied (Diskin, 2006). The STAC 
method has been originally developed in order to provide a statistical framework for 
the identification of non-random gain or losses across multiple aCGH experiments. For 
the purposes of this study, it can be easily generalised for the discovery of statistically 
significant recurring clusters of aberrant transcription, as it only accepts the genomic 




Briefly, the STAC method uses the null model that a chromosomal aberration is equally 
likely to occur in any genomic interval of the chromosome. This model can be however 
erroneous in breakage-prone chromosomal regions (Bailey and Bedford, 2006). The 
null distribution is calculated by permutations of random rearrangements of the 
predicted aberrant intervals across the chromosome. Two metrics are calculated: the 
frequency and the footprint of an aberrant interval.  The frequency is defined as the 
number of times the interval is aberrant across the samples examined, while the 
footprint takes into account the length of the different intervals and how precise their 
alignment is (Diskin, 2006).   
 
Figure 4.18, Figure 4.19 and Figure 4.20 show the results of the STAC analysis for the 
three chromosomal regions, the partial loss of chromosome 14, the distal gain of 
chromosome 14 and the distal loss of chromosome 17. These regions have been 
examined independently since it is not safe to conclude that they are linked events 
(especially in the case of the chromosome 14 deletion followed by amplification). For 
this analysis, the chromosome was divided in 1Mb intervals and 500 permutations 
have been performed in order to obtain the null distribution.  The minimal overlapping 
regions for the deletion on chromosome 14 was 59 Mb to 88 Mb, for the amplification 
on chromosome 14 was 99 Mb to 104 Mb and for the deletion on chromosome 17 was 
74 Mb to 86 Mb (p-values<0.05). In addition, expression analysis was performed in 
order to identify transcripts that were differentially expressed in more than half of the 
profiles examined for each type of aberration. The analysis was focused on transcripts 
that were present (P flag) in the samples and they demonstrated a FC higher or equal to 
2 FC in more than half of the samples. The resulting gene lists are presented in Table 
4.2, Table 4.3 and Table 4.4. 
 
In the chromosome 14 partial deletion, 18 transcripts were consistently down-
regulated in more than four of the seven samples examined (<2FC). Among these, Fgf17 
and Wdfy2 are implicated in signal transduction pathways and Bin3 functions as a 
cancer suppressor involved in cell proliferation and cell motility pathways 
(Prendergast et al., 2009).   
 
In the chromosome 14 distal end amplification, 9 genes were found consistently over-
expressed in at least three out of five cell lines examined. Lmo7 over-expression has 




cytoskeleton, motility, migration, and adhesion (Hu et al., 2011). Interestingly, a 
member of the Zn-finger transcription factor of the Kruppel-like family, Klf5, can be 
found among them. Klf5 is highly implicated in ESC self-renewal and it directly 
regulates the expression of Oct4 and Nanog (Parisi et al., 2008; Hall et al., 2009). It has 
been also shown that Klf5 regulates ESC proliferation by promoting phosphorylation of 
Akt1 via induction of Tcl1 (Ema et al., 2008). Furthermore, it is downstream of LIF 
signalling and its over-expression has been shown to significantly reduce ESC 
differentiation (Bourillot et al., 2009). It is possible, therefore, that the over-expression 
of Klf5 is conferring selective advantage to the cells by enhancing self-renewal and 
reducing differentiation.  
 
Finally, in the chromosome 17 distal deletion, only 5 transcripts were found 
consistently under-expressed (<2FC) in three out of the four ES cell lines examined. 
Among them, Lrpprc has been implicated with hexose metabolism, prostaglandin 
synthesis, and glycosphingolipid biology and it has been suggested that it could play an 
adaptive role in cell survival and apoptosis (Gohil et al., 2010; Michaud et al., 2011). 
The role of these genes in ES cell biology remains, however, unclear.  
 
 
Figure 4.18 Identification of the minimal overlapping region of chromosome 14 deletion by STAC 














Table 4.2  Differentially expressed genes in the chr14 partial loss.  
Genes in the minimal overlapping region of the chromosome 14 distal end amplification which 
demonstrate gene expression <0.5 FC in at least four of the seven ES and iPS cell lines examined 
(Hall,2008; Endoh et al., 2008; Kim et al., 2008a; Kim et al., 2009; Loh et al., 2006). 
 
Affy ID Gene Symbol Average GE 
1448499_a_at Ephx2 0.15 
1426255_at Nefl 0.17 
1456239_at Fgf17 0.19 
1451545_at Tdrd3 0.27 
1439411_a_at Xpo7 0.30 
1452436_at Loxl2 0.31 
1418399_at Kctd9 0.34 
1452254_at Mtmr9 0.35 
1418000_a_at Itm2b 0.36 
1425662_at Cdadc1 0.37 
1450385_at Kpna3 0.38 
1417691_at Bin3 0.40 
1426643_at Elp3 0.41 
1430291_at Dock5 0.41 
1456433_at Rcbtb1 0.42 
1424390_at Nupl1 0.42 
1426012_a_at 2610301G19Rik 0.44 







Figure 4.19 Identification of the minimal overlapping region of chromosome 14 amplification by 




Table 4.3 Differentially expressed genes in the chr14 partial gain.  
Genes in the minimal overlapping region of the chromosome 14 distal end amplification which 
demonstrate gene expression >2 FC in at least three of the five ES cell lines examined (Hall,2008; 
Tejedo et al., 2010; Chen et al., 2010; Endoh et al., 2008). 
 
Affy ID Gene Symbol Average GE 
1452402_at Uchl3 15.58 
1435863_at Commd6 5.08 
1419163_s_at Dnajc3a 5.04 
1426886_at Cln5 4.82 
1455056_at Lmo7 4.57 
1449855_s_at Uchl3 /// Uchl4 3.64 
1426609_at Dis3 3.54 
1454635_at Fbxl3 2.62 
1451021_a_at Klf5 2.58 
 
 
Figure 4.20 Identification of the minimal overlapping region of chromosome 17 deletion by STAC 





Table 4.4 Differentially expressed genes in the chr17 partial loss.  
Genes in the minimal overlapping region of the chromosome 17 distal part deletion which 
demonstrate gene expression <0.5 FC in at least three of the four ES cell lines examined (Hall,2008) 
(Chen et al., 2010; Endoh et al., 2008). 
 
Affy ID Gene Symbol Average GE 
1454838_s_at Pkdcc 0.16 
1428229_at Prkcn 0.32 
1428230_at Prkcn 0.36 
1416445_at 2810405J04Rik 0.38 






This chapter has presented a sensitive, transcription-tailored integrated framework for 
the analysis of a large number of publicly available datasets for contiguous changes in 
gene expression levels along the chromosomes. Large chromosomal clusters of 
concordant changes in gene expression levels are diagnostic of underlying 
aneuploidies. The majority of the predicted aberrant genomic clusters map to 
chromosomes 8 and 11. These results are consistent with those from previous 
cytogenetic studies examining culture adaptation in murine ES cell lines (Liu et al., 
1997; Sugawara et al., 2006) and highlight the necessity of rigorous karyotype 
validation of stem cell lines maintained in culture for prolonged time periods. The 
prediction power of the proposed method and the large scale of the data analysis 
revealed a complex pattern of genomic regions which are prone to be concordantly 
aberrant, such as the chromosome pairs 8 and 11, 6 and 11, 8 and 14 and 14 and 17. 
Importantly, many of the events identified here are likely to be of a functional 
significance, since they have been repeatedly selected for in culture. 
 
The integrated analysis has revealed that in a set of 315 pluripotent samples selected 
for high Nanog expression, 56.83% carry large-scale aberrant transcriptional intervals. 
A recent study has linked the occurrence of trisomy 12 in hESCs to the Nanog-Gdf3 
presence in the amplified chromosome (Mayshar et al., 2010) and since over-
expression of Nanog leads to enhanced self-renewal, proposed this as a likely 
mechanism for driving the aneuploidy. Although, such an effect cannot be excluded in 
specific cases, in the present study there are a great number of Nanog-high aberrant 
samples, irrespectively of specific chromosome change carried. It is likely that a 
chromosomal change that promotes cell growth and/ or blocks differentiation and 
apoptosis, would be selected in a self-renewing, Nanog-positive cell in culture in order 
to eventually dominate the entire cell population. As a result, the generated mixture of 
cells will show a bias towards self-renewing pluripotent state and therefore carry 
markers of such cells including Nanog. 
 
In addition, the proposed methodology presents several advantages in comparison to 
the previously published method of Mayshar and colleagues. As opposed to applying a 




sample-specific baselines with sample-specific thresholds which can improve the 
ability to identify aberrant patterns (as demonstrated in Figure 4.3). Moreover, the PGE 
method is specifically designed for the task of inferring positional enrichment in 
transcriptional data. Mayshar and colleagues apply three different methods for this task 
(EASE, Expander and CGH-Explorer). EASE and Expander can only identify enrichment 
in chromosome cytobands or whole chromosomes while CGH-explorer, designed for 
aCGH analysis, can identify continuous changes on the chromosomes. The three 
methods were used in combination to cross-validate their predictions. It is not stated 
however why only the list of up-regulated genes was used for the EASE and Expander 
analysis.  
 
Finally, the identification of key genes whose deregulation is linked with the presence 
of aneuploidy can give important insights into ES cell biology and culture condition 
requirements. This can be achieved by determining the minimal recurring regions 
across many ES cell lines in order to locate the gene or genes that demonstrate 
consistently aberrant transcriptional levels. This approach has been presented in the 


























5. Transcriptional signatures of aneuploidy 
 
The analysis of recurring abnormalities in murine ESCs and iPSCs has revealed a 
transcriptional signature common to all the samples of this study carrying any type of 
predicted aneuploidy, and specific transcriptional signatures linked to the most 
commonly recurring chromosome 8 and 11-specific aneuploidies. This chapter 
describes the methodological steps taken for the identification of the distinct 
transcriptional signatures of aneuploidy and how they can be used in combination with 





As it has been discussed in chapter 4, the prediction of recurrent patterns of aneuploidy 
in a high percentage of mouse ES and iPS cell populations examined in the present 
study (over 50% of the samples) has highlighted a very widespread problem. It is 
evident that rigorous and continuous validation of pluripotent cell lines is necessary in 
order to verify their genomic integrity and avoid the misinterpretation of experimental 
data as a result of the presence of underlying chromosomal aberrations. Especially in 
the case of human pluripotent cell populations the accumulation of aneuploidies may 
jeopardise the clinical safety of potential therapeutic applications.   
 
It is still not clear, however, why specific genomic abnormalities tend to recur in 
pluripotent cell populations. Therefore, it is equally important to discover the genes in 
the affected regions whose deregulation plays a functional role in the selective 
advantage that is believed to be conferred by aneuploidy. This could reveal key 
regulators involved in essential molecular processes of stem cell biology such as self-
renewal, cell cycle control, differentiation and apoptosis.  
 
The majority of studies that have assessed chromosomal abnormalities in human ESCs 
and iPSCs do not converge to a single mechanism. In a study assessing the role of the 




apoptosis (Pera et al., 1997), it was shown that adapted human ES cell lines express this 
receptor that could be used to identify subpopulations of abnormal cells in ES cell 
cultures (Herszfeld et al., 2006). However, in an attempt to verify this result in a 
different set of hES cell lines, Harrison et al. (2009) reported that CD30 expression is 
unable to segregate between karyotypically normal and abnormal cells, karyotypically 
abnormal cells are not protected from apoptosis and suggested that adaptation in 
culture can occur through different routes. For example, Enver et al. (2005) has 
proposed that culture adaptation represents a shift of the cell population towards self-
renewal instead of differentiation. This study also identified the Notch ligand DLK1 as 
the most differentially expressed gene between karyotypically normal and abnormal-
culture adapted cells and indicated a potential role of the Notch pathway, which is 
implicated in hESC proliferation and self-renewal (Enver et al., 2005; Fox et al., 2008).  
 
Chromosomal abnormalities of mouse or human ESCs and iPSCs can also be linked to 
oncogenesis and tumour progression. A recent study has suggested that during 
reprogramming, selection can be linked to deleted regions that contain tumour-
suppressors and maintenance of cell lines in culture can be facilitated by the presence 
of amplifications at oncogene-containing loci (Laurent et al., 2011). Other studies have 
also implicated the over-expression of oncogenes in karyotypically unstable hES cell 
lines (Narva et al., 2010; Draper et al., 2004; Blum and Benvenisty, 2009; Enver et al., 
2005). 
 
Finally, amplified or deleted genes that take part in the core circuit of pluripotency also 
represent prime candidates for the understanding of the selective nature of specific 
aneuploidies. Mayshar et al. (2010) have reported the up-regulation of the cluster of 
hallmark pluripotency genes NANOG and GDF3 in human iPS cell lines bearing the 
frequent 12p amplification. In addition, Laurent et al. (2011) have found CNVs in 
pseudogenes of NANOG and OCT4 although their potential role needs still to be 
investigated. Furthermore, Hall (2008) first identified the up-regulation of Klf5 in a 
mouse ES cell line within the amplified region of chromosome 14, part of the complex 
chromosome 14-17 aberrant pattern described in chapter 4. As discussed in section 
4.7, the Klf5 over-expression was also identified in multiple murine ES cell lines with 
the same chromosome 14 amplification by the present study.  
 




and the putative genes under selection, no comprehensive study in mouse has been 
thus far performed. The next sections present the results of the current analysis for the 
identification of differentially expressed genes between samples predicted to be 
karyotypically normal compared to aberrant samples.   




5.2. Differential Expression Analysis between Normal and 
Aberrant Samples 
 
5.2.1. Using SAM to identify differentially expressed genes 
 
In order to determine whether there is a distinct transcriptional signature that can be 
associated with specific types of aneuploidy, a two-class Significance Analysis of 
Microarrays (SAM) was performed (Tusher et al., 2001). SAM was chosen as it is one of 
the most popular methods for the identification of differentially expressed genes as 
indicated by the number of publications that employ the test (1884 citations of the 
original publication to present). In summary, SAM measures the relative difference in 
expression levels by analysing the gene expression change between conditions and the 
variation of the measurements within condition. It then defines the “expected relative 
difference” by performing a set of random data permutations. The user defines a cut-off 
for genes that significantly deviate from the expected relative difference and the FDR 
for the specified cut-off is calculated. In reality, the SAM test is a modified t-test and the 
SAM statistic is defined as following: 
     
             
       
 
where      is the relative difference of the expression levels of gene   between the 
conditions   and ,     and     are the average expression levels for gene   in conditions   
and  ,      is the “gene-specific scatter” and    is a small positive constant that 
minimises the coefficient of variation. More specifically, the “gene-specific scatter”      
is defined as: 
               
 
       
          
 
       










         
 
where    and    the number of measurements in conditions   and   respectively.  
 




between (i) normal versus abnormal samples (any type of chromosomal abnormality), 
(ii) samples with chromosome 8-specific patterns versus all other samples and (iii) 
samples with chromosome 11-specific patterns versus all other samples (See Table S3, 
Table S4 and Table S5 for complete lists of differentially expressed genes with FC≥1.5 
and q-val≤0.05 in the attached CD). Chromosome 8 and chromosome 11 were 
specifically chosen for this analysis because they are the chromosomes most frequently 
affected by aneuploidy and, in fact, 70% of the predicted aberrant samples carry whole 
or partial-chromosome aberrations on at least one of these two chromosomes. The 
results for each type of comparison are presented in the following sections (5.2.2-
5.2.4).  
 
It should be noted that this analysis has been performed for the Nanog-high group of 
samples described in section 4.6.2. Samples with low-levels of Nanog expression are 
likely to represent cell populations highly heterogeneous in differentiating or partially 
reprogrammed cells and therefore not helpful to the study of the stability of self-
renewing pluripotent cells. As it has been already discussed, the percentage of aberrant 
samples in the Nanog-low group is distinctly lower. As a result, an attempt to identify 
differentially expressed genes between karyotypically normal and aberrant samples 
when including the Nanog-low subgroup would only result to the identification of 
pluripotency-associated genes and would obscure the discovery of aneuploidy-
associated genes. In order to avoid this problem, the analysis has focused on the 
relatively homogeneous pluripotent samples of the Nanog-high subgroup.  
 
5.2.2. Global Dataset 
 
In the global dataset, samples were divided in two classes: normal samples where no 
large-scale cluster of differentially expressed genes has been identified and predicted 
aberrant samples carrying any type of aberration in any chromosome. In total, 128 
genes were found over-expressed and 543 genes were found under-expressed in the 
aberrant samples group (the complete list is available as part of the supplementary 
files provided with the attached cd, Table S5). 
 
Figure 5.1 presents a heatmap representation of the top 50 up- and down-regulated 




separate panel of the heatmap displays the expression of the three core pluripotency 
genes Nanog, Pou5f1 (Oct4) and Sox2 and demonstrates that there is no correlation 




Figure 5.1 Heatmap of Normal versus Aberrant samples.  
Heatmap representation of the top 50 differentially expressed genes between normal and aberrant 
samples carrying any type of chromosomal aberration (generated from SAM analysis). The panel of 
the three core pluripotency genes (Nanog, Pou5f1 (Oct4) and Sox2) at the bottom of each heatmap 
demonstrates the independency of the aberrant chromosomal patterns from the core pluripotency 
program in the stem cell populations. 
 
In addition, Table 5.1 presents the top 50 differentially expressed genes between the 
normal and aberrant group (ranked by FC) assigned to functional categories that could 
be linked to the selective advantage conferred by aneuploidy to the aberrant cells. 
Importantly, the presence of a deregulated gene expression signature identified across 
all predicted aneuploid samples suggests that there is a common secondary effect in 
these cells. It is possible that these cells operate under a positive selection mechanism 
the downstream consequences of which can be identified at the transcriptional level 
despite their different types of aneuploidy. Attention is drawn to the top up-regulated 
list (Table 5.1), typified by genes linked to pluripotency, genomic integrity and cell 
cycle. An example of this type of gene is Pramel7 that has been recently reported to 
promote self-renewal in the absence of exogenous LIF in mouse ESCs (Casanova et al., 
2011). Some other interesting examples of differentially over-expressed genes are 
Crxos1, a homeoprotein that has been shown to play a dual role in self-renewal and 
differentiation (Saito et al., 2010), the non-homologous end-joining repair gene Lig4 
(Frank et al., 2000), the genome maintenance regulator Zscan4 (Zalzman et al., 2010) as 
well as the cell-growth modulator Lin28 (Xu et al., 2009). The function of these genes is 
consistent with the properties of genes expected to drive aneuploidy. 
 
Finally, the protein kinase, Pkdcc (Imuta et al., 2009), that has been found consistently 
down-regulated in the chromosome 17 deletion described in section 4.7, has been also 




kinase) is a novel protein kinase found to be induced upon differentiation of mouse 
embryonic stem cells to mesendoderm (Kinoshita et al., 2009). Pkdcc could be an 
example of a gene whose deletion prevents differentiation and, thus, indirectly 
enhances self-renewal in ESC cultures.  
 







Cell Cycle / Growth  Lin28,Ccnb1ip1,Dnajc2, 
Anapc10,Syce1 
Grb10 
Survival Pou4f2, Mras - 
Protein metabolic 
process 
St8sia1, Anapc10, Dub1, 
Eif1a, Hck, Map2k6, 
Rpl39l, Eif2s2 
Rps9 
Genomic integrity Lig4, Zscan4 - 
Cell death Plagl1, Map2k6, Xaf1 Serpinh1 (Hsp47), Cdh11, 
Cyr61 (Ccn1) 
Stem cells Lin28, Mras, Pramel7, 
Crxos1, Zfp42 (Rex1) 
- 
Cancer Ceacam1, St8sia1 Malat1, Fus 
ECM - Bgn, Col1a1 , Col1a2, Col3a1, 
Col5a2, Lox, Tnc, App 
Other/ Unknown 
function 




Hck , H19,Gsta3, Glod5, 
Snrpn /// Snurf, 
2200001I15Rik,Snhg3, 
2410004A20Rik, Glrx, 
Cox7a1,  Sec23ip, Zfp560, 
Sdc4,  666185, Gprc5b 
Acta2, Thbs1,  Mid1, Tagln, 
Fstl1, Atrx, Prss23, Ptprf, Cd44,  
Cdk7, Hs6st2, Prtg, Pkdcc, 
LOC72520, F630007L15Rik, 
Axl, Lpp, Meg3, Prtg, Sox11, 
Ptgs2, A130040M12Rik  
The top 50 up- and down-regulated genes (ranked by FC) in the Global feature set (which 
in total includes 128 over-expressed and 543 under-expressed genes). In bold: candidates 





Table 5.2 GO enrichment analysis for the list of down-regulated genes in the global signature of 
aneuploidy (Benjamini corrected p-val<0.05) 
Category  Term  P-Value  Benjamini 
GOTERM_BP_5  blood vessel development  6.90E-11 6.90E-08 
GOTERM_BP_5  vasculature development  1.20E-10 5.80E-08 
GOTERM_BP_5  tissue development  2.40E-08 7.90E-06 
GOTERM_BP_5  organ morphogenesis  1.30E-07 3.20E-05 
GOTERM_BP_5  blood vessel morphogenesis  2.20E-07 4.40E-05 
GOTERM_BP_5  regulation of cell-substrate adhesion  1.60E-06 2.70E-04 
GOTERM_BP_5  muscle organ development  5.20E-06 7.30E-04 
GOTERM_BP_5  enzyme linked receptor protein 
signalling pathway  
5.90E-06 7.30E-04 
GOTERM_BP_5  head morphogenesis  7.20E-06 7.90E-04 
GOTERM_BP_5  chordate embryonic development  3.30E-05 3.30E-03 
GOTERM_BP_5  chromatin modification  4.40E-05 4.00E-03 
GOTERM_BP_5  in utero embryonic development  5.70E-05 4.70E-03 
GOTERM_BP_5  face morphogenesis  8.70E-05 6.60E-03 
GOTERM_BP_5  positive regulation of cell migration  1.20E-04 8.30E-03 
GOTERM_BP_5  actin filament organization  1.70E-04 1.10E-02 
GOTERM_BP_5  tissue morphogenesis  1.70E-04 1.10E-02 
GOTERM_BP_5  positive regulation of cell motion  2.10E-04 1.20E-02 
GOTERM_BP_5  positive regulation of cell-substrate 
adhesion  
2.30E-04 1.30E-02 
GOTERM_BP_5  gland development  3.00E-04 1.60E-02 
GOTERM_BP_5  skeletal system morphogenesis  4.50E-04 2.20E-02 
GOTERM_BP_5  angiogenesis  5.40E-04 2.50E-02 
GOTERM_BP_5  embryonic organ development  6.50E-04 2.90E-02 
GOTERM_BP_5  muscle tissue development  6.50E-04 2.80E-02 
GOTERM_BP_5  regulation of cell migration  7.50E-04 3.10E-02 
GOTERM_BP_5  heart development  9.70E-04 3.80E-02 








Table 5.3 KEGG pathway enrichment analysis for the list of down-regulated genes in the global 
signature of aneuploidy (Benjamini corrected p-val<0.05) 
Category  Term  P-Value  Benjamini 
KEGG_PATHWAY  Focal adhesion  1.10E-11 1.40E-09 
KEGG_PATHWAY  ECM-receptor interaction  1.30E-09 8.00E-08 
KEGG_PATHWAY  TGF-beta signalling pathway  3.00E-04 1.20E-02 
KEGG_PATHWAY  Pathways in cancer  1.10E-03 3.20E-02 
KEGG_PATHWAY  Prostate cancer  1.80E-03 4.20E-02 
 
 
GO biological process and KEGG pathway analyses were performed using DAVID 
(Huang et al., 2009b; Huang et al., 2009a) in order to investigate the functional 
enrichment of the identified up- and down-regulated gene lists (Table 5.2 and Table 
5.3). The shift towards self-renewal at the expense of differentiation in the aberrant 
group of samples is also supported by the significantly enriched GO_BP categories that 
are related to organ morphogenesis and embryonic development and appear down-
regulated in aberrant samples, as shown in Table 5.2. It is reasonable to hypothesise 
that GO_BP categories related to development and organ morphogenesis would appear 
enriched in cell populations with a high degree of differentiating cells where genes 
involved in the formation of the three germ layers would be up-regulated. A similar 
signature would not be present in cell populations highly homogeneous in rapidly self-
renewing pluripotent cells as the ones we expect to see in cultures where the presence 
of aneuploidy has prevailed through selection. In addition, the down-regulated gene list 
shows significant enrichment in pathways that are highly connected with changes in 
the extracellular matrix (ECM), a common mechanism for tissue remodelling in 
development. No significant enrichment was observed for the list of up-regulated 
genes.  
 
5.2.3. Chromosome 8 
 
In the chromosome 8 dataset, samples were divided in two classes: samples that carry 
no chromosome 8-specific aberration (even though these samples may carry an 
aberration on another chromosome) and samples that bear a large-scale cluster of 
differentially expressed genes spanning any genomic region of chromosome 8. In total, 




the chromosome 8 aberrant samples group (the complete list is available as part of the 
supplementary files provided with the attached cd, Table S3). 
 
Figure 5.2 presents a heatmap representation of the top 50 up- and down-regulated 
genes between normal (in terms of chromosome 8 – specific aberrations) and samples 
carrying a chromosome 8-specific pattern according to SAM analysis. Again, the lower 
separate panel of the heatmap displays the expression of the three core pluripotency 
genes Nanog, Pou5f1 (Oct4) and Sox2.  
 
 
Figure 5.2 Heatmap of Normal-Chr8 versus Aberrant-Chr8 ESCs.  
Heatmap representation of the top 50 differentially expressed genes between normal (in terms of 
chromosome 8 aberrations) and aberrant samples carrying a chromosome 8-specific aberration 
(generated from SAM analysis). The panel of the three core pluripotency genes (Nanog, Pou5f1 
(Oct4) and Sox2) at the bottom of each heatmap demonstrates the independency of the aberrant 
chromosomal patterns from the core pluripotency program in the stem cell populations. 
 
 
In the case of chromosome 8, among the most highly up-regulated genes is Bag4 (BCL2-
associated athanogene 4), also known as the silencer of death domain (SODD), which 
confers resistance to TNF-induced apoptosis (Miki and Eddy, 2002). Nob1, Mak16 
(Rbm13) and Nip7 are all involved in ribosome biogenesis in yeast (Lamanna and 
Karbstein, 2009; Pellett and Tracy, 2006) and in human (Morello et al., 2010). Fnta is a 
farnesyltransferase connected to the Raf1 oncogene, critical for cell-cycle progression 
in human (Long et al., 2002). Upf3a takes part in the nonsense-mediated decay (NMD) 
and exon-junction (EJC) pathways and it is highly conserved in eukaryotes (Kim et al., 
2005). In the down-regulated list, Clic4 is a downstream target of p53 that induces 
apoptosis upon DNA damage and down-regulates Bcl-2 (Fernández-Salas et al., 2002; 
Suh et al., 2004). Rab10 (member RAS oncogene family) is responsible for insulin-
stimulated GLUT4 translocation (Sano et al., 2008). The list of the top 10 up- and down-
regulated genes in samples with chromosome 8-specific aberrations is presented in 
Table 5.4. The GO biological process and KEGG pathway enrichment performed in 
DAVID for the full lists of the over- and under-expressed genes is also presented in 





Table 5.4 Top 10 up- and down-regulated genes in samples with a chromosome 8-specific 
aberration (ranked by SAM score) 




1454957_at Nob1 1.55 chr8:109936386-109948938 (-) // qD3 
1426426_at Mak16 1.65 chr8:32269908-32279217 (-) // qA3 
1449186_at Bag4 1.75 chr8:26877238-26895678 (-) // qA2 
1452971_at Upf3a 1.78 chr8:13785636-13798744 (+) // qA1.1 
1423873_at Lsm1 1.87 chr8:26895784-26913009 (+) // qA2 
1454659_at Dctd 1.86 chr8:49226001-49227020 (+) // qB1.2 
1417465_at Fnta 1.54 chr8:27109193-27126080 (-) // qA2 
1449724_s_at D8Ertd738e 1.61 chr8:86770135-86770593 (-) // qC3 
1448801_a_at Timm44 1.52 chr8:4259730-4274233 (-) // qA1.1 
1448480_at Nip7 1.71 chr8:109580776-109583149 (+)// qD3 
Down-regulated 
1416648_at Dync1h1 0.55 chr12:111839661-111905134(+)//qF1 
1450784_at Reck 0.50 chr4:43888401-43957677 (+) // qB1 
1435930_at Scaper 0.64 chr9:55397686-55434123 (-) // qB 
1451148_at Pink1 0.61 chr4:137869323-137882183 (-) // qD3 
1415687_a_at Psap 0.59 chr10:59740404-59765345 (+) // qB4 
1423392_at Clic4 0.56 chr4:134769821-134828686 (-) // qD3 
1459275_at Rnf17 0.52 chr14:57128119-57143869 (+) // qC3 
1434206_s_at Ppp2r5c 0.57 chr12:111818922-111821286(+)//qF1 
1416183_a_at Ldhb 0.52 chr19:22011804-22013056 (+) // qB 
1429296_at Rab10 0.53 chr12:3247427-3249567 (-) //qA1.1 
 
It is particularly interesting that in the list of the top up-regulated genes there are three 
genes localised on the 8qA3 region, namely Bag4, Lsm1 and Fnta. The genes BAG4 and 
LSM1 have been both described as breast cancer oncogenes in the syntenic 8p11-p12 
recurrent amplicon in human.  BAG4 and LSM1, in combination with C8ORF4, influence 
growth factor independence and anchorage-independent growth of MCF10A breast 
cancer cells (Yang et al., 2006). In addition, FNTA has been also significantly associated 




(Chin et al., 2006). The 8qA2 region could, therefore, be a potential selective locus on 
chromosome 8.  
 
Table 5.5 GO and KEGG pathway enrichment analysis for the list of up-regulated genes in the 
chromosome 8 signature of aneuploidy (Benjamini corrected p-val<0.05) 
Category  Term  P-Value  Benjamini 
GOTERM_BP_5  ncRNA metabolic process  2.50E-06 1.50E-03 
GOTERM_BP_5  ncRNA processing  1.50E-05 4.40E-03 
GOTERM_BP_5  RNA metabolic process  1.10E-04 2.20E-02 
GOTERM_BP_5  RNA processing  1.90E-04 2.80E-02 
KEGG_PATHWAY  RNA degradation  5.30E-06 3.20E-04 
 
Table 5.6 KEGG pathway enrichment analysis for the list of down-regulated genes in the 
chromosome 8 signature of aneuploidy (Benjamini corrected p-val<0.05) 
Category  Term  P-Value  Benjamini 
KEGG_PATHWAY  ECM-receptor interaction  7.40E-07 8.30E-05 
KEGG_PATHWAY  Focal adhesion  1.70E-04 9.70E-03 
 
 
5.2.4. Chromosome 11 
 
In a similar way, in the chromosome 11 dataset samples were divided again in two 
classes: samples that carry no chromosome 11-specific aberration (even though these 
samples may carry an aberration on another chromosome) and samples that bear a 
large-scale cluster of differentially expressed genes spanning any genomic region of 
chromosome 11. 500 genes were found over-expressed and 189 genes were found 
under-expressed in chromosome 11 aberrant samples (the complete list is available as 
part of the supplementary files provided with the attached cd, Table S4). 
 
Figure 5.3 presents a heatmap representation of the top 50 up- and down-regulated 
genes between normal (no chromosome 11 – specific aberrations but samples with 
abnormalities in other chromosomes included) and samples carrying a chromosome 
11-specific pattern according to SAM analysis. Again, the lower separate panel of the 
heatmap displays the expression of the three core pluripotency genes Nanog, Pou5f1 






Figure 5.3 Heatmap of Normal-Chr11 versus Aberrant-Chr11 ESCs.  
Heatmap representation of the top 50 differentially expressed genes between normal (in terms of 
chromosome 11 aberrations) and aberrant samples carrying a chromosome 11-specific aberration 
(generated from SAM analysis). The panel of the three core pluripotency genes (Nanog, Pou5f1 
(Oct4) and Sox2) at the bottom of each heatmap demonstrates the independency of the aberrant 
chromosomal patterns from the core pluripotency program in the stem cell populations. 
 
For chromosome 11, the list of top 10 up- and down-regulated genes is presented in 
Table 5.7. Among them, Pthr2 (else known as Bcl-2 inhibitor of transcription, Bit) is one 
of the up-regulated candidates in the feature set. Pthr2 is an anoiksis effector that 
negatively regulates Erk activity (Kairouz-Wahbe et al., 2008) and is up-regulated upon 
endoplasmic reticulum (ER) stress (Yi et al., 2010). Prpsap2 (phosphoribosyl 
pyrophosphate synthetase-associated protein 2) is responsible for de novo synthesis of 
purine and pyrimidine nucleotides, histidine and tryptophan, and NAD (Katashima et 
al., 1998). Utp6 (UTP6, small subunit (SSU) processome component, homolog) which is 
again integrated in the mitochondrial caspase activation pathway, through interaction 
with pro-apoptotic Apaf-1 (Piddubnyak et al., 2007). It is also worth noting that both 
the hedgehog (Hh) pathway receptor Ptch1 and activator Gli1 are in the list of the up-
regulated genes (see full list in attached CD – Table S4). This pathway is required in 
normal development but its abnormal activation has been also associated with 
tumorigenesis (Goodrich and Scott, 1998). 
 
 In the down-regulated list, Zimp10 has been found to regulate the TGF-beta/Smad 
signalling pathway and depletion of the gene results in impaired Smad3/4-mediated 
transcription after TGF-beta induction (Li et al., 2006). Vegfa is part of the JAK/STAT 
signalling pathway and plays a key role in angiogenesis (Suganami et al., 2004). Ltbp3 is 
also involved in the TGF-beta signalling pathway (Chen et al., 2002) and Kdel3 is an ER 
sorting receptor (Aicha et al., 2007).  
 
The enriched GO biological process categories and the KEGG pathway enrichment 
found for the list of down-regulated genes in the chromosome 11 aberrant samples is 




the list of up-regulated genes.  
 
Table 5.7 Top 10 up- and down-regulated genes in samples with a chromosome 11-specific 
aberration (ranked by SAM score) 




1427492_at Pof1b 3.28 chrX:109752035-109758938 (-) // qE1 
1451845_a_at Ptrh2 1.65 chr11:86497484-86503689 (+) // qC 
1418752_at Aldh3a1 2.28 chr11:61022246-61031916 (+) // qB2 
1427277_at Six1 2.50 chr12:74142813-74147684 (-) // qC3 
1424501_at Utp6 1.59 chr11:79747632-79775901 (-) // qB5 
1452062_at Prpsap2 1.54 chr11:61543135-61575564 (-) // qB2 
1423285_at Coch 2.49 chr12:52694360-52706762 (+) // qC1 
1435995_at Mrpl22 1.64 chr11:57985191-57993068(+) //qB1.3 
1424731_at Nle1 1.66 chr11:82714250-82721729 (-) // qC 
1457882_at Etaa1 1.60 chr11:17838756-17839369(-) // qA3.1 
Down-regulated 
1426936_at F630007L15Rik 0.22 --- 
1436841_at B230380D07Rik 0.57 chr9:70450772-70478922 (-) // qD 
1426451_at Spg11 0.59 chr18:43632469-43635374 (+) // qB3  
1448715_x_at Ccrn4l, Cog6, 
Sgip1 
0.61 chr3:51028369-51055576 (-) // qC 
chr3:52786045-52821145 (-) // qC 
chr4: 102432968-102643782 // qC6 
1437479_x_at Tbx3 0.40 chr5:120134109-120134729 (+) //qF 
1420909_at Vegfa 0.53 chr17:46153941-46169322 (-) // qC 
1455316_x_at BC094435 0.64 chr1: 145208786-145214839 (-) // 
1438312_s_at Ltbp3 0.59 chr19:5758232-5758823 (+) // qA 
1418538_at Kdelr3 0.49 chr15:79346878-79372701 (+) // qE1 









Table 5.8 GO biological process and KEGG pathway enrichment analysis for the list of down-
regulated genes in the chromosome 11 signature of aneuploidy (Benjamini corrected p-val<0.05) 
Category  Term  P-Value  Benjamini 
GOTERM_BP_5  blood vessel development  6.60E-05 3.90E-02 
GOTERM_BP_5  vasculature development  8.10E-05 2.40E-02 










The identification of distinct transcriptional signatures associated with the presence of 
aneuploidy in any chromosome or chromosome-specific aneuploidies (such as the case 
of chromosome 8 and 11), as discussed in the previous sections, hinted towards the 
ability to train classification models that can predict these signatures. Two well-
established classification techniques have been applied in order to investigate the 
possibility of identifying the aneuploidy signatures in uncharacterised samples: 
Prediction Analysis of Microarray (PAM) (Tibshirani et al., 2002) and Support Vector 
Machines (SVMs) (Vapnik, 1979).  
 
In the present study, three different binary classification tasks have been investigated 
for the sub-group of 315 Nanog-high pluripotent samples. Firstly, in the Global set, all 
aberrant samples, regardless of the chromosomal mapping of the identified change, are 
classified against all normal samples. The Chromosome 8 and 11 sets test the predictive 
ability of the classifiers to detect samples bearing a chromosome 8 or 11 specific 
aberration. The prediction power of the classifiers was validated by using the accuracy 
and F1-score (as discussed in section 2.4.4). 
 
This is the first study that attempts to build classification models which will allow 
detection of samples of any type of aneuploidy as well as chromosome 8 and 11-specific 
aneuploidies (which account for 70% of the identified aneuploidies in ES and iPS cell 





5.3.2. Prediction Analysis of Microarray (PAM) 
 
5.3.2.1. Introduction 
Prediction Analysis of Microarray (PAM) is a classification method developed 
specifically for the task of classification of microarray samples (Tibshirani et al., 2002). 
PAM is based on the shrunken nearest centroid methodology. Briefly, the method 
calculates a standardised centroid for each class and compares the gene expression 
profile of each new sample to each class centroids. The centroid of each class is defined 
as the average gene expression for each gene in the class divided by the within-class 
standard deviation for that gene. The new sample is then assigned to the class with the 
closest centroid in terms of squared distance.  The term “shrunken” refers to the 
modification that can be applied to the calculated centroids by moving the centroids 
towards zero by adding or subtracting a fixed threshold. The threshold value is defined 
by the user guided by the results of K-fold cross validation performed by PAM for a 
range of threshold values.  The threshold that produces the lowest misclassification 
rates from cross-validation is commonly selected. The shrinkage threshold can be also 
used as an indirect means of feature selection since the genes whose centroid is zero do 
not contribute to the classification model.  
 
5.3.2.2. Methodology 
The detailed methodology of the PAM method can be found in the original publication 
of Tibshirani et al. (2002) as well as the available User guide and Manual (Hastie et al., 
2001). In the present study, PAM analysis has been performed for the Global set. Two 
classes have been used: the Normal and Aberrant. A sample is assigned to the class 
Normal if no large-scale aberration has been identified by the PGE-dendrogram based 
analysis described in section 4.4 (and after visual inspection using DI.S.C.O.). The class 
Aberrant consists of samples that have a predicted large-scale aberration in any 
chromosome. As stated previously, small clusters have been excluded at this stage of 
the analysis, since they are equally likely to reflect transcriptional regulation or 
underlying aneuploidies. Even though small clusters of co-regulated genes can be very 
informative or even reflecting small scale CN variations, this distinction cannot be 
made at the transcriptional level and, therefore, these samples have not been 





This section briefly describes the formulation of the method: let      be the expression 
of a gene   in a sample   where           and          . In addition, let    be the 
indices of the     samples that belong to class  , with           (in our case    ). 
The contribution to the centroid of the class   from the     gene can be defined as: 
       
   
  
    
 
in other words the average of all the values that the     gene takes within the class  . 
Similarly, the     gene’s contribution to the global centroid is: 
     
   
 
 
   
 
A t-test-like statistic is used to compare the expression of the     gene in the     class 
with the rest of the classes after normalisation by the within-class standard deviation of 
the gene: 
    
         
         
 








  is used to scale the standard error of the denominator and    is 




   
             
 
     
 
 
In order to shrink the class centroids towards the global centroid, PAM employs soft-
thresholding. A threshold   is chosen by K-fold cross validation and subtracted from 
each     bringing each new    
  nearer to zero or equal to zero if negative: 
   
   
                                 
                
  
 
The new centroid of the     gene in the     class is then calculated as: 
     
             
  
 
Depending on the chosen threshold  , genes that have been shrunken to zero will not 
contribute in the prediction rule. These genes are more likely to have a highly variable 






Under a specific threshold  , the test samples are classified depending on the nearest 
class shrunken centroid. Let       
    
       
   be the expression vector of the new test 
sample. Then, discriminant score of the test sample for the     class can be defined as: 
    
    
   
       
   
       
 
 
   
        
 
where the first term of the above equation is the distance from the class centroid while 
the second term is a correction term based on the prior probability   , where    gives 
the overall proportion of the     class in the sample population. Class assignment is 
finally performed based on the minimum     
   and the test sample    is assigned to 
the       class as from: 
 
                
    
 
5.3.2.3. PAM – No feature selection 
PAM analysis has been performed for the Global set with the “pamr” package in the R 
statistical environment (Tibshirani et al., 2011). Firstly, all genes (features) were 
included in the analysis. The classifier was trained with a set of 224 samples and 91 
independent samples (the remaining dataset) were used for testing. In order to 
estimate an appropriate threshold for shrinkage a 10-fold cross validation was 
performed for the training dataset. A threshold value of 6 was selected in order to keep 
both the number of genes used in the prediction rule and the misclassification error to 
a minimum (Figure 5.4). Thus, even if the highest accuracy was achieved with a 
threshold value of 4.3 and more than 250 genes included in the prediction rule, high 
accuracy levels (82%) could be achieved with a threshold value of 6 and only 26 genes 





Figure 5.4 10-fold cross-validation curves for different threshold values and number of features 
(genes) used in the prediction rule.  
 
Figure 5.5 presents the centroids of the significant genes for the Aberrant and Normal 
classes. The list of the 26 significant genes at the threshold of 6 is also presented in 



















Table 5.9 List of the significant genes used in the prediction rule. 




1429483_at Calcoco2 0.0915 -0.0966 
1455831_at Fus -0.0300 0.0317 
1448259_at Fstl1 -0.1218 0.1285 
1429376_s_at Anapc10 0.0617 -0.0651 
1426208_x_at Plagl1 0.0054 -0.0056 
1453599_at Trim71 -0.0609 0.0643 
1440261_at Ap4e1 0.0227 -0.0240 
1450843_a_at Serpinh1 -0.0063 0.0066 
1429051_s_at Sox11 -0.0409 0.0432 
1425458_a_at Grb10 -0.0427 0.0450 
1420841_at Ptprf -0.0140 0.0148 
1418820_s_at Zcchc10 0.0036 -0.0038 
1426269_at Vamp7 0.0221 -0.0233 
1431353_at Pabpc4l 0.0421 -0.0444 
1439487_at Lig4 0.0266 -0.0281 
1452880_at Znhit3 0.0167 -0.0177 
1427488_a_at Birc6 -0.0111 0.0117 
1418585_at Ccnh 0.0285 -0.0300 
1452378_at Malat1 -0.0193 0.0203 
1459804_at Crebbp -0.0034 0.0036 
1441959_s_at 1200003C05Rik -0.0062 0.0066 
1443924_at Wnk3 0.0413 -0.0436 
1420935_a_at Srrm1 -0.0299 0.0315 
1429375_at Anapc10 0.0488 -0.0515 
1451238_at 1200003C05Rik -0.0016 0.0017 











5.3.2.4. PAM – Feature selection with SAM 
Gene selection was performed by SAM analysis on the training dataset (with FC>1.5 
and q-val<0.05).  The lowest misclassification error was achieved with a threshold of 
~3.7 and 63 genes included in the prediction rule (Figure 5.6). From the 26 genes 
identified by PAM without feature selection (section 5.3.2.3) 23 were also included in 
the 63 genes identified after feature selection by SAM. This high overlap can be also 
explained by the fact that the PAM method indirectly performs feature selection 
through the shrinkage threshold in a very similar way as the SAM method and both 
methods are based on the same principles. The feature selection, possibly in 
combination with a higher number of genes included in the prediction rule, has 
improved the accuracy of the method from 82% (no feature selection) to 87% (with 
feature selection by SAM) (see section 5.3.4 for a breakdown of the prediction accuracy 
of all models).  
 
 
Figure 5.6 10-fold cross-validation curves for different threshold values and number of features 















Table 5.10 List of the significant genes used in the prediction rule  
(after gene selection by SAM). 




1429483_at Calcoco2 0.12 -0.13 
1448259_at Fstl1 -0.12 0.12 
1425458_a_at Grb10 -0.08 0.09 
1426208_x_at Plagl1 0.07 -0.08 
1452378_at Malat1 -0.06 0.07 
1455831_at Fus -0.06 0.07 
1453599_at Trim71 -0.06 0.06 
1431353_at Pabpc4l 0.05 -0.06 
1429376_s_at Anapc10 0.05 -0.06 
1456270_s_at Pramel6 0.05 -0.06 
1429051_s_at Sox11 -0.05 0.05 
1429375_at Anapc10 0.05 -0.05 
1420841_at Ptprf -0.05 0.05 
1450843_a_at Serpinh1 -0.05 0.05 
1441959_s_at 1200003C05Rik -0.04 0.04 
1426269_at Vamp7 0.04 -0.04 
1420935_a_at Srrm1 -0.03 0.04 
1439487_at Lig4 0.03 -0.03 
1427488_a_at Birc6 -0.03 0.03 
1459804_at Crebbp -0.03 0.03 
1451238_at 1200003C05Rik -0.02 0.03 
1452880_at Znhit3 0.01 -0.01 
1418820_s_at Zcchc10 0.01 -0.01 
1418189_s_at Malat1 -0.07 0.07 
1420357_s_at Xlr3 0.07 -0.07 
1444529_at Eif1a 0.06 -0.07 
1457033_at Zscan4 0.06 -0.06 
1420773_at Dub1 0.05 -0.06 
1443961_at 100043292 0.04 -0.04 
1439810_s_at Pramel7 0.04 -0.04 
1449347_a_at Xlr4 0.04 -0.04 
1427479_at Eif1a 0.04 -0.04 




1460454_at Glod5 0.03 -0.03 
1416221_at Fstl1 -0.03 0.03 
1444038_at AU015836 0.03 -0.03 
1421749_at Lin28 0.02 -0.03 
1416454_s_at Acta2 -0.02 0.02 
1436343_at Chd4 -0.02 0.02 
1448194_a_at H19 0.02 -0.02 
1456733_x_at Serpinh1 -0.02 0.02 
1425457_a_at Grb10 -0.02 0.02 
1429372_at Sox11 -0.02 0.02 
1438239_at Mid1 -0.02 0.02 
1418379_s_at Gpr124 -0.02 0.02 
1437745_at Chd7 -0.02 0.02 
1431213_a_at LOC433762 -0.01 0.02 
1452160_at Tiparp -0.01 0.01 
1426755_at Ckap4 -0.01 0.01 
1438026_at Zfp560 0.01 -0.01 
1457746_at --- -0.01 0.01 
1428127_at ENSMUSG00000074747 -0.01 0.01 
1420843_at Ptprf -0.01 0.01 
1433789_at Snhg3 0.01 -0.01 
1438271_at Lpp -0.01 0.01 
1450857_a_at Col1a2 -0.01 0.01 
1438345_at --- -0.01 0.01 
1416593_at Glrx 0.01 -0.01 
1439631_at Zcchc11 -0.01 0.01 
1440764_at Araf -0.01 0.01 
1423285_at Coch 0.01 -0.01 
1423436_at Gsta3 0.00 0.00 
1430568_at Zc3h13 0.00 0.00 
 
The complete analysis results are presented for all methods in section 5.3.4 where the 





5.3.3. Support Vector Machines (SVMs) 
 
5.3.3.1. Introduction 
The Support Vector Machines (SVMs) is a powerful supervised machine learning 
technique that has been applied successfully in many biological areas (Statnikov et al., 
2004; Brown et al., 2000; Xu et al., 2010; Zhu et al., 2009; Guyon et al., 2002; Golub et 
al., 1999; Furey et al., 2000; Yeoh et al., 2002). SVMs have been shown to outperform 
other classification methods for gene expression microarray classification (Brown et al., 
2000; Li et al., 2004;  Statnikov et al., 2004; Lee et al., 2005; Statnikov and Aliferis, 
2007; Xu et al., 2010). Briefly, SVMs map the input data onto a high-dimensional space, 
where classification can be achieved by defining a hyperplane that separates the data 
points of the two or more classes. The theoretical concepts of the methodology have 
been firstly proposed by Vapnik (1979). The current standard implementation of soft-
margin SVM has been developed by Cortes and Vapnik (1995). Introductory texts and 
tutorials have been made also made available by (Stitson et al., 1996; Weston et al., 
1996; Burges, 1998; Gunn, 1998) among others, while a comprehensive book focused 
on SVM classification is the one of Cristianini and Shawe-Taylor (2000). A brief 




The concept of the decision boundary of a classification problem has been first 
introduced in section 2.4.2. SVMs try to identify the decision boundary that achieves 
the maximum margin between the classes (Figure 5.8). The margin represents the 
maximum distance between two hyperplanes parallel to the two sides of the decision 
boundary that do not contain any samples between them. In the case of non-separable 
data, the standard soft-margin implementation of (Cortes and Vapnik, 1995) allows the 
existence of mislabelled samples while still maximising the distance between the 
hyperplanes that are defined by rightly labelled samples. The maximum margin 
identification is based on the principles of the structural risk minimization (SRM) 
theory (that is the test error minimisation or minimisation of over-fitting) from 
(Vapnik, 1979) which shows that the generalisation ability of the classifier is improved 






Figure 5.8 An SVM classifier attempts to find the decision boundary that maximises the margin 
between the two classes (blue and orange points). The samples on the dashed lines are called 
support vectors (SVs). 
 
 
Following the notation used in section 2.4.2 and 5.3.2.2, let    be the vector of 
expression of a training sample   where          . In addition, let    be the indices 
of the     samples that belong to class  , with           (in our case    ). SVMs 
identify the separating hyperplane with the maximum possible margin: 
        
 
where  is the  -dimensional vector perpendicular to the hyperplane and   is the bias. 
The two margin boundary hyperplanes are formed by the samples of each class that are 
closest to the maximum-margin hyperplane (Figure 5.8). These samples are called the 
support vectors and the margin boundary hyperplanes are defined: 
       
            
            
  
 
From the above equation, it can be derived that the margin is: 
       
 
    
 
 




equivalent of minimising the norm of w. This allows us to formulate the SVM learning 
problem by introducing the Lagrange formalism to obtain the objective function    as 
following: 
  
   
 
 
          
           
 
   
 
where the non-negativity constrains are multiplied with the Lagrange multipliers  
     for each          . The minimisation problem is now equivalent to the 
identification of the  ,   and    that minimise   . This can be calculated by 






    
  
            
 
   
   
  
          
 
   
  
 
with resulting classifier: 
              
 
   
  
      
 
The solution to the problem can be given follow quandratic programming as the dual 
problem in the Lagrange multipliers   . After the identification of   and   the 
classification of a new sample    can be simply performed by identifying the sign of the 
      . 
 
In the case of linearly non-separable classification, Cortes and Vapnik (1995) 
introduced the non-negative slack variables    with           and a penalty function 
for classification errors. The original inequalities are now defined as: 
 
                
and the penalty function as: 
 
 
        
 






where   is the regularisation parameter, a positive real constant. The minimisation 
problem is now formulated as: 
         
 
 
         
 
   
 
Such that  
                        
             
 
In the case where no separation is possible in the original space, a kernel 
transformation can be applied that transforms the original input space into a high-
dimensional feature space (Figure 5.9). Each sample    is transformed into a point 
      in the new feature space and the new linear discriminating function can be then 
defined as: 
          
 
since the decision boundaries at the transformed feature space are again linear.  
 
 
Figure 5.9 With the kernel trick a non-linear separable classification can become linear separable 
in high-dimensional feature space.  
 
Some of the most common kernel functions used are the polynomial SVM (of degree  ) 
         and radial kernel (RBF)                      . 
 




SVM, that is the regularisation parameter  . In the case of more complex kernel 
functions more parameters must be tuned, usually by performing an exhaustive search 
of the parameter space and selection via cross-validation. A larger number of free 
parameters could turn, however, complex kernel methods more susceptible to over-
fitting.  
 
5.3.3.3. Model Validation 
The classification accuracy of SVMs was tested with linear, radial, polynomial and 
sigmoid kernels with default parameters (“e1071” package in R) (Dimitriadou et al., 
2005). SVM classifiers were trained for the Global set and for the chromosome-specific 
sets of Chromosome 8 and Chromosome 11. For the chromosome-specific classifiers, the 
differences in the number of input samples in both classes was accounted for by 
adjusting the weight parameters of the SVM proportional to the number of samples in 
each class. This is typically performed in the case of unbalanced classes. For the 
training of the SVM the three-way partitioning method has been chosen as described in 
the section 2.4.4. A subset of 187 samples and 37 samples was used for training and 
validation, respectively. After selection of the best scoring classifier, the training and 
validation subsets were merged in order to train the classifiers again and obtain the 
final accuracy score on a test dataset of 91 entirely independent samples (the 
remainder of the complete data collection). Samples from the same studies were kept 
together in the training, validation or test datasets in order to avoid classification bias 
as a result of very similar transcriptional profiles used both in training and in testing 
the prediction power of the classifier (see also section 2.4.5).   
 
In addition, in order to examine what is the minimum number of features required to 
achieve a low classification error and which genes are the most valuable for the 
creation of the prediction rule, the Recursive Feature Elimination algorithm for SVM 
(SVM-RFE) has been applied (Guyon et al., 2002; implementation in R provided by 
Ruifang and Visser (2010)). SVM-RFE performs feature selection by eliminating one 
feature at the time in an iterative manner. Features are ranked based on the w vector of 
the decision hyperplane (section 5.3.3.2) and the feature with the lowest ranking value 
is discarded. A small subset of the features can be then used to examine the 
classification performance. Guyon et al. (2002) implemented the algorithm for SVMs 




5.3.4. Predictive Power of the Classification Models 
 
Table 5.11 presents the classification performance of the different models described 
thus far. Remarkably, by reducing the number of genes used for training by applying 
the SVM-RFE algorithm, small subsets of candidate genes that demonstrate a high class 
prediction power have been identified. For the Global set, the top 50 genes are 
sufficient to predict abnormalities with a high accuracy (91%). In the case of 
chromosome-specific SVMs it was possible to narrow the selection down to the top 10 
ranked genes while still maintaining a high accuracy (over 80%). Interestingly, a 
selection of solely non-chromosome 8 mapped genes could still be used to train the 
classifier for chromosome 8 aberrations with an up to 71% accuracy, suggesting that 
there is a non-chromosome 8-specific program that is affected by the presence of the 
predicted transcriptional aberration on chromosome 8. It is also evident that for the 
Global set, where both methods have been applied, the SVM-RFE method outperforms 























Table 5.11 Performance of classifiers 
Classifier Set Kernel Feature Selection Accuracy F1 score 
PAM Global - None 0.82 0.88 
PAM Global - SAM All 0.87 0.90 
SVM Global Linear None 0.86 0.89 
SVM Global Linear SAM All 0.92 0.94 
SVM Global Linear  SVM-RFE Top 100 0.89 0.92 
SVM Global Linear SVM-RFE Top 50 0.91 0.94 
SVM Global Linear SVM-RFE Top 10 0.55 0.59 
SVM Chr8 Linear None 0.73 0.68 
SVM Chr8 Linear SAM All 0.80 0.78 
SVM Chr8 Linear SVM-RFE Top 50 0.81 0.78 
SVM Chr8 Linear SVM-RFE Top 10 0.80 0.79 
SVM Chr8 Linear SVM-RFE - No Chr8 0.71 0.63 
SVM Chr11 Linear None 0.73 0.29 
SVM Chr11 Linear SAM All 0.93 0.79 
SVM Chr11 Linear SVM-RFE Top 50 0.95 0.81 
SVM Chr11 Linear SVM-RFE Top 10 0.90 0.61 
Best performing classifiers from the PAM (Tibshirani et al., 2002) and SVM (Vapnik, 1998) 
classification (with bold we highlight the classifier trained with the top 50 features in each 
set). Feature selection was performed from the SAM (Tusher et al., 2001) output list by the 
Recursive Feature Elimination (RFE) algorithm (Guyon et al., 2002). In the SVM-RFE - No 






This chapter has investigated the transcriptional signatures linked to any chromosomal 
aneuploidy identified in this study as well as chromosome 8- and 11-specific 
aneuploidies. For the Global set, which includes samples with any chromosomal 
aberration, it has been shown that a secondary transcriptional effect, common to all 
samples, can be identified. This is a very important observation that paves the way for 
the identification and subsequent validation of the deregulated genes/pathways which 
may be contributing to the selective advantage conferred by aneuploidy. Similar 
signatures have been identified for samples that carry a chromosome 8 or 11 
aneuploidy.      
 
The comparison between normal and aberrant profiles has revealed a set of 
differentially expressed genes highly connected to pluripotency, cell cycle and 
apoptosis. It has been proposed before that culture adaptation can occur through 
multiple mechanisms, in particular via cell cycle progression and deregulation of the 
p53 pathway or activation of anti-apoptotic pathways (Harrison et al., 2009). 
Prominent delegates of these processes are present in the selected features (Lin28, 
Mras, Pramel7, Crxos1, Rex1, Lig4 and Zscan4 among others). In addition, it is 
interesting to note that in some aneuploid cells there is compensation for the adverse 
effects of higher DNA copy numbers by modulating pathways involved in balancing 
protein stoichiometry such as ribosome biogenesis and protein degradation (Torres et 
al., 2008). A similar effect is observed in the case of chromosome 8 clusters which 
demonstrate enrichment in the Gene Ontology (GO) categories related to RNA 
processing (Table 5.5).  
 
In this chapter, it has been also shown that it is in fact possible to use an unbiased pool 
of profiles from publicly available pluripotent samples, carrying complex or 
chromosome-specific aberrations, to train highly accurate classifiers using only a small 
set of diagnostic genes. Since genomic aberration are indeed quite often in pluripotent 
stem cell populations (chapter 4), the use of accurate classification models can provide 







6.1. General Discussion 
 
This thesis was focused on two main goals: (i) the development of computational 
methods that can be used for the analysis of transcriptional data with a main interest in 
the prediction of underlying aneuploidy and (ii) the application of these methods in 
large collections of data in an attempt to better understand the biological mechanisms 
linked to the presence of genomic changes in pluripotent stem cell populations.  
 
Each of the remaining sections of this chapter presents a recap of the methods 
developed and a summary of the results obtained from their application. More 
precisely, section 6.1.1 discusses the software application DI.S.C.O. that can be used for 
a single-experiment type of analysis. Section 6.1.2 is focused on the large-scale 
integrated analysis methodology and the findings resulting from its application in a 
large number of published pluripotent stem cell datasets. Finally, section 6.1.3 presents 
the analysis for the identification of the transcriptional signatures linked to aneuploidy 
and the development of classification models for their prediction in uncharacterised 




Chapter 3 presented DI.S.C.O., the software application that put the fundaments of this 
work. DI.S.C.O. is a stand-alone web-based application for the analysis of gene 
expression profiling data from microarray or RNA-seq technologies in the context of 
genomic position. DI.S.C.O. offers enhanced visualisation for the transcriptional view of 
the genome, coupled with three different computational methods for the identification 
of clusters of differentially expressed genes on the chromosomes. Genomic regions that 
show a positional enrichment in differentially expressed genes may be the direct 
consequence of underlying genomic abnormalities such as chromosomal gains or losses 
or even complex structural chromosomal aberrations. Gene clusters with concordantly 




methylation or histone modifications or the intrinsic structural organisation of the 
genome (such as the clustering of housekeeping genes (Lercher et al., 2002)). 
 
Several tools exist to date that can perform this type of analysis (a detailed 
presentation has been given in Table 3.1). These tools demonstrate different limitations 
that can restrict their usability for the non-expert user. Such potential limiting factors 
are the need for previous familiarisation with specific statistical or programming 
packages, the complexity of the model and the number of user-adjusted parameters, the 
type of organism/platform/technology that the method can process and the 
effectiveness and the resolution of the method to identify significant patterns. DI.S.C.O. 
addressed these limitations by providing a powerful and user-friendly analysis 
platform that accepts gene expression profiling data of any type of organism (as long as 
there is a genome annotation available) supporting all major microarray technologies 
and RNA-seq. There is no prerequisite programming knowledge required from the user 
in order to run a data analysis with DI.S.C.O. In addition, great care has been taken so all 
the major functionality of the software can be run in an automated way with no 
additional configuration by the user (or semi-automated when it cannot be avoided). 
This includes automated discovery of the appropriate FC cut-offs for over- and under-
expressed genes and initialisation of the computational methods with default 
parameters. The computational methods are based on different fundamental principles 
and they require different number of user-tuned parameters. In Chapter 3, the 
prediction power of the methods and the effect of the required parameters have been 
presented through extensive validation with artificial and biological data. It has been 
shown that the PGE method is the most appropriate for the automated analysis pipeline 
since it can effectively identify most patterns in biological datasets with the default 
parameters and the automatically defined FC thresholds. The NN method gives a good 
alternative although the gap parameter of the method might be dataset specific. The TV 
method poses the greatest challenge for the user and requires a previous knowledge of 
the type of pattern that the user seeks to discover in order to optimise the tuning of the 
method’s parameters. Nonetheless, the combination of the Multi-Level Otsu 
thresholding and the PGE methods can identify subtle patterns in the dataset with no 
additional configuration from the user.  
 
It could be suggested that the use of the fold change approach for the identification of 




popular metric, mostly because of its simplicity and straight-forward interpretability, it 
has been often criticised as an inadequate test static primarily since (i) it does not take 
into account the variance of the expression measurements of a gene across the samples 
and (ii) it does not offer any p-value for the confidence of an observation (Allison et al., 
2006). The choice of FC as the test statistic of use in DI.S.C.O. was, however, a conscious 
choice. DI.S.C.O. is not focused on the identification of differentially expressed genes per 
se (there is a wealth of available tools and methods for this purpose) but rather on the 
identification of concordant changes at the expression levels of genomic regions. For 
this reason it was desirable to choose a metric that can be easily adjusted by the use of 
different thresholds so as to facilitate both the visualisation and the computational 
discovery of the patterns. As it has been applied in the dendrogram-based enrichment 
analysis for sample-to-sample comparisons, this metric should be also effective in the 
absence of replicates (which renders metrics that are based on the population standard 
deviation, such as t-test and SAM, inappropriate). In addition, in the case of positional 
enrichment, the mere existence of successive genes on the chromosome that share 
similar changes in their expression levels gives a measure of confidence for the 
observed pattern and renders the use of a more sophisticated test statistic 
unnecessary. Finally, by offering the possibility of Absent flags removal, the user can 
choose to remove transcripts at the lower end of expression which are more likely to 
produce false positives due to technical noise.  
 
To conclude, the development of DI.S.C.O. was greatly motivated by the observation 
that a very limited number of publications, specifically in the field of stem cell biology, 
perform positional enrichment analysis in the context of gene expression data. In fact, 
at the onset of this project (2008) there was only a single publication that performed a 
similar type of analysis in human ESCs (Enver et al., 2005) and there are only two 
additional publications (Mayshar et al., 2010; Ben-David et al., 2011) at present and no 
relevant publication in mouse ESCs. Given the frequent occurrences of genomic 
aberrations in pluripotent stem cells (as discussed in section 2.2) and the broad 
popularity of the gene expression microarray analysis approach, it is essential to 
provide the scientific community with tools that can be easily, effectively and 
inexpensively used to perform a first-level validation of the genomic integrity of 






6.1.2. Large-scale integrated search of mESCs and miPSCs datasets 
 
In Chapter 4, some of the fundamental tools developed in DI.S.C.O., that is the PGE and 
the Multi-Level Otsu thresholding methods, were integrated in a framework for the 
analysis of a large-collection (largest to date) of 481 published mouse pluripotent stem 
cell samples from the Affymetrix GeneChip Mouse Genome 430 2.0 Array.  The 
dendrogram-based positional enrichment methodology (described in section 4.4) is a 
fully automated analysis pipeline that takes into consideration the specific 
characteristics of each sample (or cluster of samples) in terms of expression values 
distribution and compares it in an iterative way with the most similar sample (or 
cluster of samples) in the matrix. In this way it is possible to reveal transcriptionally 
aberrant intervals that could potentially otherwise pass unnoticed because of great 
differences in the transcriptional profiles of distant cell populations or by comparing to 
a global averaged profile (as in the case of the work by Mayshar and colleagues (2010)). 
In the proposed approach, both the FC values thresholds and the normalisation scheme 
is defined automatically after examination of the intrinsic properties of each dataset. In 
addition, the data matrix is globally normalised using RMA in order to assure that the 
distribution of gene expression measurements is comparable between samples, Absent 
flags are removed in order to stabilise the data from noisy variations at the low level of 
the expression range and each gene is represented by a single value after replacement 
of replicate probe sets with their median value so as to remove bias in genomic loci 
where multiple probe sets of the same gene map.  
 
Although it could have been possible to average replicate samples in an attempt to 
reduce potential biases in recurring aberrations present in the same cell line, it was 
chosen not to, mainly for three reasons:  
 
(i) replicate samples from the same cell lines may reflect different degrees of 
heterogeneity in the cell population, i.e. different percentages of aneuploid and diploid 
cells in the sample.  
(ii) greater number of data confers higher predictive ability, and finally, 
(iii) by retaining individual replicates it is possible to identify patterns that are present 
in multiple instances of the same cell line and infer the type and frequency of 




cell line where all examined instances carry a complex chromosome 14/17 pattern 
hinting towards an early event that has been propagated in subsequent subclones (also 
see section 4.7).  
  
The dendrogram-based positional enrichment analysis has been applied in an initial 
collection of 481 samples from mouse pluripotent stem cell studies and has revealed a 
catalogue of aberrant intervals. Samples which demonstrate low expression of the 
pluripotency markers Oct4, Sox2 and Nanog were further filtered out from the dataset 
(referred to as Nanog-low samples). Samples with low expression of pluripotency 
markers are more likely to consist of highly heterogeneous cell populations of 
differentiating or partially reprogrammed cells and pluripotent cells. As it has been 
shown in chapter 4, the percentage of predicted aneuploidy in these samples is much 
lower than in the Nanog-high subgroup which may reflect a decreased ability of the 
method to identify patterns of aneuploidy in heterogeneous cell populations. It could 
also reflect that aneuploid cells are prone to undergo apoptosis upon differentiation 
(Tichy, 2011). The subsequent analysis was focused on the Nanog-high subgroup and 
particularly in samples that carry whole or large partial chromosome spanning 
aberrant intervals which can be diagnostic of underlying aneuploidies. From the 315 
pluripotent samples selected for high Nanog expression, 56.83% carry large-scale 
aberrant transcriptional intervals. This surprising percentage stresses the need for 
rigorous and continuous validation of mouse pluripotent stem cell lines that can be 
initially achieved at the transcriptional level with tools such as DI.S.C.O.  
 
The majority of the predicted aberrant genomic intervals mapped primarily to 
chromosomes 8 and 11 (70% of the samples carried an aberration in either one or both 
of these chromosomes). In addition, high frequencies of aberrant intervals were 
discovered in chromosomes 6, 14 and X. These results are consistent with the findings 
of several previously published cytogenetic studies in mESCs (Liu et al., 1997; 
Sugawara et al., 2006; Guo et al., 2005) indicating that the transcriptionally aberrant 
intervals are indeed most probably the result of aneuploidy rather than transcriptional 
or epigenetic regulation. In addition, complex patterns of recurring simultaneously 
aberrant chromosomes were unveiled including the pairs of chromosomes 8 and 11, 6 
and 11, 8 and 14 and 14 and 17. It is not clear if genomic changes in the above pairs act 
synergistically by activating members of the same pathways or independently by 




in the cell population through advantageous selection. The hypothesis that these paired 
patterns actually represent structural subchromosomal changes (especially in the case 
of the chromosome 14/17 aberration that has been extensively discussed in section 
4.7) cannot be excluded. For the chromosome 14/17 combined pattern, it has been 
demonstrated that the identification of the minimal overlapping genomic region which 
appears aberrant in many samples can reveal potential candidate genes that may be 
driving the selection. As such, one of the affected genes in the chromosome 14 distal 
duplication was Klf5 that has been shown to play an important role in maintenance of 
ESC self-renewal (Parisi et al., 2008) and Pkdcc, a novel protein kinase found to be 
induced upon differentiation of mouse embryonic stem cells to mesendoderm 
(Kinoshita et al., 2009), was identified in the chromosome 17 deletion. Genes, which 
play a role in the maintenance or enhancement of self-renewal and the induction of 
differentiation, represent prime candidates that can be linked to the selective 
advantage conferred by their respective duplication or deletion. Unfortunately, for the 
most frequent aberrations involving chromosomes 8 and 11 such an analysis could not 
be performed since in the majority of the samples the aberrant pattern spanned the 
whole chromosome and most likely represented trisomy 8 and/or 11 as it has been 
also previously reported (Liu et al., 1997; Sugawara et al., 2006). 
 
Furthermore, Sugawara et al. (2006) and Eggan et al. (2002) have found that frequent 
aberrations also occur in the sex chromosomes. In the case of chromosome X, 25 
samples (8% of samples) carried a large-scale aberration on chromosome X. It is not 
clear, however, if these patterns represent different degrees of X chromosome 
inactivation rather than underlying genomic changes. Of note, 70% of the ESC cell lines 
of this study for which annotation was available were sexed as male. The sex of the iPSC 
lines is not however often reported. It is believed that the activation of both X 
chromosomes in female pluripotent cells is closely linked with the establishment of the 
naïve state of pluripotency (Kim et al., 2011). It is therefore possible that a percentage 
of the aberrant patterns identified on chromosome X are the result of comparisons 
between male and female lines with two active chromosomes. An attempt was made to 
identify instances of chromosome Y deletions or gains by examining the expression of 
four Y-linked genes that are expressed in mESCs and miPSCs. In this case, it has not 
been possible to conclude whether the observed up- or down-regulation of these genes 
in a number of samples could reasonably be linked to a transcriptional regulation event 




clarify the frequency and role of sex chromosomes related genomic changes.   
 
To conclude, this analysis shows that a surprising 56.83% of the 315 high Nanog 
expressing samples carry large-scale aberrant transcriptional intervals. The recent 
study of Mayshar and colleagues (2010) has attributed the high occurrence of trisomy 
12 in hESCs to the Nanog-Gdf3 presence in the amplified chromosome. Although, over-
expression of Nanog confers enhanced self-renewal (Chambers et al., 2003) and this 
effect cannot be excluded, in the examined data of this study the great number of Nanog 
over-expressing aberrant samples, irrespectively of specific chromosome change, hints 
towards a different conclusion. In fact, it is possible that a single random event that 
promotes cell growth and/ or blocks differentiation or apoptosis, occurring in a 
pluripotent cell in culture leads to a rapid domination of the entire cell population. The 
resulting culture is more homogeneous in pluripotent, albeit aberrant, cells and thus 
confers both signatures (Figure 6.1). 
 
 
Figure 6.1 A schematic model of the overtaking of the cell population in culture by the Nanog over-








6.1.3. Transcriptional signatures of aneuploidy and classification of 
aneuploid samples 
 
In chapter 6, the transcriptional profiles of aberrant and normal samples were 
compared in order to identify genes whose deregulation could be linked to the selective 
advantage conferred by aneuploidy. This comparison was effective mainly because 
samples with low expression of pluripotency markers have been filtered out. Given the 
higher percentages of aneuploid samples in the Nanog-high subgroup versus the 
Nanog-low subgroup, using the initial 481 samples dataset for this comparison would 
only reveal a high enrichment of the pluripotency signature in the aberrant samples 
and a differentiation signature in the normal samples. This finding might initially seem 
intriguing, it is however the result of the difference in percentages of aneuploid 
samples between the two subgroups.     
 
The comparison between all normal versus all aberrant samples has revealed a number 
of putative candidates involved in pluripotency, cell cycle control and apoptosis. Among 
them, Lin28, Mras, Pramel7, Crxos1, Rex1, Lig4 and Zscan4 are prominent candidates. 
The functions of these genes are consistent with those that would be expected to drive 
selection under a competitive culture environment. Moreover, normal samples show a 
significant enrichment in processes involved in organ morphogenesis and embryonic 
development (as shown by GO biological process analysis), further supporting the shift 
towards self-renewal at the expense of differentiation in aberrant samples (as it has 
been also suggested by Enver et al. (2005)). Differential expression analysis was also 
performed for the case of the frequent chromosome 8 and 11 abnormalities. In the case 
of chromosome 8, an interesting candidate region has been identified at the 8qA2 
amplicon, containing the Bag4, Lsm1 and Fnta genes that have been described as breast 
cancer oncogenes in human (Yang et al., 2006; Chin et al., 2006).  
 
In chapter 6, it has been also shown that it is in fact possible to use an unbiased pool of 
profiles from publicly available pluripotent samples, carrying complex or chromosome-
specific aberrations, to train highly accurate classifiers using only a small set of 
diagnostic genes. In addition, it is shown for the first time that many different predicted 
aneuploidies in pluripotent cells are associated with a common transcriptional 




of an aneuploidy-related transcriptional signature in pluripotent stem cells can be used 
for the identification of core pathways that can be subsequently targeted to develop 
aneuploidy anti-selective culture conditions. Such an approach has been effectively 
applied in trisomic MEFs and human cancer cell lines with compounds that are anti-
selective for karyotypically abnormal cells (Tang et al., 2011). Finally, these findings 
pave the way towards the creation of low-cost assays for the validation of ESCs and 
iPSCs, a tool much needed given the high percentages of predicted aberrant samples in 
public data sets. 
 
6.2. Open Questions and Future Directions 
 
During the completion of this thesis, a primary goal was to move from a purely 
descriptive approach of the genomic integrity of pluripotent cells to an attempt to 
understand the biological mechanisms involved in the selective growth advantage of 
recurring abnormalities. The majority of published studies thus far mostly catalogue 
the observed abnormal karyotypes and can only hypothesise about the event(s) that 
contributed and promoted their presence. Here, a comprehensive list is provided of 
candidate genes whose deregulation is linked to specific types of aneuploidy and, most 
importantly, for any type of aneuploidy. The discovered global signature of aneuploidy, 
which can be also used to predict aberrations in novel uncharacterised samples, hints 
towards a common secondary effect(s) present in all cells that undergo culture 
adaptation. Further analysis of the putative candidates is required that can be only 
performed using specialised wet lab techniques.   
 
In addition, it would be desirable to also apply the dendrogram-based positional 
enrichment methodology to a large-collection of human pluripotent stem cells. For 
example, the frequently aberrant human chromosome 17 shares orthology with a 
single mouse chromosome, the frequently aberrant chromosome 11 (specifically the 
distal part of mouse chromosome 11) (DeBry and Seldin, 1996). Furthermore, the 
cluster of predictive genes on the mouse 8qA2 amplicon is syntenic to a cluster of 
breast cancer oncogenes at the 8p11-p12 recurrent amplicon in human. Therefore, a 
comparative analysis between human and mouse pluripotent cell lines and their 
observed patterns of aneuploidy could aid narrow down the list of implicated genes by 




Moreover, it has been shown here that classification models can predict the presence of 
aneuploidy with over 90% accuracy. However, mainly due to time limitations, an 
exhaustive search in the parameter space has not been performed. Such a search could 
identify the optimal set of parameters for different SVM classifiers and it is not unlikely 
that it could even increase the prediction power of the models.  
 
Finally, it would be interesting to move from a 2D view of the genome towards a three 
dimensional representation of the transcription on the chromosomes. This approach 
could possibly reveal a whole new level of interactions between chromosome domains 
and chromosome territories. The study of the 3D spatial organisation of the 
chromosomes in the nucleus may shed additional light to our understanding of gene 
regulation and genomic stability (Meaburn and Misteli, 2007).   
 
6.3. Final Conclusions  
 
To sum up, this study: 
 
i) Has provided a software application that can be used to identify clusters of 
differentially expressed genes on the chromosomes providing a powerful tool for the 
validation of the genomic integrity of cells at the transcriptional level, 
 
ii) Has proposed an effective methodology for the analysis of the genomic integrity of 
large-collections of samples and the identification of recurring patterns of aneuploidy. 
The developed screening method can identify even small aneuploidies in mouse ES and 
iPS cells, using only existing genome-wide expression data,  
 
iii) Has found that a majority (56.83%) of ES cell lines used for global expression 
studies are predicted to carry aneuploidies.  These anomalies are likely to have led to 
systematic errors in the interpretation of expression data from many laboratories,  
 
iv) Has identified a global signature of aneuploidy, diagnosed by a small gene set, and 
built classification models which will allow detection of samples of any type of 




70% of the identified aneuploidies in ES and iPS cell lines), opening the way for a more 
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In the interest of brevity, the supplemental material is provided in the attached CD. The 
inventory of supplemental files is as following: 
 
1) The DI.S.C.O. application jar executable file,  
2) The DI.S.C.O. application user manual, 
3) Example dataset to run DI.S.C.O. The dataset includes: 
 i) The Affymetrix GeneChip Mouse Genome 430 2.0 Array genome annotation, 
 ii) RMA normalised gene expression values from the study of Kim et al. (2008) 
with GEO assession number GSE10806, 
 iii) MAS5.0 calculated P/A flags for the GSE10806 dataset, 
 iv) Mouse genome cytoband file, 
 v) The normalisation scheme file for the GSE10806 dataset. 
4) Tables:  
Table S1: Detailed list of the mouse ESC and iPSC lines used in the present analysis 
with available annotation for each sample. 
Table S2: List of identified chromosomal clusters of differentially expressed genes 
from the dendrogram-based PGE analysis. Information about the samples included in 
every comparison is also provided.  
Table S3: List of differentially expressed genes identified by SAM analysis when 
comparing every sample with a chromosome 8-specific large-scale aberrations against 
every other sample. 
Table S4: List of differentially expressed genes identified by SAM analysis when 
comparing every sample with a chromosome 11-specific large-scale aberrations against 
every other sample. 
Table S5: List of differentially expressed genes identified by SAM analysis when 
comparing every sample with any type of large-scale aberration against every normal 
sample. 
 
